<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="research-article" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">PLoS One</journal-id><journal-id journal-id-type="iso-abbrev">PLoS One</journal-id><journal-id journal-id-type="pmc-domain-id">440</journal-id><journal-id journal-id-type="pmc-domain">plosone</journal-id><journal-id journal-id-type="publisher-id">pone</journal-id><journal-title-group><journal-title>PLOS One</journal-title></journal-title-group><issn pub-type="epub">1932-6203</issn><publisher><publisher-name>PLOS</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC11984981</article-id><article-id pub-id-type="pmcid-ver">PMC11984981.1</article-id><article-id pub-id-type="pmcaid">11984981</article-id><article-id pub-id-type="pmcaiid">11984981</article-id><article-id pub-id-type="pmid">40209154</article-id><article-id pub-id-type="doi">10.1371/journal.pone.0318549</article-id><article-id pub-id-type="publisher-id">PONE-D-24-44640</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Vascular Medicine</subject><subj-group><subject>Blood Pressure</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Pharmaceutics</subject><subj-group><subject>Drug Therapy</subject><subj-group><subject>Cardiovascular Therapy</subject><subj-group><subject>Antihypertensive Drug Therapy</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Chronobiology</subject><subj-group><subject>Circadian Rhythms</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Vascular Medicine</subject><subj-group><subject>Blood Pressure</subject><subj-group><subject>Hypertension</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Anatomy</subject><subj-group><subject>Body Fluids</subject><subj-group><subject>Blood</subject><subj-group><subject>Blood Plasma</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Anatomy</subject><subj-group><subject>Body Fluids</subject><subj-group><subject>Blood</subject><subj-group><subject>Blood Plasma</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Physiology</subject><subj-group><subject>Body Fluids</subject><subj-group><subject>Blood</subject><subj-group><subject>Blood Plasma</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Research and Analysis Methods</subject><subj-group><subject>Simulation and Modeling</subject></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Physiology</subject><subj-group><subject>Physiological Parameters</subject><subj-group><subject>Body Weight</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Research and Analysis Methods</subject><subj-group><subject>Mathematical and Statistical Techniques</subject><subj-group><subject>Statistical Methods</subject><subj-group><subject>Forecasting</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Physical Sciences</subject><subj-group><subject>Mathematics</subject><subj-group><subject>Statistics</subject><subj-group><subject>Statistical Methods</subject><subj-group><subject>Forecasting</subject></subj-group></subj-group></subj-group></subj-group></subj-group></article-categories><title-group><article-title>A simulation-based framework for modeling and prediction of personalized blood pressure trajectories in hypertensive patients after antihypertensive treatment</article-title><alt-title alt-title-type="running-head">Framework for modeling and prediction blood pressure trajectories in hypertensive patients after treatment</alt-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0009-0008-6362-2321</contrib-id><name name-style="western"><surname>Hunsdieck</surname><given-names initials="B">Berit</given-names></name><role content-type="http://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role><role content-type="http://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role><role content-type="http://credit.niso.org/contributor-roles/methodology/">Methodology</role><role content-type="http://credit.niso.org/contributor-roles/software/">Software</role><role content-type="http://credit.niso.org/contributor-roles/visualization/">Visualization</role><role content-type="http://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#8211; original draft</role><xref rid="aff001" ref-type="aff">
<sup>1</sup>
</xref><xref rid="aff002" ref-type="aff">
<sup>2</sup>
</xref><xref rid="cor001" ref-type="corresp">*</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Mielke</surname><given-names initials="J">Johanna</given-names></name><role content-type="http://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role><role content-type="http://credit.niso.org/contributor-roles/methodology/">Methodology</role><role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#8211; review &amp; editing</role><xref rid="aff001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name name-style="western"><surname>Ickstadt</surname><given-names initials="K">Katja</given-names></name><role content-type="http://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role><role content-type="http://credit.niso.org/contributor-roles/supervision/">Supervision</role><role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#8211; review &amp; editing</role><xref rid="aff002" ref-type="aff">
<sup>2</sup>
</xref><xref rid="aff003" ref-type="aff">
<sup>3</sup>
</xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name name-style="western"><surname>El&#231;i</surname><given-names initials="E">Eren</given-names></name><role content-type="http://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role><role content-type="http://credit.niso.org/contributor-roles/methodology/">Methodology</role><role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#8211; review &amp; editing</role><xref rid="aff001" ref-type="aff">
<sup>1</sup>
</xref></contrib></contrib-group><aff id="aff001"><label>1</label>
<addr-line>Bayer AG, Research &amp; Early Development, Division Pharmaceuticals, Wuppertal, Germany</addr-line></aff><aff id="aff002"><label>2</label>
<addr-line>Department of Statistics, TU Dortmund University, Dortmund, Germany</addr-line></aff><aff id="aff003"><label>3</label>
<addr-line>Lamarr-Institute for Machine Learning and Artificial Intelligence, Dortmund, Germany</addr-line></aff><contrib-group><contrib contrib-type="editor"><name name-style="western"><surname>Vashistha</surname><given-names initials="VK">Vinod Kumar</given-names></name><role>Editor</role><xref rid="edit1" ref-type="aff"/></contrib></contrib-group><aff id="edit1">
<addr-line>University of Lucknow, INDIA</addr-line>
</aff><author-notes><fn fn-type="COI-statement" id="coi001"><p><bold>Competing Interests: </bold>The authors have declared that no competing interests exist.</p></fn><corresp id="cor001">* E-mail: <email>berit.hunsdieck@bayer.com</email></corresp></author-notes><pub-date pub-type="epub"><day>10</day><month>4</month><year>2025</year></pub-date><pub-date pub-type="collection"><year>2025</year></pub-date><volume>20</volume><issue>4</issue><issue-id pub-id-type="pmc-issue-id">485745</issue-id><elocation-id>e0318549</elocation-id><history><date date-type="received"><day>7</day><month>10</month><year>2024</year></date><date date-type="accepted"><day>17</day><month>1</month><year>2025</year></date></history><pub-history><event event-type="pmc-release"><date><day>10</day><month>04</month><year>2025</year></date></event><event event-type="pmc-live"><date><day>10</day><month>04</month><year>2025</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2025-04-11 16:25:14.540"><day>11</day><month>04</month><year>2025</year></date></event></pub-history><permissions><copyright-statement>&#169; 2025 Hunsdieck et al</copyright-statement><copyright-year>2025</copyright-year><copyright-holder>Hunsdieck et al</copyright-holder><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open access article distributed under the terms of the <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="pone.0318549.pdf"/><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pdf" xlink:href="pone.0318549.pdf"/><related-article xmlns:xlink="http://www.w3.org/1999/xlink" related-article-type="editor-report" xml:lang="en" ext-link-type="doi" xlink:href="10.1371/journal.pone.0318549"><pub-id pub-id-type="doi">10.1371/journal.pone.0318549</pub-id></related-article><related-article xmlns:xlink="http://www.w3.org/1999/xlink" related-article-type="reviewed-article" xml:lang="en" ext-link-type="doi" xlink:href="10.1371/journal.pone.0318549"><pub-id pub-id-type="doi">10.1371/journal.pone.0318549</pub-id></related-article><abstract><p>Hypertension, a leading global cause of death, poses challenges in stabilizing blood pressure within target values despite various therapeutic options, often necessitating multiple therapy adjustments and delayed impact assessments. Recently, the first wrist-based wearable blood pressure measurement devices were introduced which allow for a continuous assessment of blood pressure trajectories. This enables the development of statistical methodology for prediction of saturated steady-state of blood pressure under treatment&#8212;and thus allowing physicians to adjust the therapy earlier. As a prerequisite for the evaluation of such models and algorithms, it is necessary to simulate reliable and realistic hypothetical patient trajectories under treatment with antihypertensive medication. In this paper, we propose a simulation framework for blood pressure profiles through Pharmacokinetic-Pharmacodynamic modeling, which incorporates individual daily rhythms, patient characteristics, and medication effects. We also propose and evaluate two models for steady-state prediction under antihypertensive therapy, a Gaussian process and a non-linear mixed effect model. When only one day of measurements is available, the Gaussian process is preferred, but in real-world situations with more data, the non-linear mixed effect model is favored. It effectively reduces RMSE and bias in noisy data, outperforming the Gaussian process regardless of sample size.</p></abstract><funding-group><funding-statement>The author(s) received no specific funding for this work.</funding-statement></funding-group><counts><fig-count count="8"/><table-count count="1"/><page-count count="20"/></counts><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta id="data-availability"><meta-name>Data Availability</meta-name><meta-value>The underlying data used for further simulations is available via the UK biobank (see <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.ukbiobank.ac.uk/" ext-link-type="uri">https://www.ukbiobank.ac.uk/</ext-link>) under Application #28807. The data yielding to the results presented in figure 4 (fig4.tif) are available via <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.kaggle.com/datasets/berithu/logitudinal-blood-pressure" ext-link-type="uri">https://www.kaggle.com/datasets/berithu/logitudinal-blood-pressure</ext-link>.</meta-value></custom-meta></custom-meta-group></article-meta><notes><title>Data Availability</title><p>The underlying data used for further simulations is available via the UK biobank (see <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.ukbiobank.ac.uk/" ext-link-type="uri">https://www.ukbiobank.ac.uk/</ext-link>) under Application #28807. The data yielding to the results presented in figure 4 (fig4.tif) are available via <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.kaggle.com/datasets/berithu/logitudinal-blood-pressure" ext-link-type="uri">https://www.kaggle.com/datasets/berithu/logitudinal-blood-pressure</ext-link>.</p></notes></front><body><sec sec-type="intro" id="sec001"><title>Introduction</title><p>Hypertension is one of the leading causes of death worldwide. While there exist multiple therapeutic options, stabilization the blood pressure under recommended target values is challenging and often requires multiple adaptions of therapy. Traditionally, antihypertensive medicine is prescribed, and the impact of the therapy is only rechecked weeks after treatment initiation. Globally, the number of hypertensive patients requiring anti-hypertensive medication increased from 594 million in 1975 to 1.3 billion in 2019, mainly in low- and middle-income countries (relative to growth in population) [<xref rid="pone.0318549.ref001" ref-type="bibr">1</xref>]. Starting at a blood pressure of 115/75 mmHg, the risk of death from a heart attack or stroke at ages 35 to 69 years doubles with every 20-point increase in systolic blood pressure, making it the leading cause of death [<xref rid="pone.0318549.ref002" ref-type="bibr">2</xref>]. High blood pressure accounts for nearly 10% of global health concerns [<xref rid="pone.0318549.ref003" ref-type="bibr">3</xref>]. According to the current state of the art, the efficacy of the anti-hypertensive drug is not checked in the doctor&#8217;s office until a minimum of four weeks after it is taken for the first time. However, if the patient responds to the drug, an effect can be seen already after a few days [<xref rid="pone.0318549.ref004" ref-type="bibr">4</xref>]. Thus, an incorrect medication is identified only after weeks, although it could already be determined after a few days, whether the corresponding drug responds or not [<xref rid="pone.0318549.ref004" ref-type="bibr">4</xref>].</p><p>With the introduction of continuous blood pressure monitoring devices, early identification of ineffective medication becomes possible as this allows the physicians to continuously monitor (remotly) the impact of the therapy on blood pressure measurements. Physicians would be able to stop and adjust therapy early when it becomes clear that it is not leading to a steady-state blood pressure level (i.e., the state in which no additional change in blood pressure occurs as a result of further consistent administration) below the recommended targets. Current cu&#64260;ess devices on the market are for example a chest patch developed by BioBeat Technologies [<xref rid="pone.0318549.ref005" ref-type="bibr">5</xref>], a wrist-wearable device developed by Aktiia [<xref rid="pone.0318549.ref006" ref-type="bibr">6</xref>], and a CAR-T ring developed by Skylabs [<xref rid="pone.0318549.ref007" ref-type="bibr">7</xref>]. We hypothesise that by making use of longitudinal data and statistical prediction models, sub-optimal blood pressure therapy can be detected even earlier by forecasting the expected saturated steady-state level of blood pressure as early as possible. This may help to identify patients with unsuccessful therapy even earlier. Although none of these devices were accurately measuring blood pressure, they highlighted the need of re-evaluating the current practice of relying on a single blood pressure measurement in clinical settings [<xref rid="pone.0318549.ref008" ref-type="bibr">8</xref>]. Due to the novelty of wrist-based 24-hour blood pressure monitoring, there neither exists large data bases with relevant patient trajectories under recently initated blood pressure treatment nor simulation frameworks for generating artificial data. Therefore, for developing of forecasting methodology it is crucial to simulate realistic patient trajectories. In this paper, we propose such a simulation framework based on Pharmacokinetic-Pharmacodynamic (PKPD) modeling, which incorporates individual daily rhythms, patient characteristics, and medication effects. In order to integrate realistic patient covariate pattern, we integrate patient data from the UK Biobank [<xref rid="pone.0318549.ref009" ref-type="bibr">9</xref>]. Based on the simulated data, we develop two approaches to predict the steady state of a patient&#8217;s blood pressure as early as possible. Our approach is, to the best of our knowledge, the first of its kind with a focus on antihypertensive therapy. Previous approaches aimed to forecast the blood pressure-lowering effect of antihypertensive medication on population level by identification of risk factors for unsuccessful drug titration for antihypertensive therapy. However, while these results are relevant for the overall population, none of them exhibits sufficient flexibility to ensure individual patient-dependent modeling. [<xref rid="pone.0318549.ref010" ref-type="bibr">10</xref>] introduced an initial approach to individual modeling based on general pharmacokinetic modeling. However, in this model the trajectory is predetermined by a fixed parametric form, rendering it less flexible. We optimize and tailor this approach to model patient trajectories under anti-hypertensive therapy. In addition, we explore Gaussian Processes (GP) which offer even more flexibility. The models are compared in a simulation study. Based on simulated data incorporating the circadian rhythm, PKPD effects and measurements errors, the different models are evaluated. When only a single day of measurements is available, the Gaussian process is the preferred choice; however, in real-world scenarios with more data, the non-linear mixed effect model is preferred. It significantly lowers RMSE and bias in noisy data, surpassing the performance of the Gaussian process regardless of sample size. Integrating the algorithm into wearable devices presents an innovative way to monitor medication adherence in hypertensive patients. It can predict the likelihood of achieving blood pressure reduction goals within the next day, allowing for timely adjustments to dosage and medication if necessary.</p></sec><sec id="sec002"><title>A simulation-based framework for patient trajectories under antihypertensive therapy</title><p>The proposed framework aims to generate realistic patient data from continuous blood pressure devices under antihypertensive medication, i.e. a trajectory of the change of blood pressure values. We build our model on the following components:</p><list list-type="order"><list-item><p>Medication effect: The modeling of the medication effect is the core of our model; we use a PKPD model to ensure that the simulated data is realistic</p></list-item><list-item><p>Circadian rhythm: Since blood pressure varies during the day, we include the daily rhythm in the model.</p></list-item><list-item><p>Inclusion of uncertainty: Since in reality trajectories contain measurement errors, it is important to include within-day as well as day-to-day variability.</p></list-item><list-item><p>Realistic covariate patterns: We leverage UK Biobank data for getting realistic distribution of relevant covariates (e.g., age, sex) in the relevant patient population (hypertensive patient without pre-treatment)&#8212;it is known that these covariates influence the treatment effect and baseline blood pressure values.</p></list-item></list><p><xref rid="pone.0318549.g001" ref-type="fig">Fig 1</xref> provides an example of the individual components for one subject, illustrating the simulated effects on diastolic blood pressure, taking into account medication effects (a), circadian rhythms (b), and within-day variability. As different medication groups may yield to distinct patterns, the simulation will cover a large amount of variation, allowing for the prediction of diverse patterns independent of the underlying medication group. In the following, we will describe in detail the underlying mechanisms of this figure.</p><fig position="float" id="pone.0318549.g001" orientation="portrait"><object-id pub-id-type="doi">10.1371/journal.pone.0318549.g001</object-id><label>Fig 1</label><caption><title>Example: Simulated trajectory of diastolic blood pressure for a hypothetical patient over a four-day period.</title><p>(a) demonstrates the medication effect as predicted by a pharmacokinetic-pharmacodynamic (PKPD) model. (b) depicts the circadian rhythm&#8217;s impact across the duration. (c) presents a combined view, with the circadian and medication effects overlaid in red, alongside the original data adjusted for within-day variability depicted in black.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="pone.0318549.g001.jpg"/></fig><sec id="sec003"><title>PKPD medication effect</title><p>The PKPD modeling of the medication effect is the core of our framework. For each simulated patient, it is assumed that no medication is taken within the baseline period of two days (e.g. <inline-formula id="pone.0318549.e001"><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0318549.e001g" position="anchor" orientation="portrait" xlink:href="pone.0318549.e001.jpg"/><mml:math id="m1" display="inline" overflow="scroll"><mml:msub><mml:mrow><mml:mi>t</mml:mi></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mi>a</mml:mi><mml:mi>y</mml:mi></mml:mrow></mml:msub><mml:mo stretchy="false">&#8712;</mml:mo><mml:mo stretchy="false">{</mml:mo><mml:mo stretchy="false">&#8722;</mml:mo><mml:mn>2</mml:mn><mml:mo stretchy="false">,</mml:mo><mml:mo stretchy="false">&#8722;</mml:mo><mml:mn>1</mml:mn><mml:mo stretchy="false">}</mml:mo></mml:math></alternatives></inline-formula>). The medication phase begins on day 0 (<inline-formula id="pone.0318549.e002"><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0318549.e002g" position="anchor" orientation="portrait" xlink:href="pone.0318549.e002.jpg"/><mml:math id="m2" display="inline" overflow="scroll"><mml:msub><mml:mrow><mml:mi>t</mml:mi></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mi>a</mml:mi><mml:mi>y</mml:mi></mml:mrow></mml:msub><mml:mo stretchy="false">=</mml:mo><mml:mn>0</mml:mn></mml:math></alternatives></inline-formula>), with the medication being administered every morning at 8 a.m. from this point on. The corresponding timeline is illustrated in <xref rid="pone.0318549.g002" ref-type="fig">Fig 2</xref>.</p><fig position="float" id="pone.0318549.g002" orientation="portrait"><object-id pub-id-type="doi">10.1371/journal.pone.0318549.g002</object-id><label>Fig 2</label><caption><title>Timeline of simulated drug administration.</title></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="pone.0318549.g002.jpg"/></fig><p>The modeling of the medication effect is done by modeling the concentration-effect relationship. In pharmacology, this can usually be achieved by different PKPD modeling approaches. In a PKPD approach, the plasma concentration of the drug as a function of dose has to be modeled first by using a pharmacokinetic model. Given this time-dependent concentration, the effect can be modeled as a function of plasma concentration using a pharmacodynamic model. This scheme is illustrated in the Appendix, <xref rid="pcbi.0318549.s002" ref-type="supplementary-material">S1 Fig</xref>. In the following, we first describe the PK model and afterwards the PD model.</p><p>
<bold>Pharmacokinetic modeling</bold>
</p><p>Pharmacokinetic modeling uses compartment models to describe plasma concentration. These models vary in compartment number and absorption rates, such as single or three compartments in the literature. Although there are already complex compartment modeling approaches, a two-compartment model will be applied in the following analysis since this model is mainly used for modeling medication effects of blood pressure lowering drugs [<xref rid="pone.0318549.ref011" ref-type="bibr">11</xref>&#8211;<xref rid="pone.0318549.ref013" ref-type="bibr">13</xref>] . This choice is justified by the fact that a two-compartment PKPD model offers a balanced combination of simplicity, appropriateness, and clinical relevance, making it a preferred choice in many applications [<xref rid="pone.0318549.ref014" ref-type="bibr">14</xref>]. We opt for a widely-used two-compartment effect model, outlined in [<xref rid="pone.0318549.ref015" ref-type="bibr">15</xref>] and [<xref rid="pone.0318549.ref016" ref-type="bibr">16</xref>], with central plasma, gut, and peripheral tissue compartments, as visualized in <xref rid="pone.0318549.g003" ref-type="fig">Fig 3</xref>.</p><fig position="float" id="pone.0318549.g003" orientation="portrait"><object-id pub-id-type="doi">10.1371/journal.pone.0318549.g003</object-id><label>Fig 3</label><caption><title>Relationships within the pharmacokinetic model: Compartmental model parameters <italic toggle="yes">C</italic>&#160;(&#160;1&#160;)&#160;,&#160;<italic toggle="yes">C</italic>&#160;(&#160;2&#160;)&#160;,&#160; and <italic toggle="yes">C</italic>&#160;(&#160;3&#160;)&#160; represent compartments (Gut, Central, Peripheral), <inline-formula id="pone.0318549.e005"><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0318549.e005g" position="anchor" orientation="portrait" xlink:href="pone.0318549.e005.jpg"/><mml:math id="m5" display="inline" overflow="scroll"><mml:mstyle mathvariant="bold-italic"><mml:msub><mml:mrow><mml:mi>K</mml:mi></mml:mrow><mml:mrow><mml:mi>a</mml:mi></mml:mrow></mml:msub><mml:mo stretchy="false">,</mml:mo><mml:msub><mml:mrow><mml:mi>K</mml:mi></mml:mrow><mml:mrow><mml:mrow><mml:mn>1</mml:mn></mml:mrow><mml:mn>0</mml:mn></mml:mrow></mml:msub><mml:mo stretchy="false">,</mml:mo><mml:msub><mml:mrow><mml:mi>K</mml:mi></mml:mrow><mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mo stretchy="false">,</mml:mo></mml:mstyle></mml:math></alternatives></inline-formula> and <inline-formula id="pone.0318549.e006"><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0318549.e006g" position="anchor" orientation="portrait" xlink:href="pone.0318549.e006.jpg"/><mml:math id="m6" display="inline" overflow="scroll"><mml:mstyle mathvariant="bold-italic"><mml:msub><mml:mrow><mml:mi>K</mml:mi></mml:mrow><mml:mrow><mml:mrow><mml:mn>1</mml:mn></mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msub></mml:mstyle></mml:math></alternatives></inline-formula> denote absorption and transport rates; Relationships within the Pharmacodynamic model: <italic toggle="yes">C</italic>&#160;(&#160;4&#160;)&#160; represents effect compartment.</title><p><inline-formula id="pone.0318549.e008"><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0318549.e008g" position="anchor" orientation="portrait" xlink:href="pone.0318549.e008.jpg"/><mml:math id="m8" display="inline" overflow="scroll"><mml:msub><mml:mrow><mml:mi>K</mml:mi></mml:mrow><mml:mrow><mml:mi>e</mml:mi><mml:mn>0</mml:mn></mml:mrow></mml:msub></mml:math></alternatives></inline-formula> denotes rate constant for transfer to the effect compartment.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="pone.0318549.g003.jpg"/></fig><p>The underlying equations for the compartment model illustrated in <xref rid="pone.0318549.g003" ref-type="fig">Fig 3</xref> are given by</p><disp-formula id="pone.0318549.e090"><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0318549.e090g" position="anchor" orientation="portrait" xlink:href="pone.0318549.e090.jpg"/><mml:math id="m01" display="block" overflow="scroll"><mml:mtable><mml:mtr><mml:mtd><mml:mfrac><mml:mrow><mml:mi>d</mml:mi><mml:mi>C</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:mn>1</mml:mn><mml:mo stretchy="false">)</mml:mo><mml:mo stretchy="false">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac></mml:mtd><mml:mtd><mml:mo stretchy="false">=</mml:mo><mml:mo stretchy="false">&#8722;</mml:mo><mml:msub><mml:mrow><mml:mi>K</mml:mi></mml:mrow><mml:mrow><mml:mi>a</mml:mi></mml:mrow></mml:msub><mml:mo stretchy="false">&#8901;</mml:mo><mml:mi>C</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:mn>1</mml:mn><mml:mo stretchy="false">)</mml:mo><mml:mo stretchy="false">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mtd><mml:mtd/><mml:mtd><mml:mtext/></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mfrac><mml:mrow><mml:mi>d</mml:mi><mml:mi>C</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:mn>2</mml:mn><mml:mo stretchy="false">)</mml:mo><mml:mo stretchy="false">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac></mml:mtd><mml:mtd><mml:mo stretchy="false">=</mml:mo><mml:mfrac><mml:mrow><mml:mo stretchy="false">&#8722;</mml:mo><mml:mo stretchy="false">(</mml:mo><mml:msub><mml:mrow><mml:mi>K</mml:mi></mml:mrow><mml:mrow><mml:mrow><mml:mn>1</mml:mn></mml:mrow><mml:mn>0</mml:mn></mml:mrow></mml:msub><mml:mo stretchy="false">+</mml:mo><mml:msub><mml:mrow><mml:mi>K</mml:mi></mml:mrow><mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mo stretchy="false">)</mml:mo><mml:mo stretchy="false">&#8901;</mml:mo><mml:mi>C</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:mn>2</mml:mn><mml:mo stretchy="false">)</mml:mo><mml:mo stretchy="false">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy="false">)</mml:mo><mml:mo stretchy="false">+</mml:mo><mml:msub><mml:mrow><mml:mi>K</mml:mi></mml:mrow><mml:mrow><mml:mi>a</mml:mi></mml:mrow></mml:msub><mml:mo stretchy="false">&#8901;</mml:mo><mml:mi>C</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:mn>1</mml:mn><mml:mo stretchy="false">)</mml:mo><mml:mo stretchy="false">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy="false">)</mml:mo><mml:mo stretchy="false">+</mml:mo><mml:msub><mml:mrow><mml:mi>K</mml:mi></mml:mrow><mml:mrow><mml:mrow><mml:mn>1</mml:mn></mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msub><mml:mo stretchy="false">&#8901;</mml:mo><mml:mi>C</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:mn>3</mml:mn><mml:mo stretchy="false">)</mml:mo><mml:mo stretchy="false">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow><mml:mrow><mml:mi>V</mml:mi><mml:mi>C</mml:mi></mml:mrow></mml:mfrac></mml:mtd><mml:mtd/><mml:mtd><mml:mtext/></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mfrac><mml:mrow><mml:mi>d</mml:mi><mml:mi>C</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:mn>3</mml:mn><mml:mo stretchy="false">)</mml:mo><mml:mo stretchy="false">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac></mml:mtd><mml:mtd><mml:mo stretchy="false">=</mml:mo><mml:msub><mml:mrow><mml:mi>K</mml:mi></mml:mrow><mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mo stretchy="false">&#8901;</mml:mo><mml:mi>C</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:mn>2</mml:mn><mml:mo stretchy="false">)</mml:mo><mml:mo stretchy="false">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy="false">)</mml:mo><mml:mo stretchy="false">&#8722;</mml:mo><mml:msub><mml:mrow><mml:mi>K</mml:mi></mml:mrow><mml:mrow><mml:mrow><mml:mn>1</mml:mn></mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msub><mml:mo stretchy="false">&#8901;</mml:mo><mml:mi>C</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:mn>3</mml:mn><mml:mo stretchy="false">)</mml:mo><mml:mo stretchy="false">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy="false">)</mml:mo><mml:mspace class="nbsp" width="0.33em"/><mml:mspace class="nbsp" width="0.33em"/><mml:mspace class="nbsp" width="0.33em"/><mml:mo stretchy="false">.</mml:mo></mml:mtd><mml:mtd/></mml:mtr></mml:mtable></mml:math></alternatives><label>(1)</label></disp-formula><p>The parameters are defined as</p><disp-formula id="pone.0318549.e091"><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0318549.e091g" position="anchor" orientation="portrait" xlink:href="pone.0318549.e091.jpg"/><mml:math id="m02" display="block" overflow="scroll"><mml:mtable><mml:mtr><mml:mtd><mml:mi>C</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:mn>1</mml:mn><mml:mo stretchy="false">)</mml:mo></mml:mtd><mml:mtd><mml:mo stretchy="false">:</mml:mo><mml:mstyle class="text"><mml:mtext>Gut</mml:mtext></mml:mstyle></mml:mtd><mml:mtd/><mml:mtd><mml:mtext/></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mi>C</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:mn>2</mml:mn><mml:mo stretchy="false">)</mml:mo></mml:mtd><mml:mtd><mml:mo stretchy="false">:</mml:mo><mml:mstyle class="text"><mml:mtext>Central (Plasma)</mml:mtext></mml:mstyle></mml:mtd><mml:mtd/><mml:mtd><mml:mtext/></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mi>C</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:mn>3</mml:mn><mml:mo stretchy="false">)</mml:mo></mml:mtd><mml:mtd><mml:mo stretchy="false">:</mml:mo><mml:mstyle class="text"><mml:mtext>Peripheral (Tissue)</mml:mtext></mml:mstyle></mml:mtd><mml:mtd/><mml:mtd><mml:mtext/></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:msub><mml:mrow><mml:mi>K</mml:mi></mml:mrow><mml:mrow><mml:mi>a</mml:mi></mml:mrow></mml:msub><mml:mo stretchy="false">,</mml:mo><mml:mspace class="nbsp" width="0.33em"/><mml:mspace class="nbsp" width="0.33em"/><mml:msub><mml:mrow><mml:mi>K</mml:mi></mml:mrow><mml:mrow><mml:mrow><mml:mn>1</mml:mn></mml:mrow><mml:mn>0</mml:mn></mml:mrow></mml:msub></mml:mtd><mml:mtd><mml:mo stretchy="false">:</mml:mo><mml:mo stretchy="false">=</mml:mo><mml:mstyle class="text"><mml:mtext>Rate of absorption</mml:mtext></mml:mstyle></mml:mtd><mml:mtd/><mml:mtd><mml:mtext/></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:msub><mml:mrow><mml:mi>K</mml:mi></mml:mrow><mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow><mml:mn>1</mml:mn></mml:mrow></mml:msub></mml:mtd><mml:mtd><mml:mo stretchy="false">:</mml:mo><mml:mstyle class="text"><mml:mtext>Rate of transport of the drug from the central to the peripheral</mml:mtext></mml:mstyle></mml:mtd><mml:mtd/><mml:mtd><mml:mtext/></mml:mtd></mml:mtr><mml:mtr><mml:mtd/><mml:mtd><mml:mspace class="quad" width="1em"/><mml:mstyle class="text"><mml:mtext>compartment</mml:mtext></mml:mstyle></mml:mtd><mml:mtd/><mml:mtd><mml:mtext/></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:msub><mml:mrow><mml:mi>K</mml:mi></mml:mrow><mml:mrow><mml:mrow><mml:mn>1</mml:mn></mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msub></mml:mtd><mml:mtd><mml:mo stretchy="false">:</mml:mo><mml:mstyle class="text"><mml:mtext>Rate of transport of the drug from the peripheral to the central</mml:mtext></mml:mstyle></mml:mtd><mml:mtd/><mml:mtd><mml:mtext/></mml:mtd></mml:mtr><mml:mtr><mml:mtd/><mml:mtd><mml:mspace class="quad" width="1em"/><mml:mstyle class="text"><mml:mtext>compartment</mml:mtext></mml:mstyle></mml:mtd><mml:mtd/><mml:mtd><mml:mtext/></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:msub><mml:mrow><mml:mi>K</mml:mi></mml:mrow><mml:mrow><mml:mi>e</mml:mi><mml:mn>0</mml:mn></mml:mrow></mml:msub></mml:mtd><mml:mtd><mml:mo stretchy="false">:</mml:mo><mml:mstyle class="text"><mml:mtext>Rate constant for transfer to effect compartment</mml:mtext></mml:mstyle><mml:mo stretchy="false">.</mml:mo></mml:mtd><mml:mtd/></mml:mtr></mml:mtable></mml:math></alternatives><label>(2)</label></disp-formula><p>One important additional parameter is the volume of distribution (or volume capacity, <italic toggle="yes">VC</italic>), which is the volume of the central compartment. It relates the total amount of drug in the body to the plasma concentration of the drug at a given time. The following equation applies:</p><disp-formula id="pone.0318549.e092"><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0318549.e092g" position="anchor" orientation="portrait" xlink:href="pone.0318549.e092.jpg"/><mml:math id="m03" display="block" overflow="scroll"><mml:mtable><mml:mtr><mml:mtd><mml:mi>V</mml:mi><mml:mi>C</mml:mi><mml:mo stretchy="false">[</mml:mo><mml:mi>L</mml:mi><mml:mo stretchy="false">]</mml:mo><mml:mo stretchy="false">=</mml:mo><mml:mfrac><mml:mrow><mml:mstyle class="text"><mml:mtext>Amount of drug in the body [mg]</mml:mtext></mml:mstyle></mml:mrow><mml:mrow><mml:mstyle class="text"><mml:mtext>Plasma concentration of drug [mg/L]</mml:mtext></mml:mstyle></mml:mrow></mml:mfrac></mml:mtd><mml:mtd/><mml:mtd/></mml:mtr></mml:mtable></mml:math></alternatives><label>(3)</label></disp-formula><p>A drug with a high <italic toggle="yes">VC</italic> tends to leave the plasma and enter the extravascular compartments of the body. Conversely, a drug with a low <italic toggle="yes">VC</italic> tends to remain in the plasma, meaning that a lower dose of a drug is required to reach a given plasma concentration [<xref rid="pone.0318549.ref017" ref-type="bibr">17</xref>]. An increase of <inline-formula id="pone.0318549.e009"><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0318549.e009g" position="anchor" orientation="portrait" xlink:href="pone.0318549.e009.jpg"/><mml:math id="m9" display="inline" overflow="scroll"><mml:msub><mml:mrow><mml:mi>K</mml:mi></mml:mrow><mml:mrow><mml:mrow><mml:mn>1</mml:mn></mml:mrow><mml:mn>0</mml:mn></mml:mrow></mml:msub></mml:math></alternatives></inline-formula> corresponds to the situation that the concentration cannot be held at a high level for a long time. In general, the concentration is lower and the steady state is reached faster. An increase in <inline-formula id="pone.0318549.e010"><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0318549.e010g" position="anchor" orientation="portrait" xlink:href="pone.0318549.e010.jpg"/><mml:math id="m10" display="inline" overflow="scroll"><mml:msub><mml:mrow><mml:mi>K</mml:mi></mml:mrow><mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow><mml:mn>1</mml:mn></mml:mrow></mml:msub></mml:math></alternatives></inline-formula> behaves similarly to an increase in <inline-formula id="pone.0318549.e011"><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0318549.e011g" position="anchor" orientation="portrait" xlink:href="pone.0318549.e011.jpg"/><mml:math id="m11" display="inline" overflow="scroll"><mml:msub><mml:mrow><mml:mi>K</mml:mi></mml:mrow><mml:mrow><mml:mrow><mml:mn>1</mml:mn></mml:mrow><mml:mn>0</mml:mn></mml:mrow></mml:msub></mml:math></alternatives></inline-formula>. The general plasma concentration reaches higher values and there are more significant peaks within one day. In addition, the steady state is reached more quickly. In contrast, an increase in <inline-formula id="pone.0318549.e012"><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0318549.e012g" position="anchor" orientation="portrait" xlink:href="pone.0318549.e012.jpg"/><mml:math id="m12" display="inline" overflow="scroll"><mml:msub><mml:mrow><mml:mi>K</mml:mi></mml:mrow><mml:mrow><mml:mrow><mml:mn>1</mml:mn></mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msub></mml:math></alternatives></inline-formula> leads to a longer time to reach the steady state, and the decline within individual days is weaker.The steady state is defined as the plateau where the effect will not increase further. An increase in <inline-formula id="pone.0318549.e013"><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0318549.e013g" position="anchor" orientation="portrait" xlink:href="pone.0318549.e013.jpg"/><mml:math id="m13" display="inline" overflow="scroll"><mml:msub><mml:mrow><mml:mi>K</mml:mi></mml:mrow><mml:mrow><mml:mi>e</mml:mi><mml:mn>0</mml:mn></mml:mrow></mml:msub></mml:math></alternatives></inline-formula> results in a slight increase in the effective height. An increase in <inline-formula id="pone.0318549.e014"><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0318549.e014g" position="anchor" orientation="portrait" xlink:href="pone.0318549.e014.jpg"/><mml:math id="m14" display="inline" overflow="scroll"><mml:msub><mml:mrow><mml:mi>K</mml:mi></mml:mrow><mml:mrow><mml:mi>a</mml:mi></mml:mrow></mml:msub></mml:math></alternatives></inline-formula> affects the pattern of plasma concentration within a day. It leads to a steeper decrease. Parameter choice involves considering factors like time to peak concentration (for blood pressure medication: 0.25 to 2 hours [<xref rid="pone.0318549.ref018" ref-type="bibr">18</xref>]) and how age and weight impact clearance and volume capacity [<xref rid="pone.0318549.ref019" ref-type="bibr">19</xref>,<xref rid="pone.0318549.ref020" ref-type="bibr">20</xref>]. A balance between literature values and desired characteristics is essential to avoid unrealistic drug effect curves. The selected corresponding parameters are listed in section &#8220;Evaluation of proposed prediction approaches&#8221;.</p><p><bold>Pharmacodynamic modeling</bold> Given the plasma concentration the drug effect can be modeled by common pharmacodynamic models. The specific choice of the concentration-effect relationships needs to consider that, in real life, the effect of anti-hypertensives will reach the steady state after a few days. For this scenario, the model typically used in literature is the sigmoid <inline-formula id="pone.0318549.e015"><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0318549.e015g" position="anchor" orientation="portrait" xlink:href="pone.0318549.e015.jpg"/><mml:math id="m15" display="inline" overflow="scroll"><mml:msub><mml:mrow><mml:mi>E</mml:mi></mml:mrow><mml:mrow><mml:mi>m</mml:mi><mml:mi>a</mml:mi><mml:mi>x</mml:mi></mml:mrow></mml:msub></mml:math></alternatives></inline-formula> (cf. [<xref rid="pone.0318549.ref021" ref-type="bibr">21</xref>], [<xref rid="pone.0318549.ref022" ref-type="bibr">22</xref>]). Given the sigmoid <inline-formula id="pone.0318549.e016"><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0318549.e016g" position="anchor" orientation="portrait" xlink:href="pone.0318549.e016.jpg"/><mml:math id="m16" display="inline" overflow="scroll"><mml:msub><mml:mrow><mml:mi>E</mml:mi></mml:mrow><mml:mrow><mml:mi>m</mml:mi><mml:mi>a</mml:mi><mml:mi>x</mml:mi></mml:mrow></mml:msub></mml:math></alternatives></inline-formula>-model, the blood pressure lowering effect <inline-formula id="pone.0318549.e017"><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0318549.e017g" position="anchor" orientation="portrait" xlink:href="pone.0318549.e017.jpg"/><mml:math id="m17" display="inline" overflow="scroll"><mml:mi>B</mml:mi><mml:msub><mml:mrow><mml:mi>P</mml:mi></mml:mrow><mml:mrow><mml:mi>e</mml:mi><mml:mi>f</mml:mi><mml:mi>f</mml:mi></mml:mrow></mml:msub></mml:math></alternatives></inline-formula> is defined as</p><disp-formula id="pone.0318549.e093"><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0318549.e093g" position="anchor" orientation="portrait" xlink:href="pone.0318549.e093.jpg"/><mml:math id="m04" display="block" overflow="scroll"><mml:mtable><mml:mtr><mml:mtd><mml:mi>B</mml:mi><mml:msub><mml:mrow><mml:mi>P</mml:mi></mml:mrow><mml:mrow><mml:mi>e</mml:mi><mml:mi>f</mml:mi><mml:mi>f</mml:mi></mml:mrow></mml:msub></mml:mtd><mml:mtd><mml:mo stretchy="false">=</mml:mo><mml:msub><mml:mrow><mml:mi>E</mml:mi></mml:mrow><mml:mrow><mml:mi>m</mml:mi><mml:mi>a</mml:mi><mml:mi>x</mml:mi></mml:mrow></mml:msub><mml:mo stretchy="false">&#8901;</mml:mo><mml:mfrac><mml:mrow><mml:mi>C</mml:mi><mml:mi>E</mml:mi></mml:mrow><mml:mrow><mml:mi>C</mml:mi><mml:mi>E</mml:mi><mml:mo stretchy="false">+</mml:mo><mml:mi>E</mml:mi><mml:msub><mml:mrow><mml:mi>C</mml:mi></mml:mrow><mml:mrow><mml:mrow><mml:mn>5</mml:mn></mml:mrow><mml:mn>0</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:mfrac><mml:mspace class="nbsp" width="0.33em"/><mml:mspace class="nbsp" width="0.33em"/><mml:mspace class="nbsp" width="0.33em"/><mml:mo stretchy="false">,</mml:mo></mml:mtd><mml:mtd/></mml:mtr></mml:mtable></mml:math></alternatives><label>(4)</label></disp-formula><p>where <italic toggle="yes">CE</italic> is the drug concentration and <inline-formula id="pone.0318549.e018"><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0318549.e018g" position="anchor" orientation="portrait" xlink:href="pone.0318549.e018.jpg"/><mml:math id="m18" display="inline" overflow="scroll"><mml:msub><mml:mrow><mml:mi>E</mml:mi></mml:mrow><mml:mrow><mml:mi>m</mml:mi><mml:mi>a</mml:mi><mml:mi>x</mml:mi></mml:mrow></mml:msub></mml:math></alternatives></inline-formula> can be interpreted as the maximum effect of a specific drug and <inline-formula id="pone.0318549.e019"><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0318549.e019g" position="anchor" orientation="portrait" xlink:href="pone.0318549.e019.jpg"/><mml:math id="m19" display="inline" overflow="scroll"><mml:mi>E</mml:mi><mml:msub><mml:mrow><mml:mi>C</mml:mi></mml:mrow><mml:mrow><mml:mrow><mml:mn>5</mml:mn></mml:mrow><mml:mn>0</mml:mn></mml:mrow></mml:msub></mml:math></alternatives></inline-formula> as the half-life time, e.g. the time period after which half of the effect has been achieved. These parameters vary depending on the drug and the subject. In the literature, it is reported that the anti-hypertensive steady state effect is reached in approximately five to seven days based on calcium channel blockers [<xref rid="pone.0318549.ref023" ref-type="bibr">23</xref>,<xref rid="pone.0318549.ref024" ref-type="bibr">24</xref>]). This is used as a reference for simulation. The maximal effect (<inline-formula id="pone.0318549.e020"><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0318549.e020g" position="anchor" orientation="portrait" xlink:href="pone.0318549.e020.jpg"/><mml:math id="m20" display="inline" overflow="scroll"><mml:msub><mml:mrow><mml:mi>E</mml:mi></mml:mrow><mml:mrow><mml:mi>m</mml:mi><mml:mi>a</mml:mi><mml:mi>x</mml:mi></mml:mrow></mml:msub></mml:math></alternatives></inline-formula>) directly influences a drug&#8217;s maximal effect, with baseline blood pressure and ethnicity playing roles. Higher baseline blood pressure leads to higher expected absolute drug effects [<xref rid="pone.0318549.ref021" ref-type="bibr">21</xref>]. Ethnicity can also impact drug effectiveness; for instance, the Angiotensin II receptor antagonist Eprosartan has little effect on blood pressure in Black Africans [<xref rid="pone.0318549.ref025" ref-type="bibr">25</xref>]. The selected corresponding parameters are listed in section &#8220;Evaluation of proposed prediction approaches&#8221;.</p><sec id="sec004"><title>Circadian rhythm.</title><p>Often the time of day is not taken into account when blood pressure is assessed [<xref rid="pone.0318549.ref026" ref-type="bibr">26</xref>]. However, for continuous blood pressure trajectories, this is considered a crucial information. We assume a circadian rhythm during the day, which is influenced e.g. by sleeping phases [<xref rid="pone.0318549.ref027" ref-type="bibr">27</xref>]. An example of such a pattern is displayed in <xref rid="pone.0318549.g004" ref-type="fig">Fig 4</xref>.</p><fig position="float" id="pone.0318549.g004" orientation="portrait"><object-id pub-id-type="doi">10.1371/journal.pone.0318549.g004</object-id><label>Fig 4</label><caption><title>Internal study data with eleven voluntary, healthy employees wearing a wearable device for a time frame of around two weeks.</title><p>In grey: Individual aggregated circadian rhythms; In black: Mean individual circadian rhythm; In black (dashed): Simulated circadian rhythm.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="pone.0318549.g004.jpg"/></fig><p>For the simulation, we use a simplified Fourier construction with two cosine functions [<xref rid="pone.0318549.ref028" ref-type="bibr">28</xref>], which yields</p><disp-formula id="pone.0318549.e094"><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0318549.e094g" position="anchor" orientation="portrait" xlink:href="pone.0318549.e094.jpg"/><mml:math id="m05" display="block" overflow="scroll"><mml:mtable><mml:mtr><mml:mtd><mml:mi>S</mml:mi><mml:mi>B</mml:mi><mml:mi>P</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy="false">)</mml:mo><mml:mo stretchy="false">=</mml:mo><mml:mi>B</mml:mi><mml:mi>S</mml:mi><mml:mi>L</mml:mi><mml:mo stretchy="false">+</mml:mo><mml:mi>a</mml:mi><mml:mi>m</mml:mi><mml:msub><mml:mrow><mml:mi>p</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mo stretchy="false">&#8901;</mml:mo><mml:mi>c</mml:mi><mml:mi>o</mml:mi><mml:mi>s</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:mfrac><mml:mrow><mml:mn>2</mml:mn><mml:mi>&#960;</mml:mi><mml:mo stretchy="false">&#8901;</mml:mo><mml:mo stretchy="false">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy="false">+</mml:mo><mml:mi>h</mml:mi><mml:mi>o</mml:mi><mml:mi>r</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow><mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow><mml:mn>4</mml:mn></mml:mrow></mml:mfrac><mml:mo stretchy="false">)</mml:mo><mml:mo stretchy="false">+</mml:mo><mml:mi>a</mml:mi><mml:mi>m</mml:mi><mml:msub><mml:mrow><mml:mi>p</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msub><mml:mo stretchy="false">&#8901;</mml:mo><mml:mi>c</mml:mi><mml:mi>o</mml:mi><mml:mi>s</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:mfrac><mml:mrow><mml:mn>2</mml:mn><mml:mi>&#960;</mml:mi><mml:mo stretchy="false">&#8901;</mml:mo><mml:mo stretchy="false">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy="false">+</mml:mo><mml:mi>h</mml:mi><mml:mi>o</mml:mi><mml:mi>r</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow><mml:mrow><mml:mrow><mml:mn>1</mml:mn></mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:mfrac><mml:mo stretchy="false">)</mml:mo></mml:mtd><mml:mtd/><mml:mtd/></mml:mtr></mml:mtable></mml:math></alternatives><label>(5)</label></disp-formula><p>with</p><disp-formula id="pone.0318549.e095"><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0318549.e095g" position="anchor" orientation="portrait" xlink:href="pone.0318549.e095.jpg"/><mml:math id="m06" display="block" overflow="scroll"><mml:mtable><mml:mtr><mml:mtd><mml:mi>n</mml:mi><mml:mi>a</mml:mi><mml:mi>d</mml:mi><mml:mi>i</mml:mi><mml:mi>r</mml:mi></mml:mtd><mml:mtd><mml:mo stretchy="false">=</mml:mo><mml:mo stretchy="false">(</mml:mo><mml:mi>B</mml:mi><mml:mi>S</mml:mi><mml:mi>L</mml:mi><mml:mo stretchy="false">&#8722;</mml:mo><mml:mfrac><mml:mrow><mml:mn>2</mml:mn></mml:mrow><mml:mrow><mml:mn>3</mml:mn></mml:mrow></mml:mfrac><mml:mo stretchy="false">&#8901;</mml:mo><mml:mi>c</mml:mi><mml:mi>h</mml:mi><mml:mi>a</mml:mi><mml:mi>n</mml:mi><mml:mi>g</mml:mi><mml:mi>e</mml:mi><mml:mo stretchy="false">)</mml:mo><mml:mo stretchy="false">&#8901;</mml:mo><mml:mo stretchy="false">(</mml:mo><mml:mn>1</mml:mn><mml:mo stretchy="false">+</mml:mo><mml:mi>e</mml:mi><mml:mi>x</mml:mi><mml:mi>p</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:mi>&#957;</mml:mi><mml:mo stretchy="false">)</mml:mo><mml:mo stretchy="false">)</mml:mo></mml:mtd><mml:mtd/><mml:mtd><mml:mtext/></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mi>a</mml:mi><mml:mi>m</mml:mi><mml:msub><mml:mrow><mml:mi>p</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msub></mml:mtd><mml:mtd><mml:mo stretchy="false">=</mml:mo><mml:mfrac><mml:mrow><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mn>3</mml:mn></mml:mrow></mml:mfrac><mml:mo stretchy="false">&#8901;</mml:mo><mml:mo stretchy="false">(</mml:mo><mml:mi>B</mml:mi><mml:mi>S</mml:mi><mml:mi>L</mml:mi><mml:mo stretchy="false">&#8722;</mml:mo><mml:mi>n</mml:mi><mml:mi>a</mml:mi><mml:mi>d</mml:mi><mml:mi>i</mml:mi><mml:mi>r</mml:mi><mml:mo stretchy="false">)</mml:mo><mml:mo stretchy="false">&#8722;</mml:mo><mml:mfrac><mml:mrow><mml:mn>4</mml:mn></mml:mrow><mml:mrow><mml:mn>9</mml:mn></mml:mrow></mml:mfrac><mml:mo stretchy="false">&#8901;</mml:mo><mml:mi>c</mml:mi><mml:mi>h</mml:mi><mml:mi>a</mml:mi><mml:mi>n</mml:mi><mml:mi>g</mml:mi><mml:mi>e</mml:mi></mml:mtd><mml:mtd/><mml:mtd><mml:mtext/></mml:mtd></mml:mtr><mml:mtr><mml:mtd/><mml:mtd><mml:mspace class="nbsp" width="0.33em"/><mml:mspace class="nbsp" width="0.33em"/><mml:mspace class="nbsp" width="0.33em"/><mml:mo stretchy="false">&#8722;</mml:mo><mml:mfrac><mml:mrow><mml:mn>2</mml:mn></mml:mrow><mml:mrow><mml:mn>9</mml:mn></mml:mrow></mml:mfrac><mml:mo stretchy="false">&#8901;</mml:mo><mml:msqrt><mml:mrow><mml:mn>6</mml:mn><mml:mo stretchy="false">&#8901;</mml:mo><mml:mi>c</mml:mi><mml:mi>h</mml:mi><mml:mi>a</mml:mi><mml:mi>n</mml:mi><mml:mi>g</mml:mi><mml:mi>e</mml:mi><mml:mo stretchy="false">&#8901;</mml:mo><mml:mo stretchy="false">(</mml:mo><mml:mi>n</mml:mi><mml:mi>a</mml:mi><mml:mi>d</mml:mi><mml:mi>i</mml:mi><mml:mi>r</mml:mi><mml:mo stretchy="false">&#8722;</mml:mo><mml:mi>B</mml:mi><mml:mi>S</mml:mi><mml:mi>L</mml:mi><mml:mo stretchy="false">)</mml:mo><mml:mo stretchy="false">+</mml:mo><mml:mn>4</mml:mn><mml:mo stretchy="false">&#8901;</mml:mo><mml:mi>c</mml:mi><mml:mi>h</mml:mi><mml:mi>a</mml:mi><mml:mi>n</mml:mi><mml:mi>g</mml:mi><mml:msup><mml:mrow><mml:mi>e</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msup></mml:mrow></mml:msqrt></mml:mtd><mml:mtd/><mml:mtd><mml:mtext/></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mi>a</mml:mi><mml:mi>m</mml:mi><mml:msub><mml:mrow><mml:mi>p</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn></mml:mrow></mml:msub></mml:mtd><mml:mtd><mml:mo stretchy="false">=</mml:mo><mml:mi>B</mml:mi><mml:mi>S</mml:mi><mml:mi>L</mml:mi><mml:mo stretchy="false">&#8722;</mml:mo><mml:mi>n</mml:mi><mml:mi>a</mml:mi><mml:mi>d</mml:mi><mml:mi>i</mml:mi><mml:mi>r</mml:mi><mml:mo stretchy="false">+</mml:mo><mml:mi>a</mml:mi><mml:mi>m</mml:mi><mml:msub><mml:mrow><mml:mi>p</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msub><mml:mspace class="nbsp" width="0.33em"/><mml:mspace class="nbsp" width="0.33em"/><mml:mspace class="nbsp" width="0.33em"/><mml:mo stretchy="false">.</mml:mo></mml:mtd><mml:mtd/></mml:mtr></mml:mtable></mml:math></alternatives><label>(6)</label></disp-formula><p><italic toggle="yes">SBP</italic> denotes the systolic blood pressure, <italic toggle="yes">BSL</italic> denotes the baseline (systolic) blood pressure. The parameters <italic toggle="yes">nadir</italic> and <italic toggle="yes">change</italic> represent patient characteristics. First, <italic toggle="yes">nadir</italic> is defined as the minimum systolic blood pressure during the night. Second, <italic toggle="yes">change</italic> is defined as the difference between the maximum systolic blood pressure during the day and the minimum systolic blood pressure during the night. The corresponding parameters can be derived from data given by an internal study. In the internal study, eleven voluntary, healthy employees tested a wearable device for a time frame of around two weeks. The individual trajectories as well as the derived simulated trajectory based on internal study data are given in <xref rid="pone.0318549.g004" ref-type="fig">Fig 4</xref>. The specific parameter selection, which results from this, can be found in the subsequent section.</p></sec><sec id="sec005"><title>Variations from the ideal curve: Within-day and day-to-day variability.</title><p>Noise on the data should be added for capturing the measurement error present in real-world data. This noise can fluctuate within a day (intra-daily, within-day) as well as between different days (inter-daily, day-to-day noise). To account for additional noise within a day, such as coffee consumption, individual lifestyle, or environmental impacts, we can introduce variability by adding random noise to each measurement. For this intra-daily variability, we rely on data from current marketed wearable devices, such as Aktiia (see <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://aktiia.com/de/" ext-link-type="uri">https://aktiia.com/de/</ext-link>, accessed on May 11, 2024). It was estimated that the within-day variability of individual measurements is approximately 5 mmHg. This is consistent with the variability measured in an internal study as well the variability given in [<xref rid="pone.0318549.ref029" ref-type="bibr">29</xref>]. We assume that the intra-daily variability is independently normally distributed around zero. When assuming that 5 mmHg corresponds to the 95<italic toggle="yes">%</italic>-quantile of this distribution, the final distribution is given by</p><disp-formula id="pone.0318549.e096"><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0318549.e096g" position="anchor" orientation="portrait" xlink:href="pone.0318549.e096.jpg"/><mml:math id="m07" display="block" overflow="scroll"><mml:mtable class="align-star" columnalign="left" displaystyle="true"><mml:mtr><mml:mtd><mml:mi>n</mml:mi><mml:mi>o</mml:mi><mml:mi>i</mml:mi><mml:mi>s</mml:mi><mml:msub><mml:mrow><mml:mi>e</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mi>n</mml:mi><mml:mi>t</mml:mi><mml:mi>r</mml:mi><mml:mi>a</mml:mi></mml:mrow></mml:msub><mml:mo stretchy="false">&#8764;</mml:mo><mml:mstyle mathvariant="script"><mml:mi>N</mml:mi></mml:mstyle><mml:mo stretchy="false">(</mml:mo><mml:mn>0</mml:mn><mml:mo stretchy="false">,</mml:mo><mml:msup><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mn>5</mml:mn><mml:mo stretchy="false">&#8725;</mml:mo><mml:msub><mml:mrow><mml:mi>z</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn><mml:mo stretchy="false">.</mml:mo><mml:mrow><mml:mn>9</mml:mn></mml:mrow><mml:mn>9</mml:mn><mml:mo stretchy="false">&#8725;</mml:mo><mml:mn>2</mml:mn></mml:mrow></mml:msub><mml:mo stretchy="false">)</mml:mo></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msup><mml:mo stretchy="false">)</mml:mo><mml:mo stretchy="false">=</mml:mo><mml:mstyle mathvariant="script"><mml:mi>N</mml:mi></mml:mstyle><mml:mo stretchy="false">(</mml:mo><mml:mn>0</mml:mn><mml:mo stretchy="false">,</mml:mo><mml:mn>1</mml:mn><mml:mo stretchy="false">.</mml:mo><mml:mn>9</mml:mn><mml:msup><mml:mrow><mml:mn>4</mml:mn></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msup><mml:mo stretchy="false">)</mml:mo></mml:mtd><mml:mtd><mml:mspace width="2em"/></mml:mtd><mml:mtd/></mml:mtr></mml:mtable></mml:math></alternatives></disp-formula><p>for the intra-daily variability.</p><p>In addition, we assume inter-daily variability given by about &#160;&#177;&#160;8 mmHg. This can be validated by the internal study as well. Inter-daily variability in the measurements can be caused by unusual activities like doing sports or being sick. As before, assuming that the inter-daily variability is normally distributed around 0, the corresponding standard deviation can be derived by assuming 8 mmHg as the 99% quantile of it&#8217;s distribution, which then yields to</p><disp-formula id="pone.0318549.e097"><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0318549.e097g" position="anchor" orientation="portrait" xlink:href="pone.0318549.e097.jpg"/><mml:math id="m08" display="block" overflow="scroll"><mml:mtable class="align-star" columnalign="left" displaystyle="true"><mml:mtr><mml:mtd><mml:mi>n</mml:mi><mml:mi>o</mml:mi><mml:mi>i</mml:mi><mml:mi>s</mml:mi><mml:msub><mml:mrow><mml:mi>e</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mi>n</mml:mi><mml:mi>t</mml:mi><mml:mi>e</mml:mi><mml:mi>r</mml:mi></mml:mrow></mml:msub><mml:mo stretchy="false">&#8764;</mml:mo><mml:mstyle mathvariant="script"><mml:mi>N</mml:mi></mml:mstyle><mml:mo stretchy="false">(</mml:mo><mml:mn>0</mml:mn><mml:mo stretchy="false">,</mml:mo><mml:msup><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mn>8</mml:mn><mml:mo stretchy="false">&#8725;</mml:mo><mml:msub><mml:mrow><mml:mi>z</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn><mml:mo stretchy="false">.</mml:mo><mml:mrow><mml:mn>9</mml:mn></mml:mrow><mml:mn>9</mml:mn><mml:mo stretchy="false">&#8725;</mml:mo><mml:mn>2</mml:mn></mml:mrow></mml:msub><mml:mo stretchy="false">)</mml:mo></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msup><mml:mo stretchy="false">)</mml:mo><mml:mo stretchy="false">=</mml:mo><mml:mstyle mathvariant="script"><mml:mi>N</mml:mi></mml:mstyle><mml:mo stretchy="false">(</mml:mo><mml:mn>0</mml:mn><mml:mo stretchy="false">,</mml:mo><mml:mn>3</mml:mn><mml:mo stretchy="false">.</mml:mo><mml:mn>1</mml:mn><mml:msup><mml:mrow><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msup><mml:mo stretchy="false">)</mml:mo><mml:mspace class="nbsp" width="0.33em"/><mml:mspace class="nbsp" width="0.33em"/><mml:mspace class="nbsp" width="0.33em"/><mml:mo stretchy="false">.</mml:mo></mml:mtd><mml:mtd><mml:mspace width="2em"/></mml:mtd><mml:mtd/></mml:mtr></mml:mtable></mml:math></alternatives></disp-formula></sec></sec><sec id="sec006"><title>Covariate-specific impact on blood pressure trajectories</title><p>We have already mentioned that covariates like the body weight can have a huge impact on the blood pressure as well as on the blood pressure lowering effect of anti-hypertensives [<xref rid="pone.0318549.ref020" ref-type="bibr">20</xref>] and, therefore, some of the parameters introduced above for the PKPD-model are dependent on patient specific covariates. A summary of the hypothesized relationships between (clinical) covariates and the individual submodels is presented in <xref rid="pone.0318549.g005" ref-type="fig">Fig 5</xref>: e.g, we assume that weight, age and sex both influences the <italic toggle="yes">VC</italic> and baseline blood pressure. Ethnicity influences the maximum effect of the antihypertensive drug. Indirectly, all components contribute to the individual blood pressure profiles. The individual literature sources can be found in the Appendix, <xref rid="pcbi.0318549.s003" ref-type="supplementary-material">S2 table</xref>.</p><fig position="float" id="pone.0318549.g005" orientation="portrait"><object-id pub-id-type="doi">10.1371/journal.pone.0318549.g005</object-id><label>Fig 5</label><caption><title>Impact of covariates on simulated blood pressure profiles; red: Clinical covariates, blue: Variables affected by covariates essential for PKPD modeling and circadian rhythm, black: Models encompassing circadian rhythm and medication effects.</title></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="pone.0318549.g005.jpg"/></fig><p>Assuming that we have simulated a dataset with realistic patient characteristics, we now need to simulate a blood pressure trajectory per patient. For that, we need to consider that it is known that some parameters from the PKPD model need to be adjusted to account, for example, for different sex and age. More concretely, according to <xref rid="pone.0318549.g005" ref-type="fig">Fig 5</xref>, the above introduced parameters from the PKPD model, <inline-formula id="pone.0318549.e023"><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0318549.e023g" position="anchor" orientation="portrait" xlink:href="pone.0318549.e023.jpg"/><mml:math id="m23" display="inline" overflow="scroll"><mml:msub><mml:mrow><mml:mi>E</mml:mi></mml:mrow><mml:mrow><mml:mi>m</mml:mi><mml:mi>a</mml:mi><mml:mi>x</mml:mi></mml:mrow></mml:msub></mml:math></alternatives></inline-formula>, <italic toggle="yes">VC</italic>, and <italic toggle="yes">BSL</italic>, need to be adjusted by modeling the impact of the patient-specific covariates (relative to the population mean) by</p><disp-formula id="pone.0318549.e098"><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0318549.e098g" position="anchor" orientation="portrait" xlink:href="pone.0318549.e098.jpg"/><mml:math id="m09" display="block" overflow="scroll"><mml:mtable><mml:mtr><mml:mtd><mml:msub><mml:mrow><mml:mi>&#956;</mml:mi></mml:mrow><mml:mrow><mml:mi>B</mml:mi><mml:mi>S</mml:mi><mml:msub><mml:mrow><mml:mi>L</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub></mml:mtd><mml:mtd><mml:mo stretchy="false">=</mml:mo><mml:mi>B</mml:mi><mml:mi>S</mml:mi><mml:msub><mml:mrow><mml:mi>L</mml:mi></mml:mrow><mml:mrow><mml:mn>0</mml:mn></mml:mrow></mml:msub><mml:mo stretchy="false">+</mml:mo><mml:msub><mml:mrow><mml:mi>&#945;</mml:mi></mml:mrow><mml:mrow><mml:mi>a</mml:mi><mml:mi>g</mml:mi><mml:mi>e</mml:mi></mml:mrow></mml:msub><mml:mo stretchy="false">&#8901;</mml:mo><mml:mo stretchy="false">(</mml:mo><mml:mi>a</mml:mi><mml:mi>g</mml:mi><mml:msub><mml:mrow><mml:mi>e</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo stretchy="false">&#8722;</mml:mo><mml:mover accent="false" class="mml-overline"><mml:mrow><mml:mi>a</mml:mi><mml:mi>g</mml:mi><mml:mi>e</mml:mi></mml:mrow><mml:mo accent="true">&#175;</mml:mo></mml:mover><mml:mo stretchy="false">)</mml:mo><mml:mo stretchy="false">+</mml:mo><mml:msub><mml:mrow><mml:mi>&#945;</mml:mi></mml:mrow><mml:mrow><mml:mi>s</mml:mi><mml:mi>e</mml:mi><mml:mi>x</mml:mi></mml:mrow></mml:msub><mml:mo stretchy="false">&#8901;</mml:mo><mml:mi>s</mml:mi><mml:mi>e</mml:mi><mml:msub><mml:mrow><mml:mi>x</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo stretchy="false">+</mml:mo><mml:msub><mml:mrow><mml:mi>&#945;</mml:mi></mml:mrow><mml:mrow><mml:mi>w</mml:mi><mml:mi>e</mml:mi><mml:mi>i</mml:mi><mml:mi>g</mml:mi><mml:mi>h</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:msub><mml:mo stretchy="false">&#8901;</mml:mo><mml:mo stretchy="false">(</mml:mo><mml:mi>w</mml:mi><mml:mi>e</mml:mi><mml:mi>i</mml:mi><mml:mi>g</mml:mi><mml:mi>h</mml:mi><mml:msub><mml:mrow><mml:mi>t</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo stretchy="false">&#8722;</mml:mo><mml:mover accent="false" class="mml-overline"><mml:mrow><mml:mi>w</mml:mi><mml:mi>e</mml:mi><mml:mi>i</mml:mi><mml:mi>g</mml:mi><mml:mi>h</mml:mi><mml:mi>t</mml:mi></mml:mrow><mml:mo accent="true">&#175;</mml:mo></mml:mover><mml:mo stretchy="false">)</mml:mo></mml:mtd><mml:mtd/><mml:mtd><mml:mtext/></mml:mtd></mml:mtr><mml:mtr><mml:mtd/><mml:mtd><mml:mo stretchy="false">&#8658;</mml:mo><mml:mi>B</mml:mi><mml:mi>S</mml:mi><mml:msub><mml:mrow><mml:mi>L</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo stretchy="false">&#8764;</mml:mo><mml:mstyle mathvariant="script"><mml:mi>N</mml:mi></mml:mstyle><mml:mo stretchy="false">(</mml:mo><mml:msub><mml:mrow><mml:mi>&#956;</mml:mi></mml:mrow><mml:mrow><mml:mi>B</mml:mi><mml:mi>S</mml:mi><mml:mi>L</mml:mi><mml:mo stretchy="false">,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo stretchy="false">,</mml:mo><mml:mi>s</mml:mi><mml:msubsup><mml:mrow><mml:mi>d</mml:mi></mml:mrow><mml:mrow><mml:mi>B</mml:mi><mml:mi>S</mml:mi><mml:mi>L</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msubsup><mml:mo stretchy="false">)</mml:mo></mml:mtd><mml:mtd/><mml:mtd><mml:mtext/></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:msub><mml:mrow><mml:mi>&#956;</mml:mi></mml:mrow><mml:mrow><mml:mi>V</mml:mi><mml:mi>C</mml:mi><mml:mo stretchy="false">,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mtd><mml:mtd><mml:mo stretchy="false">=</mml:mo><mml:mi>V</mml:mi><mml:msub><mml:mrow><mml:mi>C</mml:mi></mml:mrow><mml:mrow><mml:mn>0</mml:mn></mml:mrow></mml:msub><mml:mo stretchy="false">+</mml:mo><mml:msub><mml:mrow><mml:mi>&#947;</mml:mi></mml:mrow><mml:mrow><mml:mi>a</mml:mi><mml:mi>g</mml:mi><mml:mi>e</mml:mi></mml:mrow></mml:msub><mml:mo stretchy="false">&#8901;</mml:mo><mml:mo stretchy="false">(</mml:mo><mml:mi>a</mml:mi><mml:mi>g</mml:mi><mml:msub><mml:mrow><mml:mi>e</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo stretchy="false">&#8722;</mml:mo><mml:mover accent="false" class="mml-overline"><mml:mrow><mml:mi>a</mml:mi><mml:mi>g</mml:mi><mml:mi>e</mml:mi></mml:mrow><mml:mo accent="true">&#175;</mml:mo></mml:mover><mml:mo stretchy="false">)</mml:mo><mml:mo stretchy="false">+</mml:mo><mml:msub><mml:mrow><mml:mi>&#947;</mml:mi></mml:mrow><mml:mrow><mml:mi>w</mml:mi><mml:mi>e</mml:mi><mml:mi>i</mml:mi><mml:mi>g</mml:mi><mml:mi>h</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:msub><mml:mo stretchy="false">&#8901;</mml:mo><mml:mo stretchy="false">(</mml:mo><mml:mi>w</mml:mi><mml:mi>e</mml:mi><mml:mi>i</mml:mi><mml:mi>g</mml:mi><mml:mi>h</mml:mi><mml:msub><mml:mrow><mml:mi>t</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo stretchy="false">&#8722;</mml:mo><mml:mover accent="false" class="mml-overline"><mml:mrow><mml:mi>w</mml:mi><mml:mi>e</mml:mi><mml:mi>i</mml:mi><mml:mi>g</mml:mi><mml:mi>h</mml:mi><mml:mi>t</mml:mi></mml:mrow><mml:mo accent="true">&#175;</mml:mo></mml:mover><mml:mo stretchy="false">)</mml:mo></mml:mtd><mml:mtd/><mml:mtd><mml:mtext/></mml:mtd></mml:mtr><mml:mtr><mml:mtd/><mml:mtd><mml:mo stretchy="false">&#8658;</mml:mo><mml:mi>V</mml:mi><mml:msub><mml:mrow><mml:mi>C</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo stretchy="false">&#8764;</mml:mo><mml:mstyle mathvariant="script"><mml:mi>N</mml:mi></mml:mstyle><mml:mo stretchy="false">(</mml:mo><mml:msub><mml:mrow><mml:mi>&#956;</mml:mi></mml:mrow><mml:mrow><mml:mi>V</mml:mi><mml:mi>C</mml:mi><mml:mo stretchy="false">,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo stretchy="false">,</mml:mo><mml:mi>s</mml:mi><mml:msubsup><mml:mrow><mml:mi>d</mml:mi></mml:mrow><mml:mrow><mml:mi>V</mml:mi><mml:mi>C</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msubsup><mml:mo stretchy="false">)</mml:mo></mml:mtd><mml:mtd/><mml:mtd><mml:mtext/></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:msub><mml:mrow><mml:mi>&#956;</mml:mi></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>E</mml:mi></mml:mrow><mml:mrow><mml:mi>m</mml:mi><mml:mi>a</mml:mi><mml:mi>x</mml:mi></mml:mrow></mml:msub><mml:mo stretchy="false">,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mtd><mml:mtd><mml:mo stretchy="false">=</mml:mo><mml:msub><mml:mrow><mml:mi>E</mml:mi></mml:mrow><mml:mrow><mml:mi>m</mml:mi><mml:mi>a</mml:mi><mml:mi>x</mml:mi><mml:mo stretchy="false">,</mml:mo><mml:mn>0</mml:mn></mml:mrow></mml:msub><mml:mo stretchy="false">+</mml:mo><mml:msub><mml:mrow><mml:mi>&#946;</mml:mi></mml:mrow><mml:mrow><mml:mi>B</mml:mi><mml:mi>S</mml:mi><mml:mi>L</mml:mi></mml:mrow></mml:msub><mml:mo stretchy="false">&#8901;</mml:mo><mml:mo stretchy="false">(</mml:mo><mml:mi>B</mml:mi><mml:mi>S</mml:mi><mml:msub><mml:mrow><mml:mi>L</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo stretchy="false">&#8722;</mml:mo><mml:mover accent="false" class="mml-overline"><mml:mrow><mml:mi>B</mml:mi><mml:mi>S</mml:mi><mml:mi>L</mml:mi></mml:mrow><mml:mo accent="true">&#175;</mml:mo></mml:mover><mml:mo stretchy="false">)</mml:mo><mml:mo stretchy="false">+</mml:mo><mml:msub><mml:mrow><mml:mi>&#946;</mml:mi></mml:mrow><mml:mrow><mml:mi>e</mml:mi><mml:mi>t</mml:mi><mml:mi>h</mml:mi><mml:mi>n</mml:mi></mml:mrow></mml:msub><mml:mo stretchy="false">&#8901;</mml:mo><mml:mo stretchy="false">(</mml:mo><mml:mi>e</mml:mi><mml:mi>t</mml:mi><mml:mi>h</mml:mi><mml:msub><mml:mrow><mml:mi>n</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo stretchy="false">&#8722;</mml:mo><mml:mover accent="false" class="mml-overline"><mml:mrow><mml:mi>e</mml:mi><mml:mi>t</mml:mi><mml:mi>h</mml:mi><mml:mi>n</mml:mi></mml:mrow><mml:mo accent="true">&#175;</mml:mo></mml:mover><mml:mo stretchy="false">)</mml:mo></mml:mtd><mml:mtd/><mml:mtd><mml:mtext/></mml:mtd></mml:mtr><mml:mtr><mml:mtd/><mml:mtd><mml:mo stretchy="false">&#8658;</mml:mo><mml:msub><mml:mrow><mml:mi>E</mml:mi></mml:mrow><mml:mrow><mml:mi>m</mml:mi><mml:mi>a</mml:mi><mml:mi>x</mml:mi><mml:mo stretchy="false">,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo stretchy="false">&#8764;</mml:mo><mml:mstyle mathvariant="script"><mml:mi>N</mml:mi></mml:mstyle><mml:mo stretchy="false">(</mml:mo><mml:msub><mml:mrow><mml:mi>&#956;</mml:mi></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>E</mml:mi></mml:mrow><mml:mrow><mml:mi>m</mml:mi><mml:mi>a</mml:mi><mml:mi>x</mml:mi><mml:mo stretchy="false">,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub><mml:mo stretchy="false">,</mml:mo><mml:mi>s</mml:mi><mml:msubsup><mml:mrow><mml:mi>d</mml:mi></mml:mrow><mml:mrow><mml:mi>E</mml:mi><mml:mi>m</mml:mi><mml:mi>a</mml:mi><mml:mi>x</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msubsup><mml:mo stretchy="false">)</mml:mo></mml:mtd><mml:mtd/></mml:mtr></mml:mtable></mml:math></alternatives><label>(7)</label></disp-formula><p>The above introduced parameters from the PKPD model, <inline-formula id="pone.0318549.e024"><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0318549.e024g" position="anchor" orientation="portrait" xlink:href="pone.0318549.e024.jpg"/><mml:math id="m24" display="inline" overflow="scroll"><mml:mi>B</mml:mi><mml:mi>S</mml:mi><mml:msub><mml:mrow><mml:mi>L</mml:mi></mml:mrow><mml:mrow><mml:mn>0</mml:mn></mml:mrow></mml:msub></mml:math></alternatives></inline-formula>, <inline-formula id="pone.0318549.e025"><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0318549.e025g" position="anchor" orientation="portrait" xlink:href="pone.0318549.e025.jpg"/><mml:math id="m25" display="inline" overflow="scroll"><mml:mi>V</mml:mi><mml:msub><mml:mrow><mml:mi>C</mml:mi></mml:mrow><mml:mrow><mml:mn>0</mml:mn></mml:mrow></mml:msub></mml:math></alternatives></inline-formula>, and <inline-formula id="pone.0318549.e026"><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0318549.e026g" position="anchor" orientation="portrait" xlink:href="pone.0318549.e026.jpg"/><mml:math id="m26" display="inline" overflow="scroll"><mml:msub><mml:mrow><mml:mi>E</mml:mi></mml:mrow><mml:mrow><mml:mi>m</mml:mi><mml:mi>a</mml:mi><mml:mi>x</mml:mi><mml:mo stretchy="false">,</mml:mo><mml:mn>0</mml:mn></mml:mrow></mml:msub></mml:math></alternatives></inline-formula>, are the baseline parameters without any influence of additional covariates. The factors <inline-formula id="pone.0318549.e027"><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0318549.e027g" position="anchor" orientation="portrait" xlink:href="pone.0318549.e027.jpg"/><mml:math id="m27" display="inline" overflow="scroll"><mml:msub><mml:mrow><mml:mi>&#945;</mml:mi></mml:mrow><mml:mrow><mml:mi>a</mml:mi><mml:mi>g</mml:mi><mml:mi>e</mml:mi></mml:mrow></mml:msub></mml:math></alternatives></inline-formula>, <inline-formula id="pone.0318549.e028"><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0318549.e028g" position="anchor" orientation="portrait" xlink:href="pone.0318549.e028.jpg"/><mml:math id="m28" display="inline" overflow="scroll"><mml:msub><mml:mrow><mml:mi>&#945;</mml:mi></mml:mrow><mml:mrow><mml:mi>s</mml:mi><mml:mi>e</mml:mi><mml:mi>x</mml:mi></mml:mrow></mml:msub></mml:math></alternatives></inline-formula>, <inline-formula id="pone.0318549.e029"><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0318549.e029g" position="anchor" orientation="portrait" xlink:href="pone.0318549.e029.jpg"/><mml:math id="m29" display="inline" overflow="scroll"><mml:msub><mml:mrow><mml:mi>&#945;</mml:mi></mml:mrow><mml:mrow><mml:mi>w</mml:mi><mml:mi>e</mml:mi><mml:mi>i</mml:mi><mml:mi>g</mml:mi><mml:mi>h</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:msub></mml:math></alternatives></inline-formula>, <inline-formula id="pone.0318549.e030"><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0318549.e030g" position="anchor" orientation="portrait" xlink:href="pone.0318549.e030.jpg"/><mml:math id="m30" display="inline" overflow="scroll"><mml:msub><mml:mrow><mml:mi>&#947;</mml:mi></mml:mrow><mml:mrow><mml:mi>a</mml:mi><mml:mi>g</mml:mi><mml:mi>e</mml:mi></mml:mrow></mml:msub></mml:math></alternatives></inline-formula>, <inline-formula id="pone.0318549.e031"><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0318549.e031g" position="anchor" orientation="portrait" xlink:href="pone.0318549.e031.jpg"/><mml:math id="m31" display="inline" overflow="scroll"><mml:msub><mml:mrow><mml:mi>&#947;</mml:mi></mml:mrow><mml:mrow><mml:mi>w</mml:mi><mml:mi>e</mml:mi><mml:mi>i</mml:mi><mml:mi>g</mml:mi><mml:mi>h</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:msub></mml:math></alternatives></inline-formula>, <inline-formula id="pone.0318549.e032"><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0318549.e032g" position="anchor" orientation="portrait" xlink:href="pone.0318549.e032.jpg"/><mml:math id="m32" display="inline" overflow="scroll"><mml:msub><mml:mrow><mml:mi>&#946;</mml:mi></mml:mrow><mml:mrow><mml:mi>B</mml:mi><mml:mi>S</mml:mi><mml:mi>L</mml:mi></mml:mrow></mml:msub></mml:math></alternatives></inline-formula>, and <inline-formula id="pone.0318549.e033"><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0318549.e033g" position="anchor" orientation="portrait" xlink:href="pone.0318549.e033.jpg"/><mml:math id="m33" display="inline" overflow="scroll"><mml:msub><mml:mrow><mml:mi>&#946;</mml:mi></mml:mrow><mml:mrow><mml:mi>e</mml:mi><mml:mi>t</mml:mi><mml:mi>h</mml:mi><mml:mi>n</mml:mi></mml:mrow></mml:msub></mml:math></alternatives></inline-formula>, are derived by literature review (e.g., see [<xref rid="pone.0318549.ref021" ref-type="bibr">21</xref>,<xref rid="pone.0318549.ref030" ref-type="bibr">30</xref>,<xref rid="pone.0318549.ref031" ref-type="bibr">31</xref>]) as well as explorative analyses so that the effects given in literature are well expressed. The final values are given in the Appendix, <xref rid="pcbi.0318549.s006" ref-type="supplementary-material">S5 table</xref>. The corresponding reference values, i.e. for ethnicity, are given by the population means, i.e. denoted by <inline-formula id="pone.0318549.e034"><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0318549.e034g" position="anchor" orientation="portrait" xlink:href="pone.0318549.e034.jpg"/><mml:math id="m34" display="inline" overflow="scroll"><mml:mover accent="false" class="mml-overline"><mml:mrow><mml:mi>e</mml:mi><mml:mi>t</mml:mi><mml:mi>h</mml:mi><mml:mi>n</mml:mi></mml:mrow><mml:mo accent="true">&#175;</mml:mo></mml:mover></mml:math></alternatives></inline-formula>. For the categorical variable ethnicity, <inline-formula id="pone.0318549.e035"><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0318549.e035g" position="anchor" orientation="portrait" xlink:href="pone.0318549.e035.jpg"/><mml:math id="m35" display="inline" overflow="scroll"><mml:mover accent="false" class="mml-overline"><mml:mrow><mml:mi>e</mml:mi><mml:mi>t</mml:mi><mml:mi>h</mml:mi><mml:mi>n</mml:mi></mml:mrow><mml:mo accent="true">&#175;</mml:mo></mml:mover><mml:mo stretchy="false">=</mml:mo><mml:mn>0</mml:mn></mml:math></alternatives></inline-formula> denotes people of white ethnicity.</p></sec></sec><sec id="sec007"><title>Models for forecasting individual patient trajectories</title><p>Based on the simulated data, the aim is to model the drug effect on blood pressure and predict the effect course of anti-hypertensive medication in the early stages of titration phases. Since the individual courses within a day are irrelevant for this goal, the daily average values are considered. In this section, we develop a non-parametric (GP) and a parametric (nlme) which can be used for forecasting individual patient trajectories. Let the time courses be aggregated by the daily means of the systolic blood pressure for <italic toggle="yes">N</italic> individuals given in the present data set. In addition, the covariates height, weight, age, sex, and ethnicity are assumed to be known for all individuals.</p><p>In the following, <italic toggle="yes">i</italic>&#160;,&#160;<italic toggle="yes">i</italic>&#160;&#8712;&#160;{&#160;1&#160;,&#160;<italic toggle="yes">&#8230;</italic>&#160;,&#160;<italic toggle="yes">N</italic>&#160;}&#160; denotes the individual patient ID and <inline-formula id="pone.0318549.e037"><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0318549.e037g" position="anchor" orientation="portrait" xlink:href="pone.0318549.e037.jpg"/><mml:math id="m37" display="inline" overflow="scroll"><mml:mi>t</mml:mi><mml:mo stretchy="false">,</mml:mo><mml:mspace class="nbsp" width="0.33em"/><mml:mi>t</mml:mi><mml:mo stretchy="false">&#8712;</mml:mo><mml:mo stretchy="false">{</mml:mo><mml:mn>0</mml:mn><mml:mo stretchy="false">,</mml:mo><mml:mi>&#8230;</mml:mi><mml:mo stretchy="false">,</mml:mo><mml:msub><mml:mrow><mml:mi>n</mml:mi></mml:mrow><mml:mrow><mml:mi>o</mml:mi></mml:mrow></mml:msub><mml:mo stretchy="false">}</mml:mo></mml:math></alternatives></inline-formula> the day of observation. <inline-formula id="pone.0318549.e038"><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0318549.e038g" position="anchor" orientation="portrait" xlink:href="pone.0318549.e038.jpg"/><mml:math id="m38" display="inline" overflow="scroll"><mml:msub><mml:mrow><mml:mi>t</mml:mi></mml:mrow><mml:mrow><mml:mi>m</mml:mi><mml:mi>a</mml:mi><mml:mi>x</mml:mi></mml:mrow></mml:msub><mml:mo stretchy="false">,</mml:mo><mml:mspace class="nbsp" width="0.33em"/><mml:msub><mml:mrow><mml:mi>t</mml:mi></mml:mrow><mml:mrow><mml:mi>m</mml:mi><mml:mi>a</mml:mi><mml:mi>x</mml:mi></mml:mrow></mml:msub><mml:mo stretchy="false">&#8712;</mml:mo><mml:mo stretchy="false">{</mml:mo><mml:mn>1</mml:mn><mml:mo stretchy="false">,</mml:mo><mml:mi>&#8230;</mml:mi><mml:mo stretchy="false">,</mml:mo><mml:msub><mml:mrow><mml:mi>n</mml:mi></mml:mrow><mml:mrow><mml:mi>m</mml:mi></mml:mrow></mml:msub><mml:mo stretchy="false">}</mml:mo></mml:math></alternatives></inline-formula> is the day of last known observation in test data, which is constant over all test individuals. Further, <inline-formula id="pone.0318549.e039"><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0318549.e039g" position="anchor" orientation="portrait" xlink:href="pone.0318549.e039.jpg"/><mml:math id="m39" display="inline" overflow="scroll"><mml:msub><mml:mrow><mml:mi>y</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo stretchy="false">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:math></alternatives></inline-formula> is the blood pressure value of individual <italic toggle="yes">i</italic> at day <italic toggle="yes">t</italic>. The corresponding predicted values of individual <italic toggle="yes">i</italic> at day <inline-formula id="pone.0318549.e040"><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0318549.e040g" position="anchor" orientation="portrait" xlink:href="pone.0318549.e040.jpg"/><mml:math id="m40" display="inline" overflow="scroll"><mml:mi>t</mml:mi><mml:mo stretchy="false">,</mml:mo><mml:mspace class="nbsp" width="0.33em"/><mml:mi>t</mml:mi><mml:mo stretchy="false">&#8712;</mml:mo><mml:mo stretchy="false">{</mml:mo><mml:mn>1</mml:mn><mml:mo stretchy="false">,</mml:mo><mml:mi>&#8230;</mml:mi><mml:mo stretchy="false">,</mml:mo><mml:msub><mml:mrow><mml:mi>n</mml:mi></mml:mrow><mml:mrow><mml:mi>o</mml:mi></mml:mrow></mml:msub><mml:mo stretchy="false">}</mml:mo></mml:math></alternatives></inline-formula>, are denoted as <inline-formula id="pone.0318549.e041"><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0318549.e041g" position="anchor" orientation="portrait" xlink:href="pone.0318549.e041.jpg"/><mml:math id="m41" display="inline" overflow="scroll"><mml:msubsup><mml:mrow><mml:mi>&#375;</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mo stretchy="false">,</mml:mo><mml:msub><mml:mrow><mml:mi>t</mml:mi></mml:mrow><mml:mrow><mml:mi>m</mml:mi><mml:mi>a</mml:mi><mml:mi>x</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>G</mml:mi><mml:mi>P</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:msubsup><mml:mo stretchy="false">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:math></alternatives></inline-formula> and <inline-formula id="pone.0318549.e042"><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0318549.e042g" position="anchor" orientation="portrait" xlink:href="pone.0318549.e042.jpg"/><mml:math id="m42" display="inline" overflow="scroll"><mml:msubsup><mml:mrow><mml:mi>&#375;</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mo stretchy="false">,</mml:mo><mml:msub><mml:mrow><mml:mi>t</mml:mi></mml:mrow><mml:mrow><mml:mi>m</mml:mi><mml:mi>a</mml:mi><mml:mi>x</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>n</mml:mi><mml:mi>l</mml:mi><mml:mi>m</mml:mi><mml:mi>e</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:msubsup><mml:mo stretchy="false">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:math></alternatives></inline-formula> based on the GP model and nlme model given <inline-formula id="pone.0318549.e043"><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0318549.e043g" position="anchor" orientation="portrait" xlink:href="pone.0318549.e043.jpg"/><mml:math id="m43" display="inline" overflow="scroll"><mml:msub><mml:mrow><mml:mi>t</mml:mi></mml:mrow><mml:mrow><mml:mi>m</mml:mi><mml:mi>a</mml:mi><mml:mi>x</mml:mi></mml:mrow></mml:msub></mml:math></alternatives></inline-formula> data points, respectively.</p><sec id="sec008"><title>Parametric approach: Non-linear mixed effects model</title><p>In cases where additional information concerning the shape of a curve is available such information can be harnessed by a parametric model to optimize the parameters of interest. A widely adopted model for this purpose is the mixed effects model, which enables the estimation of both population-wide influences and subject-specific effects. In our use case, the model formula is motivated by [<xref rid="pone.0318549.ref010" ref-type="bibr">10</xref>], where the blood pressure reduction <inline-formula id="pone.0318549.e044"><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0318549.e044g" position="anchor" orientation="portrait" xlink:href="pone.0318549.e044.jpg"/><mml:math id="m44" display="inline" overflow="scroll"><mml:mi>B</mml:mi><mml:msub><mml:mrow><mml:mi>P</mml:mi></mml:mrow><mml:mrow><mml:mi>R</mml:mi><mml:mi>e</mml:mi><mml:mi>d</mml:mi><mml:mi>u</mml:mi><mml:mi>c</mml:mi><mml:mi>t</mml:mi><mml:mi>i</mml:mi><mml:mi>o</mml:mi><mml:mi>n</mml:mi></mml:mrow></mml:msub><mml:mo stretchy="false">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:math></alternatives></inline-formula> at time <italic toggle="yes">t</italic> is modeled by an asymptotic approach to a plateau given by</p><disp-formula id="pone.0318549.e099"><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0318549.e099g" position="anchor" orientation="portrait" xlink:href="pone.0318549.e099.jpg"/><mml:math id="m010" display="block" overflow="scroll"><mml:mtable><mml:mtr><mml:mtd><mml:mi>B</mml:mi><mml:msub><mml:mrow><mml:mi>P</mml:mi></mml:mrow><mml:mrow><mml:mi>R</mml:mi><mml:mi>e</mml:mi><mml:mi>d</mml:mi><mml:mi>u</mml:mi><mml:mi>c</mml:mi><mml:mi>t</mml:mi><mml:mi>i</mml:mi><mml:mi>o</mml:mi><mml:mi>n</mml:mi></mml:mrow></mml:msub><mml:mo stretchy="false">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy="false">)</mml:mo><mml:mo stretchy="false">=</mml:mo><mml:msub><mml:mrow><mml:mi>R</mml:mi></mml:mrow><mml:mrow><mml:mi>m</mml:mi><mml:mi>a</mml:mi><mml:mi>x</mml:mi></mml:mrow></mml:msub><mml:mo stretchy="false">&#8901;</mml:mo><mml:mrow><mml:mo fence="true" form="prefix"> (</mml:mo><mml:mrow><mml:mn>1</mml:mn><mml:mo stretchy="false">&#8722;</mml:mo><mml:mi>e</mml:mi><mml:mi>x</mml:mi><mml:mi>p</mml:mi><mml:mrow><mml:mo fence="true" form="prefix"> (</mml:mo><mml:mrow><mml:mo stretchy="false">&#8722;</mml:mo><mml:mfrac><mml:mrow><mml:mi>t</mml:mi><mml:mo stretchy="false">&#8901;</mml:mo><mml:mi>l</mml:mi><mml:mi>n</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:mn>2</mml:mn><mml:mo stretchy="false">)</mml:mo></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:msub><mml:mrow><mml:mi>t</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn><mml:mo stretchy="false">&#8725;</mml:mo><mml:mn>2</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:mfrac></mml:mrow><mml:mo fence="true" form="postfix">)</mml:mo></mml:mrow></mml:mrow><mml:mo fence="true" form="postfix">)</mml:mo></mml:mrow></mml:mtd><mml:mtd/><mml:mtd/></mml:mtr></mml:mtable></mml:math></alternatives><label>(8)</label></disp-formula><p>with <inline-formula id="pone.0318549.e045"><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0318549.e045g" position="anchor" orientation="portrait" xlink:href="pone.0318549.e045.jpg"/><mml:math id="m45" display="inline" overflow="scroll"><mml:msub><mml:mrow><mml:mi>R</mml:mi></mml:mrow><mml:mrow><mml:mi>m</mml:mi><mml:mi>a</mml:mi><mml:mi>x</mml:mi></mml:mrow></mml:msub></mml:math></alternatives></inline-formula> as the maximal reduction in blood pressure, <inline-formula id="pone.0318549.e046"><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0318549.e046g" position="anchor" orientation="portrait" xlink:href="pone.0318549.e046.jpg"/><mml:math id="m46" display="inline" overflow="scroll"><mml:mi>d</mml:mi><mml:msub><mml:mrow><mml:mi>t</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn><mml:mo stretchy="false">&#8725;</mml:mo><mml:mn>2</mml:mn></mml:mrow></mml:msub></mml:math></alternatives></inline-formula> as dynamic half-life time, i.e., time to reach 50% of maximal reduction, and <italic toggle="yes">t</italic> is the time since the beginning of therapy or taking medication. To account for uncertainty in the analysis and enable more robust inference and predictive accuracy despite limited data, we will adopt a Bayesian modeling framework. For our use case, we need to adjust the model given by formula (<xref rid="pone.0318549.e099" ref-type="disp-formula">8</xref>) as our objective is to model individual patient trajectories. This specifically means that we need to allow for patient-specific saturation levels <inline-formula id="pone.0318549.e047"><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0318549.e047g" position="anchor" orientation="portrait" xlink:href="pone.0318549.e047.jpg"/><mml:math id="m47" display="inline" overflow="scroll"><mml:msub><mml:mrow><mml:mi>R</mml:mi></mml:mrow><mml:mrow><mml:mi>m</mml:mi><mml:mi>a</mml:mi><mml:mi>x</mml:mi></mml:mrow></mml:msub></mml:math></alternatives></inline-formula> and patients-specific half lives <inline-formula id="pone.0318549.e048"><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0318549.e048g" position="anchor" orientation="portrait" xlink:href="pone.0318549.e048.jpg"/><mml:math id="m48" display="inline" overflow="scroll"><mml:mi>d</mml:mi><mml:msub><mml:mrow><mml:mi>t</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn><mml:mo stretchy="false">&#8725;</mml:mo><mml:mn>2</mml:mn></mml:mrow></mml:msub></mml:math></alternatives></inline-formula>. We also introduce an additional population-wide parameter <italic toggle="yes">&#969;</italic>, that allows for additional variations in formula (<xref rid="pone.0318549.e099" ref-type="disp-formula">8</xref>). To avoid high complexity and computational intensity of the model, an individual effect on <italic toggle="yes">&#969;</italic> is not considered, as it exerts no direct influence on effect magnitude or time to full effect. In other words, we assume that the general curve shape depends on <italic toggle="yes">&#969;</italic>, with variations limited to half-life time and effect magnitude among individuals. To ensure that the estimators remain in the positive range, we log-transform the parameters, resulting in the following equation for the likelihood:</p><disp-formula id="pone.0318549.e100"><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0318549.e100g" position="anchor" orientation="portrait" xlink:href="pone.0318549.e100.jpg"/><mml:math id="m011" display="block" overflow="scroll"><mml:mtable><mml:mtr><mml:mtd><mml:msubsup><mml:mrow><mml:mi>&#375;</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mo stretchy="false">,</mml:mo><mml:msub><mml:mrow><mml:mi>t</mml:mi></mml:mrow><mml:mrow><mml:mi>m</mml:mi><mml:mi>a</mml:mi><mml:mi>x</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>n</mml:mi><mml:mi>l</mml:mi><mml:mi>m</mml:mi><mml:mi>e</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:msubsup><mml:mo stretchy="false">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy="false">)</mml:mo><mml:msub><mml:mrow><mml:mo stretchy="false">|</mml:mo></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>&#951;</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub></mml:mtd><mml:mtd><mml:mo stretchy="false">=</mml:mo><mml:mi>e</mml:mi><mml:mi>x</mml:mi><mml:mi>p</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:mi>l</mml:mi><mml:msub><mml:mrow><mml:mi>R</mml:mi></mml:mrow><mml:mrow><mml:mi>m</mml:mi><mml:mi>a</mml:mi><mml:mi>x</mml:mi><mml:mo stretchy="false">,</mml:mo><mml:mi>i</mml:mi><mml:mo stretchy="false">,</mml:mo><mml:msub><mml:mrow><mml:mi>t</mml:mi></mml:mrow><mml:mrow><mml:mi>m</mml:mi><mml:mi>a</mml:mi><mml:mi>x</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub><mml:mo stretchy="false">)</mml:mo><mml:mo stretchy="false">&#8901;</mml:mo><mml:mrow><mml:mo fence="true" form="prefix"> (</mml:mo><mml:mrow><mml:mn>1</mml:mn><mml:mo stretchy="false">&#8722;</mml:mo><mml:mi>e</mml:mi><mml:mi>x</mml:mi><mml:mi>p</mml:mi><mml:mrow><mml:mo fence="true" form="prefix"> (</mml:mo><mml:mrow><mml:mo stretchy="false">&#8722;</mml:mo><mml:msup><mml:mrow><mml:mrow><mml:mo fence="true" form="prefix"> (</mml:mo><mml:mrow><mml:mfrac><mml:mrow><mml:mi>t</mml:mi><mml:mo stretchy="false">&#8901;</mml:mo><mml:mi>l</mml:mi><mml:mi>n</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:mn>2</mml:mn><mml:mo stretchy="false">)</mml:mo></mml:mrow><mml:mrow><mml:mi>e</mml:mi><mml:mi>x</mml:mi><mml:mi>p</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:mi>l</mml:mi><mml:msub><mml:mrow><mml:mi>t</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn><mml:mo stretchy="false">&#8725;</mml:mo><mml:mn>2</mml:mn><mml:mo stretchy="false">,</mml:mo><mml:mi>i</mml:mi><mml:mo stretchy="false">,</mml:mo><mml:msub><mml:mrow><mml:mi>t</mml:mi></mml:mrow><mml:mrow><mml:mi>m</mml:mi><mml:mi>a</mml:mi><mml:mi>x</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mfrac></mml:mrow><mml:mo fence="true" form="postfix">)</mml:mo></mml:mrow></mml:mrow><mml:mrow><mml:mi>e</mml:mi><mml:mi>x</mml:mi><mml:mi>p</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:mi>l</mml:mi><mml:mi>&#969;</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:msup></mml:mrow><mml:mo fence="true" form="postfix">)</mml:mo></mml:mrow></mml:mrow><mml:mo fence="true" form="postfix">)</mml:mo></mml:mrow></mml:mtd><mml:mtd/></mml:mtr><mml:mtr><mml:mtd><mml:mi>l</mml:mi><mml:msub><mml:mrow><mml:mi>R</mml:mi></mml:mrow><mml:mrow><mml:mstyle class="text"><mml:mtext>max</mml:mtext></mml:mstyle><mml:mo stretchy="false">,</mml:mo><mml:mi>i</mml:mi><mml:mo stretchy="false">,</mml:mo><mml:msub><mml:mrow><mml:mi>t</mml:mi></mml:mrow><mml:mrow><mml:mi>m</mml:mi><mml:mi>a</mml:mi><mml:mi>x</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub></mml:mtd><mml:mtd><mml:mo stretchy="false">=</mml:mo><mml:mi>l</mml:mi><mml:msub><mml:mrow><mml:mi>R</mml:mi></mml:mrow><mml:mrow><mml:mstyle class="text"><mml:mtext>max,pop</mml:mtext></mml:mstyle></mml:mrow></mml:msub><mml:mo stretchy="false">+</mml:mo><mml:msub><mml:mrow><mml:mi>&#951;</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mo stretchy="false">,</mml:mo><mml:mn>1</mml:mn><mml:mo stretchy="false">,</mml:mo><mml:msub><mml:mrow><mml:mi>t</mml:mi></mml:mrow><mml:mrow><mml:mi>m</mml:mi><mml:mi>a</mml:mi><mml:mi>x</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub><mml:mo stretchy="false">,</mml:mo><mml:mspace class="nbsp" width="0.33em"/><mml:mspace class="nbsp" width="0.33em"/><mml:mspace class="nbsp" width="0.33em"/><mml:mi>l</mml:mi><mml:msub><mml:mrow><mml:mi>t</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn><mml:mo stretchy="false">&#8725;</mml:mo><mml:mn>2</mml:mn><mml:mo stretchy="false">,</mml:mo><mml:mi>i</mml:mi><mml:mo stretchy="false">,</mml:mo><mml:msub><mml:mrow><mml:mi>t</mml:mi></mml:mrow><mml:mrow><mml:mi>m</mml:mi><mml:mi>a</mml:mi><mml:mi>x</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub><mml:mo stretchy="false">=</mml:mo><mml:mi>l</mml:mi><mml:msub><mml:mrow><mml:mi>t</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn><mml:mo stretchy="false">&#8725;</mml:mo><mml:mn>2</mml:mn><mml:mo stretchy="false">,</mml:mo><mml:mstyle class="text"><mml:mtext>pop</mml:mtext></mml:mstyle></mml:mrow></mml:msub><mml:mo stretchy="false">+</mml:mo><mml:msub><mml:mrow><mml:mi>&#951;</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mo stretchy="false">,</mml:mo><mml:mn>2</mml:mn><mml:mo stretchy="false">,</mml:mo><mml:msub><mml:mrow><mml:mi>t</mml:mi></mml:mrow><mml:mrow><mml:mi>m</mml:mi><mml:mi>a</mml:mi><mml:mi>x</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub></mml:mtd><mml:mtd/><mml:mtd><mml:mtext/></mml:mtd></mml:mtr></mml:mtable></mml:math></alternatives><label>(9)</label></disp-formula><p>with <inline-formula id="pone.0318549.e052"><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0318549.e052g" position="anchor" orientation="portrait" xlink:href="pone.0318549.e052.jpg"/><mml:math id="m52" display="inline" overflow="scroll"><mml:msub><mml:mrow><mml:mstyle mathvariant="bold"><mml:mi>&#951;</mml:mi></mml:mstyle></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mo stretchy="false">,</mml:mo><mml:msub><mml:mrow><mml:mi>t</mml:mi></mml:mrow><mml:mrow><mml:mi>m</mml:mi><mml:mi>a</mml:mi><mml:mi>x</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub><mml:mo stretchy="false">=</mml:mo><mml:msup><mml:mrow><mml:mrow><mml:mo fence="true" form="prefix"> (</mml:mo><mml:mrow><mml:msub><mml:mrow><mml:mi>&#951;</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mo stretchy="false">,</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mo stretchy="false">,</mml:mo><mml:msub><mml:mrow><mml:mi>&#951;</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mo stretchy="false">,</mml:mo><mml:mn>2</mml:mn></mml:mrow></mml:msub></mml:mrow><mml:mo fence="true" form="postfix">)</mml:mo></mml:mrow></mml:mrow><mml:mrow><mml:mi>T</mml:mi></mml:mrow></mml:msup></mml:math></alternatives></inline-formula>. The priors for the Bayesian framework are given by</p><disp-formula id="pone.0318549.e101"><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0318549.e101g" position="anchor" orientation="portrait" xlink:href="pone.0318549.e101.jpg"/><mml:math id="m012" display="block" overflow="scroll"><mml:mtable><mml:mtr><mml:mtd><mml:mi>l</mml:mi><mml:msub><mml:mrow><mml:mi>R</mml:mi></mml:mrow><mml:mrow><mml:mstyle class="text"><mml:mtext>max,pop</mml:mtext></mml:mstyle></mml:mrow></mml:msub><mml:mo stretchy="false">&#8764;</mml:mo><mml:mstyle mathvariant="script"><mml:mi>N</mml:mi></mml:mstyle><mml:mo stretchy="false">(</mml:mo><mml:mn>1</mml:mn><mml:mo stretchy="false">.</mml:mo><mml:mn>2</mml:mn><mml:mo stretchy="false">,</mml:mo><mml:mn>0</mml:mn><mml:mo stretchy="false">.</mml:mo><mml:mn>1</mml:mn><mml:mo stretchy="false">)</mml:mo><mml:mo stretchy="false">,</mml:mo><mml:mspace class="nbsp" width="0.33em"/><mml:mspace class="nbsp" width="0.33em"/><mml:mi>l</mml:mi><mml:msub><mml:mrow><mml:mi>t</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn><mml:mo stretchy="false">&#8725;</mml:mo><mml:mn>2</mml:mn><mml:mo stretchy="false">,</mml:mo><mml:mstyle class="text"><mml:mtext>pop</mml:mtext></mml:mstyle></mml:mrow></mml:msub><mml:mo stretchy="false">&#8764;</mml:mo><mml:mstyle mathvariant="script"><mml:mi>N</mml:mi></mml:mstyle><mml:mo stretchy="false">(</mml:mo><mml:mn>0</mml:mn><mml:mo stretchy="false">.</mml:mo><mml:mn>5</mml:mn><mml:mo stretchy="false">,</mml:mo><mml:mn>0</mml:mn><mml:mo stretchy="false">.</mml:mo><mml:mn>2</mml:mn><mml:mo stretchy="false">)</mml:mo><mml:mo stretchy="false">,</mml:mo><mml:mspace class="nbsp" width="0.33em"/><mml:mspace class="nbsp" width="0.33em"/><mml:mi>l</mml:mi><mml:mi>&#969;</mml:mi><mml:mo stretchy="false">&#8764;</mml:mo><mml:mstyle mathvariant="script"><mml:mi>N</mml:mi></mml:mstyle><mml:mo stretchy="false">(</mml:mo><mml:mn>1</mml:mn><mml:mo stretchy="false">,</mml:mo><mml:mn>0</mml:mn><mml:mo stretchy="false">.</mml:mo><mml:mn>1</mml:mn><mml:mo stretchy="false">)</mml:mo><mml:mspace class="nbsp" width="0.33em"/><mml:mspace class="nbsp" width="0.33em"/><mml:mspace class="nbsp" width="0.33em"/><mml:mo stretchy="false">.</mml:mo></mml:mtd><mml:mtd/><mml:mtd/></mml:mtr></mml:mtable></mml:math></alternatives><label>(10)</label></disp-formula><p>resulting from analysing the shape with regard to the known properties regarding mean half-life time and mean effect size. The model is fitted using Bayesian techniques using the <italic toggle="yes">brms</italic> R package [<xref rid="pone.0318549.ref032" ref-type="bibr">32</xref>]. For this model, we assume homoscedasticity, normal-distributed residuals and independence of individuals.</p><p>We assume that data is split in a training dataset (which is used for fitting the model) and then applied to unseen observations. In practice, the first step needs to be completed prior to the first application of this approach whereas the application to unseen observations represents the realistic scenario for a use in practice (novel patients need to get a forecast).</p></sec><sec id="sec009"><title>Non-parametric approach: Advanced Gaussian process</title><p>GPs provide a non-parametric method for estimating functions, allowing for the fitting of flexible models which capture the data while quantifying uncertainties in predictions. In hierarchical GPs, the data follows a nested structure given by a population-based GP and an individual GP. The population-based GP captures broad trends, while the individual GPs link observations to these trends. Prior knowledge enhances predictions [<xref rid="pone.0318549.ref033" ref-type="bibr">33</xref>,<xref rid="pone.0318549.ref034" ref-type="bibr">34</xref>].</p><p>To address challenges with convergence of Bayesian estimation as well as extrapolation problems using GPs, we propose an alternative approach: The proposed step-wise procedure, here called advanced GP, combines classical likelihood estimation methods and Bayesian methods in GP modeling. The analytical process consists of fitting a mean population GP to capture global trends. Residuals are then calculated. A Bayesian approach refines the model by estimating individual effects using training data. This completes the model building. For an estimation of effects on previously unseen data, we match the unseen observations to the subjects from the training data, identify trajectory-like data and make use of those for an accurate forecasting of the blood pressure saturation levels. More concretely, we follow these steps:</p><list list-type="order"><list-item><p><italic toggle="yes">Fit of Mean Population Gaussian Process:</italic> In the initial step of our analysis, we fit a mean GP <inline-formula id="pone.0318549.e053"><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0318549.e053g" position="anchor" orientation="portrait" xlink:href="pone.0318549.e053.jpg"/><mml:math id="m53" display="inline" overflow="scroll"><mml:msub><mml:mrow><mml:mi>&#375;</mml:mi></mml:mrow><mml:mrow><mml:mi>m</mml:mi><mml:mi>e</mml:mi><mml:mi>a</mml:mi><mml:mi>n</mml:mi><mml:mo stretchy="false">,</mml:mo><mml:mi>G</mml:mi><mml:mi>P</mml:mi></mml:mrow></mml:msub><mml:mo stretchy="false">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:math></alternatives></inline-formula> given by<disp-formula id="pone.0318549.e102"><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0318549.e102g" position="anchor" orientation="portrait" xlink:href="pone.0318549.e102.jpg"/><mml:math id="m013" display="block" overflow="scroll"><mml:mtable><mml:mtr><mml:mtd><mml:msub><mml:mrow><mml:mi>&#375;</mml:mi></mml:mrow><mml:mrow><mml:mi>m</mml:mi><mml:mi>e</mml:mi><mml:mi>a</mml:mi><mml:mi>n</mml:mi><mml:mo stretchy="false">,</mml:mo><mml:mi>G</mml:mi><mml:mi>P</mml:mi></mml:mrow></mml:msub><mml:mo stretchy="false">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy="false">)</mml:mo><mml:mo stretchy="false">|</mml:mo><mml:mo stretchy="false">(</mml:mo><mml:msub><mml:mrow><mml:mi>y</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo stretchy="false">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy="false">)</mml:mo><mml:mo stretchy="false">,</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy="false">)</mml:mo><mml:mo stretchy="false">&#8764;</mml:mo><mml:mstyle mathvariant="script"><mml:mi>N</mml:mi></mml:mstyle><mml:mrow><mml:mo fence="true" form="prefix"> (</mml:mo><mml:mrow><mml:msub><mml:mrow><mml:mi>&#956;</mml:mi></mml:mrow><mml:mrow><mml:mi>m</mml:mi><mml:mi>e</mml:mi><mml:mi>a</mml:mi><mml:mi>n</mml:mi></mml:mrow></mml:msub><mml:mo stretchy="false">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy="false">)</mml:mo><mml:mo stretchy="false">,</mml:mo><mml:msub><mml:mrow><mml:mstyle mathvariant="bold-italic"><mml:mi mathvariant="normal">&#931;</mml:mi></mml:mstyle></mml:mrow><mml:mrow><mml:mi>m</mml:mi><mml:mi>e</mml:mi><mml:mi>a</mml:mi><mml:mi>n</mml:mi></mml:mrow></mml:msub><mml:mo stretchy="false">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow><mml:mo fence="true" form="postfix">)</mml:mo></mml:mrow></mml:mtd><mml:mtd/><mml:mtd/></mml:mtr></mml:mtable></mml:math></alternatives><label>(11)</label></disp-formula></p><p>given the squared exponential kernel<disp-formula id="pone.0318549.e103"><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0318549.e103g" position="anchor" orientation="portrait" xlink:href="pone.0318549.e103.jpg"/><mml:math id="m014" display="block" overflow="scroll"><mml:mtable><mml:mtr><mml:mtd><mml:mi>k</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:mi>x</mml:mi><mml:mo stretchy="false">,</mml:mo><mml:msub><mml:mrow><mml:mi>x</mml:mi></mml:mrow><mml:mrow><mml:mo stretchy="false">&#8902;</mml:mo></mml:mrow></mml:msub><mml:mo stretchy="false">)</mml:mo><mml:mo stretchy="false">=</mml:mo><mml:msup><mml:mrow><mml:mi>&#963;</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msup><mml:mo stretchy="false">&#8901;</mml:mo><mml:mi>e</mml:mi><mml:mi>x</mml:mi><mml:mi>p</mml:mi><mml:mrow><mml:mo fence="true" form="prefix"> (</mml:mo><mml:mrow><mml:mo stretchy="false">&#8722;</mml:mo><mml:mfrac><mml:mrow><mml:msup><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>x</mml:mi><mml:mo stretchy="false">&#8722;</mml:mo><mml:msub><mml:mrow><mml:mi>x</mml:mi></mml:mrow><mml:mrow><mml:mo stretchy="false">&#8902;</mml:mo></mml:mrow></mml:msub><mml:mo stretchy="false">)</mml:mo></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msup></mml:mrow><mml:mrow><mml:mn>2</mml:mn><mml:msup><mml:mrow><mml:mi>l</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msup></mml:mrow></mml:mfrac></mml:mrow><mml:mo fence="true" form="postfix">)</mml:mo></mml:mrow><mml:mspace class="nbsp" width="0.33em"/><mml:mspace class="nbsp" width="0.33em"/><mml:mspace class="nbsp" width="0.33em"/><mml:mo stretchy="false">.</mml:mo></mml:mtd><mml:mtd/><mml:mtd/></mml:mtr></mml:mtable></mml:math></alternatives><label>(12)</label></disp-formula></p><p>Therefore, first the hyperparameters <italic toggle="yes">&#952;</italic>&#160;=&#160;(&#160;<italic toggle="yes">l</italic>&#160;,&#160;<italic toggle="yes">&#963;</italic>&#160;)&#160; are fitted by optimizing the log marginal likelihood<disp-formula id="pone.0318549.e104"><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0318549.e104g" position="anchor" orientation="portrait" xlink:href="pone.0318549.e104.jpg"/><mml:math id="m015" display="block" overflow="scroll"><mml:mtable><mml:mtr><mml:mtd><mml:mi>l</mml:mi><mml:mi>n</mml:mi><mml:mspace class="nbsp" width="0.33em"/><mml:mi>p</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:mi mathvariant="bold">y</mml:mi><mml:mo stretchy="false">|</mml:mo><mml:mi mathvariant="bold">X</mml:mi><mml:mo>,</mml:mo><mml:mi mathvariant="bold">&#952;</mml:mi><mml:mo stretchy="false">)</mml:mo><mml:mo stretchy="false">=</mml:mo><mml:mo stretchy="false">&#8722;</mml:mo><mml:mfrac><mml:mrow><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:mfrac><mml:msup><mml:mrow><mml:mi mathvariant="bold">y</mml:mi></mml:mrow><mml:mrow><mml:mi>T</mml:mi></mml:mrow></mml:msup><mml:msup><mml:mrow><mml:mi mathvariant="bold">K</mml:mi></mml:mrow><mml:mrow><mml:mo stretchy="false">&#8722;</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msup><mml:mi mathvariant="bold">y</mml:mi><mml:mo stretchy="false">&#8722;</mml:mo><mml:mfrac><mml:mrow><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:mfrac><mml:mi>l</mml:mi><mml:mi>n</mml:mi><mml:mspace class="nbsp" width="0.33em"/><mml:mo stretchy="false">|</mml:mo><mml:mi mathvariant="bold">K</mml:mi><mml:mo stretchy="false">+</mml:mo><mml:msub><mml:mrow><mml:mi>&#963;</mml:mi></mml:mrow><mml:mrow><mml:mi>n</mml:mi></mml:mrow></mml:msub><mml:mi mathvariant="bold">I</mml:mi><mml:mo stretchy="false">|</mml:mo><mml:mo stretchy="false">&#8722;</mml:mo><mml:mfrac><mml:mrow><mml:mi>n</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:mfrac><mml:mi>l</mml:mi><mml:mi>n</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:mn>2</mml:mn><mml:mi>&#960;</mml:mi><mml:mo stretchy="false">)</mml:mo><mml:mspace class="nbsp" width="0.33em"/><mml:mspace class="nbsp" width="0.33em"/><mml:mspace class="nbsp" width="0.33em"/><mml:mo stretchy="false">,</mml:mo></mml:mtd></mml:mtr></mml:mtable></mml:math></alternatives><label>(13)</label></disp-formula></p><p>given the training data <inline-formula id="pone.0318549.e055"><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0318549.e055g" position="anchor" orientation="portrait" xlink:href="pone.0318549.e055.jpg"/><mml:math id="m55" display="inline" overflow="scroll"><mml:mo stretchy="false">{</mml:mo><mml:mo stretchy="false">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy="false">,</mml:mo><mml:msub><mml:mrow><mml:mi>y</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo stretchy="false">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy="false">)</mml:mo><mml:mo stretchy="false">)</mml:mo><mml:mo stretchy="false">:</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy="false">&#8712;</mml:mo><mml:mo stretchy="false">{</mml:mo><mml:mn>0</mml:mn><mml:mo stretchy="false">,</mml:mo><mml:mi>&#8230;</mml:mi><mml:mo stretchy="false">,</mml:mo><mml:msub><mml:mrow><mml:mi>n</mml:mi></mml:mrow><mml:mrow><mml:mi>o</mml:mi></mml:mrow></mml:msub><mml:mo stretchy="false">}</mml:mo><mml:mo stretchy="false">,</mml:mo><mml:mstyle class="text"><mml:mtext>individual </mml:mtext><mml:mstyle class="math"><mml:mi>i</mml:mi></mml:mstyle><mml:mtext> included in training subset</mml:mtext></mml:mstyle><mml:mo stretchy="false">}</mml:mo></mml:math></alternatives></inline-formula> and <inline-formula id="pone.0318549.e056"><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0318549.e056g" position="anchor" orientation="portrait" xlink:href="pone.0318549.e056.jpg"/><mml:math id="m56" display="inline" overflow="scroll"><mml:mi mathvariant="bold">K</mml:mi><mml:mo stretchy="false">=</mml:mo><mml:msub><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>k</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:msub><mml:mrow><mml:mi>t</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo stretchy="false">,</mml:mo><mml:msub><mml:mrow><mml:mi>t</mml:mi></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:mo stretchy="false">)</mml:mo><mml:mo stretchy="false">)</mml:mo></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mo stretchy="false">,</mml:mo><mml:mi>j</mml:mi><mml:mo stretchy="false">,</mml:mo><mml:mo stretchy="false">&#8712;</mml:mo><mml:mo stretchy="false">{</mml:mo><mml:mn>0</mml:mn><mml:mo stretchy="false">,</mml:mo><mml:mi>&#8230;</mml:mi><mml:mo stretchy="false">,</mml:mo><mml:msub><mml:mrow><mml:mi>n</mml:mi></mml:mrow><mml:mrow><mml:mi>o</mml:mi></mml:mrow></mml:msub><mml:mo stretchy="false">}</mml:mo></mml:mrow></mml:msub></mml:math></alternatives></inline-formula>. To achieve this, we employ the GPy Python package [<xref rid="pone.0318549.ref035" ref-type="bibr">35</xref>], which provides the necessary tools and functionalities for GP modeling. Given the fitted kernel <inline-formula id="pone.0318549.e057"><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0318549.e057g" position="anchor" orientation="portrait" xlink:href="pone.0318549.e057.jpg"/><mml:math id="m57" display="inline" overflow="scroll"><mml:mover accent="true"><mml:mrow><mml:mi>k</mml:mi></mml:mrow><mml:mo accent="true">^</mml:mo></mml:mover></mml:math></alternatives></inline-formula> for the fitted hyperparameters <inline-formula id="pone.0318549.e058"><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0318549.e058g" position="anchor" orientation="portrait" xlink:href="pone.0318549.e058.jpg"/><mml:math id="m58" display="inline" overflow="scroll"><mml:mover accent="true"><mml:mrow><mml:mstyle mathvariant="bold"><mml:mi>&#952;</mml:mi></mml:mstyle></mml:mrow><mml:mo accent="true">^</mml:mo></mml:mover><mml:mo stretchy="false">=</mml:mo><mml:mo stretchy="false">(</mml:mo><mml:mover accent="true"><mml:mrow><mml:mi>l</mml:mi></mml:mrow><mml:mo accent="true">^</mml:mo></mml:mover><mml:mo stretchy="false">,</mml:mo><mml:mover accent="true"><mml:mrow><mml:mi>&#963;</mml:mi></mml:mrow><mml:mo accent="true">^</mml:mo></mml:mover><mml:mo stretchy="false">)</mml:mo></mml:math></alternatives></inline-formula>, the fitted GP is used to estimate <inline-formula id="pone.0318549.e059"><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0318549.e059g" position="anchor" orientation="portrait" xlink:href="pone.0318549.e059.jpg"/><mml:math id="m59" display="inline" overflow="scroll"><mml:msub><mml:mrow><mml:mi>f</mml:mi></mml:mrow><mml:mrow><mml:mo stretchy="false">&#8902;</mml:mo></mml:mrow></mml:msub></mml:math></alternatives></inline-formula>. <inline-formula id="pone.0318549.e060"><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0318549.e060g" position="anchor" orientation="portrait" xlink:href="pone.0318549.e060.jpg"/><mml:math id="m60" display="inline" overflow="scroll"><mml:msub><mml:mrow><mml:mi>f</mml:mi></mml:mrow><mml:mrow><mml:mo stretchy="false">&#8902;</mml:mo></mml:mrow></mml:msub><mml:mo stretchy="false">&#8712;</mml:mo><mml:msup><mml:mrow><mml:mi>&#8477;</mml:mi></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>n</mml:mi></mml:mrow><mml:mrow><mml:mi>o</mml:mi></mml:mrow></mml:msub><mml:mo stretchy="false">+</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msup></mml:math></alternatives></inline-formula> denotes the the estimated mean population values, which are be derived by<disp-formula id="pone.0318549.e105"><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0318549.e105g" position="anchor" orientation="portrait" xlink:href="pone.0318549.e105.jpg"/><mml:math id="m016" display="block" overflow="scroll"><mml:mtable><mml:mtr><mml:mtd><mml:msub><mml:mrow><mml:mi>f</mml:mi></mml:mrow><mml:mrow><mml:mo stretchy="false">&#8902;</mml:mo></mml:mrow></mml:msub><mml:mo stretchy="false">|</mml:mo><mml:mo stretchy="false">(</mml:mo><mml:msub><mml:mrow><mml:mi mathvariant="bold">X</mml:mi></mml:mrow><mml:mrow><mml:mo stretchy="false">&#8902;</mml:mo></mml:mrow></mml:msub><mml:mo stretchy="false">,</mml:mo><mml:mi mathvariant="bold">X</mml:mi><mml:mo stretchy="false">,</mml:mo><mml:mi>f</mml:mi><mml:mo stretchy="false">)</mml:mo><mml:mo stretchy="false">&#8764;</mml:mo><mml:mstyle mathvariant="script"><mml:mi>N</mml:mi></mml:mstyle><mml:mo stretchy="false">(</mml:mo></mml:mtd><mml:mtd><mml:mover accent="true"><mml:mrow><mml:mi mathvariant="bold">K</mml:mi></mml:mrow><mml:mo accent="true">^</mml:mo></mml:mover><mml:mo stretchy="false">(</mml:mo><mml:msub><mml:mrow><mml:mi mathvariant="bold">X</mml:mi></mml:mrow><mml:mrow><mml:mo stretchy="false">&#8902;</mml:mo></mml:mrow></mml:msub><mml:mo stretchy="false">,</mml:mo><mml:mi mathvariant="bold">X</mml:mi><mml:mo stretchy="false">)</mml:mo><mml:mo stretchy="false">&#8901;</mml:mo><mml:mover accent="true"><mml:mrow><mml:mi mathvariant="bold">K</mml:mi></mml:mrow><mml:mo accent="true">^</mml:mo></mml:mover><mml:msup><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi mathvariant="bold">X</mml:mi><mml:mo stretchy="false">,</mml:mo><mml:mi mathvariant="bold">X</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow><mml:mrow><mml:mo stretchy="false">&#8722;</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msup><mml:mi>f</mml:mi><mml:mo stretchy="false">,</mml:mo></mml:mtd><mml:mtd/><mml:mtd><mml:mtext/></mml:mtd></mml:mtr><mml:mtr><mml:mtd/><mml:mtd><mml:mover accent="true"><mml:mrow><mml:mi mathvariant="bold">K</mml:mi></mml:mrow><mml:mo accent="true">^</mml:mo></mml:mover><mml:mo stretchy="false">(</mml:mo><mml:msub><mml:mrow><mml:mi mathvariant="bold">X</mml:mi></mml:mrow><mml:mrow><mml:mo stretchy="false">&#8902;</mml:mo></mml:mrow></mml:msub><mml:mo stretchy="false">,</mml:mo><mml:msub><mml:mrow><mml:mi mathvariant="bold">X</mml:mi></mml:mrow><mml:mrow><mml:mo stretchy="false">&#8902;</mml:mo></mml:mrow></mml:msub><mml:mo stretchy="false">)</mml:mo><mml:mo stretchy="false">&#8722;</mml:mo><mml:mo stretchy="false">(</mml:mo><mml:mover accent="true"><mml:mrow><mml:mi mathvariant="bold">K</mml:mi></mml:mrow><mml:mo accent="true">^</mml:mo></mml:mover><mml:mo stretchy="false">(</mml:mo><mml:msub><mml:mrow><mml:mi mathvariant="bold">X</mml:mi></mml:mrow><mml:mrow><mml:mo stretchy="false">&#8902;</mml:mo></mml:mrow></mml:msub><mml:mo stretchy="false">,</mml:mo><mml:mi mathvariant="bold">X</mml:mi><mml:mo stretchy="false">)</mml:mo><mml:mo stretchy="false">&#8901;</mml:mo><mml:mover accent="true"><mml:mrow><mml:mi mathvariant="bold">K</mml:mi></mml:mrow><mml:mo accent="true">^</mml:mo></mml:mover><mml:msup><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi mathvariant="bold">X</mml:mi><mml:mo stretchy="false">,</mml:mo><mml:mi mathvariant="bold">X</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow><mml:mrow><mml:mo stretchy="false">&#8722;</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msup><mml:mo stretchy="false">(</mml:mo><mml:mover accent="true"><mml:mrow><mml:mi mathvariant="bold">K</mml:mi></mml:mrow><mml:mo accent="true">^</mml:mo></mml:mover><mml:mo stretchy="false">(</mml:mo><mml:mi mathvariant="bold">X</mml:mi><mml:mo stretchy="false">,</mml:mo><mml:msub><mml:mrow><mml:mi mathvariant="bold">X</mml:mi></mml:mrow><mml:mrow><mml:mo stretchy="false">&#8902;</mml:mo></mml:mrow></mml:msub><mml:mo stretchy="false">)</mml:mo><mml:mo stretchy="false">)</mml:mo><mml:mo stretchy="false">,</mml:mo></mml:mtd><mml:mtd/></mml:mtr></mml:mtable></mml:math></alternatives><label>(14)</label></disp-formula></p><p>with <inline-formula id="pone.0318549.e061"><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0318549.e061g" position="anchor" orientation="portrait" xlink:href="pone.0318549.e061.jpg"/><mml:math id="m61" display="inline" overflow="scroll"><mml:mo stretchy="false">(</mml:mo><mml:mi mathvariant="bold">X</mml:mi><mml:mo stretchy="false">,</mml:mo><mml:mi>f</mml:mi><mml:mo stretchy="false">)</mml:mo><mml:mo stretchy="false">=</mml:mo><mml:mo stretchy="false">{</mml:mo><mml:mo stretchy="false">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy="false">,</mml:mo><mml:msub><mml:mrow><mml:mi>y</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo stretchy="false">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy="false">)</mml:mo><mml:mo stretchy="false">)</mml:mo><mml:mo stretchy="false">:</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy="false">&#8712;</mml:mo><mml:mo stretchy="false">{</mml:mo><mml:mn>0</mml:mn><mml:mo stretchy="false">,</mml:mo><mml:mi>&#8230;</mml:mi><mml:mo stretchy="false">,</mml:mo><mml:msub><mml:mrow><mml:mi>n</mml:mi></mml:mrow><mml:mrow><mml:mi>o</mml:mi></mml:mrow></mml:msub><mml:mo stretchy="false">}</mml:mo><mml:mo stretchy="false">,</mml:mo><mml:mstyle class="text"><mml:mtext>individual i included in training subset</mml:mtext></mml:mstyle><mml:mo stretchy="false">}</mml:mo></mml:math></alternatives></inline-formula> given <inline-formula id="pone.0318549.e062"><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0318549.e062g" position="anchor" orientation="portrait" xlink:href="pone.0318549.e062.jpg"/><mml:math id="m62" display="inline" overflow="scroll"><mml:msub><mml:mrow><mml:mi mathvariant="bold">X</mml:mi></mml:mrow><mml:mrow><mml:mo stretchy="false">&#8902;</mml:mo></mml:mrow></mml:msub><mml:mo stretchy="false">=</mml:mo><mml:mo stretchy="false">(</mml:mo><mml:mn>0</mml:mn><mml:mo stretchy="false">,</mml:mo><mml:mi>&#8230;</mml:mi><mml:mo stretchy="false">,</mml:mo><mml:msub><mml:mrow><mml:mi>n</mml:mi></mml:mrow><mml:mrow><mml:mi>o</mml:mi></mml:mrow></mml:msub><mml:mo stretchy="false">)</mml:mo></mml:math></alternatives></inline-formula>.</p></list-item><list-item><p><italic toggle="yes">Calculation of Remaining Residuals:</italic> After fitting the mean GP model, we calculate the remaining residuals<disp-formula id="pone.0318549.e106"><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0318549.e106g" position="anchor" orientation="portrait" xlink:href="pone.0318549.e106.jpg"/><mml:math id="m017" display="block" overflow="scroll"><mml:mtable><mml:mtr><mml:mtd><mml:msub><mml:mrow><mml:mi>&#120598;</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo stretchy="false">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy="false">)</mml:mo><mml:mo stretchy="false">=</mml:mo><mml:msub><mml:mrow><mml:mi>y</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo stretchy="false">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy="false">)</mml:mo><mml:mo stretchy="false">&#8722;</mml:mo><mml:msub><mml:mrow><mml:mi>&#375;</mml:mi></mml:mrow><mml:mrow><mml:mi>m</mml:mi><mml:mi>e</mml:mi><mml:mi>a</mml:mi><mml:mi>n</mml:mi><mml:mo stretchy="false">,</mml:mo><mml:mi>G</mml:mi><mml:mi>P</mml:mi></mml:mrow></mml:msub><mml:mo stretchy="false">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy="false">)</mml:mo><mml:mspace class="nbsp" width="0.33em"/><mml:mspace class="nbsp" width="0.33em"/><mml:mspace class="nbsp" width="0.33em"/><mml:mo stretchy="false">.</mml:mo></mml:mtd><mml:mtd/><mml:mtd/></mml:mtr></mml:mtable></mml:math></alternatives><label>(15)</label></disp-formula></p><p>These residuals represent the differences between the observed data points and the values predicted by the GP model.</p></list-item><list-item><p><italic toggle="yes">Bayesian Fit of GP for Training Data:</italic> Moving forward, we transition into a Bayesian framework for model fitting. Specifically, we apply Bayesian methods to fit GP models on the remaining residuals <inline-formula id="pone.0318549.e063"><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0318549.e063g" position="anchor" orientation="portrait" xlink:href="pone.0318549.e063.jpg"/><mml:math id="m63" display="inline" overflow="scroll"><mml:msub><mml:mrow><mml:mi>&#120598;</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo stretchy="false">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:math></alternatives></inline-formula>, so that the corresponding estimates <inline-formula id="pone.0318549.e064"><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0318549.e064g" position="anchor" orientation="portrait" xlink:href="pone.0318549.e064.jpg"/><mml:math id="m64" display="inline" overflow="scroll"><mml:msub><mml:mrow><mml:mover accent="true"><mml:mrow><mml:mi>&#120598;</mml:mi></mml:mrow><mml:mo accent="true">^</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo stretchy="false">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:math></alternatives></inline-formula> are given by<disp-formula id="pone.0318549.e107"><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0318549.e107g" position="anchor" orientation="portrait" xlink:href="pone.0318549.e107.jpg"/><mml:math id="m018" display="block" overflow="scroll"><mml:mtable><mml:mtr><mml:mtd><mml:msub><mml:mrow><mml:mover accent="true"><mml:mrow><mml:mi>&#120598;</mml:mi></mml:mrow><mml:mo accent="true">^</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo stretchy="false">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy="false">)</mml:mo><mml:mo stretchy="false">&#8764;</mml:mo><mml:mstyle mathvariant="script"><mml:mi>N</mml:mi></mml:mstyle><mml:mrow><mml:mo fence="true" form="prefix"> (</mml:mo><mml:mrow><mml:msub><mml:mrow><mml:mi>&#956;</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mi>n</mml:mi><mml:mi>d</mml:mi><mml:mi>i</mml:mi><mml:mi>v</mml:mi></mml:mrow></mml:msub><mml:mo stretchy="false">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy="false">)</mml:mo><mml:mo stretchy="false">,</mml:mo><mml:msub><mml:mrow><mml:mi mathvariant="normal">&#931;</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mi>n</mml:mi><mml:mi>d</mml:mi><mml:mi>i</mml:mi><mml:mi>v</mml:mi></mml:mrow></mml:msub><mml:mo stretchy="false">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow><mml:mo fence="true" form="postfix">)</mml:mo></mml:mrow></mml:mtd><mml:mtd/><mml:mtd/></mml:mtr></mml:mtable></mml:math></alternatives><label>(16)</label></disp-formula></p><p>at the individual level within the training data set. This Bayesian approach allows us to quantify uncertainties, and make probabilistic predictions based on the observed data.</p></list-item><list-item><p><italic toggle="yes">Bayesian Gaussian Process Modeling for Test Data:</italic> When dealing with the test dataset, we employ a slightly different strategy. We identify a pre-selected number of individuals from the training data that are closest to each test case. To determine this proximity, we use a distance measure, specifically the smallest Euclidean distance<disp-formula id="pone.0318549.e108"><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0318549.e108g" position="anchor" orientation="portrait" xlink:href="pone.0318549.e108.jpg"/><mml:math id="m019" display="block" overflow="scroll"><mml:mtable><mml:mtr><mml:mtd><mml:mi>d</mml:mi><mml:mi>i</mml:mi><mml:mi>s</mml:mi><mml:msub><mml:mrow><mml:mi>t</mml:mi></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>t</mml:mi></mml:mrow><mml:mrow><mml:mi>m</mml:mi><mml:mi>a</mml:mi><mml:mi>x</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub><mml:mo stretchy="false">(</mml:mo><mml:msub><mml:mrow><mml:mi>&#120598;</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo stretchy="false">,</mml:mo><mml:msub><mml:mrow><mml:mi>&#120598;</mml:mi></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:mo stretchy="false">)</mml:mo></mml:mtd><mml:mtd><mml:mo stretchy="false">=</mml:mo><mml:msqrt><mml:mrow><mml:munderover accent="false" accentunder="false"><mml:mrow><mml:mo>&#8721;</mml:mo></mml:mrow><mml:mrow><mml:mi>t</mml:mi><mml:mo stretchy="false">=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>t</mml:mi></mml:mrow><mml:mrow><mml:mi>m</mml:mi><mml:mi>a</mml:mi><mml:mi>x</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:munderover><mml:msup><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:msub><mml:mrow><mml:mi>&#120598;</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo stretchy="false">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy="false">)</mml:mo><mml:mo stretchy="false">&#8722;</mml:mo><mml:msub><mml:mrow><mml:mi>&#120598;</mml:mi></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:mo stretchy="false">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy="false">)</mml:mo><mml:mo stretchy="false">)</mml:mo></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msup></mml:mrow></mml:msqrt></mml:mtd><mml:mtd/></mml:mtr></mml:mtable></mml:math></alternatives><label>(17)</label></disp-formula></p><p>computed from the residuals of the GP models calculated in step 2. The data of these five nearest individuals are selected to inform the subsequent modeling step and to serve as the basis for our Bayesian fitting of a GP. The selection process is driven by the need to have a representative and informative subset for modeling the test data, allowing us to leverage the information contained within the training data set. The resulting distribution is given by<disp-formula id="pone.0318549.e109"><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0318549.e109g" position="anchor" orientation="portrait" xlink:href="pone.0318549.e109.jpg"/><mml:math id="m020" display="block" overflow="scroll"><mml:mtable><mml:mtr><mml:mtd><mml:msub><mml:mrow><mml:mover accent="true"><mml:mrow><mml:mi>&#120598;</mml:mi></mml:mrow><mml:mo accent="true">^</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo stretchy="false">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy="false">)</mml:mo><mml:mo stretchy="false">|</mml:mo><mml:msub><mml:mrow><mml:mi mathvariant="bold">S</mml:mi></mml:mrow><mml:mrow><mml:mi>n</mml:mi><mml:mi>e</mml:mi><mml:mi>a</mml:mi><mml:mi>r</mml:mi><mml:mi>e</mml:mi><mml:mi>s</mml:mi><mml:mi>t</mml:mi><mml:mo stretchy="false">,</mml:mo><mml:mi>i</mml:mi><mml:mo stretchy="false">,</mml:mo><mml:msub><mml:mrow><mml:mi>t</mml:mi></mml:mrow><mml:mrow><mml:mi>m</mml:mi><mml:mi>a</mml:mi><mml:mi>x</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub><mml:mo stretchy="false">&#8764;</mml:mo><mml:mstyle mathvariant="script"><mml:mi>N</mml:mi></mml:mstyle><mml:mrow><mml:mo fence="true" form="prefix"> (</mml:mo><mml:mrow><mml:msub><mml:mrow><mml:mi>&#956;</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mi>n</mml:mi><mml:mi>d</mml:mi><mml:mi>i</mml:mi><mml:mi>v</mml:mi></mml:mrow></mml:msub><mml:mo stretchy="false">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy="false">)</mml:mo><mml:mo stretchy="false">,</mml:mo><mml:msub><mml:mrow><mml:mstyle mathvariant="bold"><mml:mi mathvariant="normal">&#931;</mml:mi></mml:mstyle></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mi>n</mml:mi><mml:mi>d</mml:mi><mml:mi>i</mml:mi><mml:mi>v</mml:mi></mml:mrow></mml:msub><mml:mo stretchy="false">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow><mml:mo fence="true" form="postfix">)</mml:mo></mml:mrow><mml:mspace class="nbsp" width="0.33em"/><mml:mspace class="nbsp" width="0.33em"/><mml:mspace class="nbsp" width="0.33em"/><mml:mo stretchy="false">,</mml:mo></mml:mtd><mml:mtd/><mml:mtd/></mml:mtr></mml:mtable></mml:math></alternatives><label>(18)</label></disp-formula></p><p>where <inline-formula id="pone.0318549.e065"><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0318549.e065g" position="anchor" orientation="portrait" xlink:href="pone.0318549.e065.jpg"/><mml:math id="m65" display="inline" overflow="scroll"><mml:msub><mml:mrow><mml:mi mathvariant="bold">S</mml:mi></mml:mrow><mml:mrow><mml:mi>n</mml:mi><mml:mi>e</mml:mi><mml:mi>a</mml:mi><mml:mi>r</mml:mi><mml:mi>e</mml:mi><mml:mi>s</mml:mi><mml:mi>t</mml:mi><mml:mo stretchy="false">,</mml:mo><mml:mi>i</mml:mi><mml:mo stretchy="false">,</mml:mo><mml:msub><mml:mrow><mml:mi>t</mml:mi></mml:mrow><mml:mrow><mml:mi>m</mml:mi><mml:mi>a</mml:mi><mml:mi>x</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub></mml:math></alternatives></inline-formula> contains all data of the nearest training IDs and the data up to day <inline-formula id="pone.0318549.e066"><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0318549.e066g" position="anchor" orientation="portrait" xlink:href="pone.0318549.e066.jpg"/><mml:math id="m66" display="inline" overflow="scroll"><mml:msub><mml:mrow><mml:mi>t</mml:mi></mml:mrow><mml:mrow><mml:mi>m</mml:mi><mml:mi>a</mml:mi><mml:mi>x</mml:mi></mml:mrow></mml:msub></mml:math></alternatives></inline-formula> of individual <italic toggle="yes">i</italic>.</p></list-item></list><p>Combining the results of step 1 to step 4, the individual effect estimate <inline-formula id="pone.0318549.e067"><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0318549.e067g" position="anchor" orientation="portrait" xlink:href="pone.0318549.e067.jpg"/><mml:math id="m67" display="inline" overflow="scroll"><mml:msubsup><mml:mrow><mml:mi>&#375;</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mo stretchy="false">,</mml:mo><mml:msub><mml:mrow><mml:mi>t</mml:mi></mml:mrow><mml:mrow><mml:mi>m</mml:mi><mml:mi>a</mml:mi><mml:mi>x</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>G</mml:mi><mml:mi>P</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:msubsup><mml:mo stretchy="false">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:math></alternatives></inline-formula> for individual i at time t is given by<disp-formula id="pone.0318549.e110"><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0318549.e110g" position="anchor" orientation="portrait" xlink:href="pone.0318549.e110.jpg"/><mml:math id="m021" display="block" overflow="scroll"><mml:mtable><mml:mtr><mml:mtd><mml:msubsup><mml:mrow><mml:mi>&#375;</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mo stretchy="false">,</mml:mo><mml:msub><mml:mrow><mml:mi>t</mml:mi></mml:mrow><mml:mrow><mml:mi>m</mml:mi><mml:mi>a</mml:mi><mml:mi>x</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>G</mml:mi><mml:mi>P</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:msubsup><mml:mo stretchy="false">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy="false">)</mml:mo><mml:mo stretchy="false">=</mml:mo><mml:msub><mml:mrow><mml:mi>&#375;</mml:mi></mml:mrow><mml:mrow><mml:mi>m</mml:mi><mml:mi>e</mml:mi><mml:mi>a</mml:mi><mml:mi>n</mml:mi><mml:mo stretchy="false">,</mml:mo><mml:mi>G</mml:mi><mml:mi>P</mml:mi></mml:mrow></mml:msub><mml:mo stretchy="false">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy="false">)</mml:mo><mml:mo stretchy="false">+</mml:mo><mml:msub><mml:mrow><mml:mover accent="true"><mml:mrow><mml:mi>&#120598;</mml:mi></mml:mrow><mml:mo accent="true">^</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo stretchy="false">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy="false">)</mml:mo><mml:mspace class="nbsp" width="0.33em"/><mml:mo stretchy="false">.</mml:mo></mml:mtd><mml:mtd/><mml:mtd/></mml:mtr></mml:mtable></mml:math></alternatives><label>(19)</label></disp-formula></p></sec></sec><sec id="sec010"><title>Evaluation of simulation framework and comparison of statistical models</title><p>In this section, we describe how we use the proposed simulation framework to generate realistic patient trajectories. Afterwards, we explain how we test the two proposed forecasting approaches, namely the non-linear mixed-effects model and the advanced GP. We aim to compare the performance of the parametric and the non-parametric model for different simulation settings.</p><sec id="sec011"><title>Simulation of realistic patient characteristics</title><p>In a simulation study, it is necessary to simulate a realistic set of covariates of each patient. In order to generate realistic patient-dependent datasets, we need to ensure that the underlying baseline characteristics are representative for a patient population (with high untreated blood pressure). Modeling realistic distributions of the covariates (e.g., generating a dataset with artificial patients with specific sex, age, height) can be achieved by mimicking a given data set of hypertensive patients and their covariates. One way to obtain a large data set of hypertensive patients without medication is given by the UK Biobank [<xref rid="pone.0318549.ref009" ref-type="bibr">9</xref>]. The UK Biobank gives access to detailed phenotype information as well as real world information regarding health status, genetics, clinical tests and many other parameters for around 500.000 adults across the UK. For the retrieval of realistic distributions of covariates, we focus on on patients reported not to take any antihypertensive medication, but still having a diastolic blood pressure of at least 90 mmHg or a systolic blood pressure of at least 140 mmHg which corresponds to so-called hypertension stage 2 (see Appendix, <xref rid="pcbi.0318549.s001" ref-type="supplementary-material">S1 table</xref>).</p></sec><sec id="sec012"><title>Evaluation of proposed prediction approaches</title><p>We aim to compare the proposed approaches in a simulation study. For that, we conducted an analysis based on 50 bootstrap test data sets. We employed a train-test split ratio of 2/3 to 1/3 to evaluate the model&#8217;s performance. For the patients from the training dataset, all observations from day 0 to day 10 are included. For patients from the test dataset, we aim to mimic the situation in practice and therefore only include data for the one individual of interest with data spanning from day 0 to day <inline-formula id="pone.0318549.e068"><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0318549.e068g" position="anchor" orientation="portrait" xlink:href="pone.0318549.e068.jpg"/><mml:math id="m68" display="inline" overflow="scroll"><mml:msub><mml:mrow><mml:mi>t</mml:mi></mml:mrow><mml:mrow><mml:mi>m</mml:mi><mml:mi>a</mml:mi><mml:mi>x</mml:mi></mml:mrow></mml:msub></mml:math></alternatives></inline-formula> (where <inline-formula id="pone.0318549.e069"><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0318549.e069g" position="anchor" orientation="portrait" xlink:href="pone.0318549.e069.jpg"/><mml:math id="m69" display="inline" overflow="scroll"><mml:mn>1</mml:mn><mml:mo stretchy="false">&#8804;</mml:mo><mml:msub><mml:mrow><mml:mi>t</mml:mi></mml:mrow><mml:mrow><mml:mi>m</mml:mi><mml:mi>a</mml:mi><mml:mi>x</mml:mi></mml:mrow></mml:msub><mml:mo stretchy="false">&#8804;</mml:mo><mml:mn>5</mml:mn></mml:math></alternatives></inline-formula>). We aim to predict the blood pressure level at day <italic toggle="yes">t</italic>&#160;=&#160;10. We vary the number of days to be included for the test data (<inline-formula id="pone.0318549.e071"><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0318549.e071g" position="anchor" orientation="portrait" xlink:href="pone.0318549.e071.jpg"/><mml:math id="m71" display="inline" overflow="scroll"><mml:msub><mml:mrow><mml:mi>t</mml:mi></mml:mrow><mml:mrow><mml:mi>m</mml:mi><mml:mi>a</mml:mi><mml:mi>x</mml:mi></mml:mrow></mml:msub></mml:math></alternatives></inline-formula>) from 1 to 5 to identify the minimal number of observations for solid predictions. We vary the number of subjects (<italic toggle="yes">N</italic>&#160;&#8712;&#160;{&#160;60&#160;,&#160;120&#160;,&#160;200&#160;}&#160;) to estimate a minimum sample size for the different approaches. Lastly, the influence of different numbers of neighbours for the GP are compared given two cases, namely 5 and 10 nearest neighbours. The PKPD parameter choices for simulating the corresponding patient trajectories can be found in <xref rid="pcbi.0318549.s004" ref-type="supplementary-material">S3 table</xref>.</p><p>For the evaluation of the proposed methodlogy, we focus on two different strategies: Firstly, the model-based predicted blood pressure curve can be compared with the true &#8220;raw&#8221; value (without noise). However, in a real-world setting, this value is always influenced by noise. Therefore, it is sensible to consider a second scenario, in which the estimated value is compared with the underlying measured noisy value, i.e. the observed value. We assess the models&#8217; quality of fit by calculating the bias and the root mean squared error (RMSE) per day.</p></sec></sec><sec sec-type="results" id="sec013"><title>Results</title><p>As outlined in previous chapters, the covariates must be simulated first in order to simulate the trajectories. This will be done based on the UK Biobank. A normal distribution is assumed, whereby the mean value and the standard deviation are estimated based on the UK Biobank cohort. Therefore, the UK Biobank patients with a systolic blood pressure of at least 140 mmHg or a diastolic blood pressure of at least 90 mmHg and no ongoing medication are obtained. The distribution of age and weight, separated by sex and ethnicity, is given by <xref rid="pone.0318549.t001" ref-type="table">Table 1</xref>.</p><table-wrap position="float" id="pone.0318549.t001" orientation="portrait"><object-id pub-id-type="doi">10.1371/journal.pone.0313772.t001</object-id><label>Table 1</label><caption><title>Summary statistics of covariates age (in years), weight (in kg), and sex in patients with hypertension stage 2, i.e., diastolic blood pressure greater than 90 mmHg or systolic blood pressure greater than 140 mmHg (see Appendix, <xref rid="pcbi.0318549.s001" ref-type="supplementary-material">S1 table</xref>), in the UK Biobank data.</title></caption><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0318549.t001g" position="float" orientation="portrait" xlink:href="pone.0318549.t001.jpg"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1">Sex</th><th align="left" rowspan="1" colspan="1">Ethnicity</th><th align="left" rowspan="1" colspan="1">Covariate</th><th align="left" rowspan="1" colspan="1">Mean</th><th align="left" rowspan="1" colspan="1">Standard deviation</th><th align="left" rowspan="1" colspan="1">Cohort size</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Female</td><td align="left" rowspan="1" colspan="1">Black</td><td align="left" rowspan="1" colspan="1">Weight</td><td align="left" rowspan="1" colspan="1">82.3</td><td align="left" rowspan="1" colspan="1">16.8</td><td align="left" rowspan="1" colspan="1">2.228</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Age</td><td align="left" rowspan="1" colspan="1">54.2</td><td align="left" rowspan="1" colspan="1">7.94</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Female</td><td align="left" rowspan="1" colspan="1">White</td><td align="left" rowspan="1" colspan="1">Weight</td><td align="left" rowspan="1" colspan="1">73.3</td><td align="left" rowspan="1" colspan="1">14.7</td><td align="left" rowspan="1" colspan="1">109.327</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Age</td><td align="left" rowspan="1" colspan="1">59</td><td align="left" rowspan="1" colspan="1">7.19</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Male</td><td align="left" rowspan="1" colspan="1">Black</td><td align="left" rowspan="1" colspan="1">Weight</td><td align="left" rowspan="1" colspan="1">86.5</td><td align="left" rowspan="1" colspan="1">14.4</td><td align="left" rowspan="1" colspan="1">1.025</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Age</td><td align="left" rowspan="1" colspan="1">51.6</td><td align="left" rowspan="1" colspan="1">7.95</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Male</td><td align="left" rowspan="1" colspan="1">White</td><td align="left" rowspan="1" colspan="1">Weight</td><td align="left" rowspan="1" colspan="1">86.3</td><td align="left" rowspan="1" colspan="1">13.8</td><td align="left" rowspan="1" colspan="1">79.705</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Age</td><td align="left" rowspan="1" colspan="1">57.2</td><td align="left" rowspan="1" colspan="1">7.92</td><td align="left" rowspan="1" colspan="1"/></tr></tbody></table></alternatives></table-wrap><p>The resulting simulated dataset is based on these simulated covariates. Three concrete examples of simulated patient trajectories are given in <xref rid="pone.0318549.g006" ref-type="fig">Fig 6</xref>. The simulation incorporates both individual covariate-specific effects as well as within-day and day-to-day variability. It is noted that if specific characteristics of a mediciation class would be known (e.g., a specific half life), these could be easily integrated into the simulation framework. First, we compare the red lines (without noise) and note that the individual patient characteristics (gender, age, height, size, ethnicity) highly influence the observed trajectories. For example, Patient 2 observes a higher reduction of blood pressure. The introduced variability leads to further variation which are visible in the observed data (black dots).</p><fig position="float" id="pone.0318549.g006" orientation="portrait"><object-id pub-id-type="doi">10.1371/journal.pone.0318549.g006</object-id><label>Fig 6</label><caption><title>Simulated trajectories of systolic blood pressure after taking anti-hypertensive medication of three hypothetical patients.</title><p>The red line corresponds to the raw blood pressure curve without any noise.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="pone.0318549.g006.jpg"/></fig><p>Before systematically comparing the properties of the proposed forecasting approaches in the described simulation study, we aim to illustrate the characteristics in a single-patient example. In <xref rid="pone.0318549.g007" ref-type="fig">Fig 7</xref> an example of individual predictions based on the different model types are given. The cohort size is given by <italic toggle="yes">N</italic>&#160;=&#160;200. The forecasting tasks changes based on the available information from left to right: In the figure on the left, blood pressure measurement has only been measured for a single day after initiation of treatment. From left to right, more and more days of observations are given so that on the right, we have five days of blood pressure measurements given, which can be used for predicting the further course of blood pressure. In yellow, the corresponding predicted curve of using the GP with 5 nearest neighbours is given. In blue the non-linear mixed effects model is used for prediction. The black curve marks the underlying real trajectory without noise. It has been observed that, with limited information, the GP estimates the true curve more accurately than the nlme model. However, as more days of measurements are provided, the nlme model begins to outperform the advanced GP. Specifically, after five days of measurements, the estimated trajectory closely aligns with the true (unobserved) trajectory.</p><fig position="float" id="pone.0318549.g007" orientation="portrait"><object-id pub-id-type="doi">10.1371/journal.pone.0318549.g007</object-id><label>Fig 7</label><caption><title>Prediction of individual effect curve using a non-linear mixed-effects model (nlme) and an advanced Gaussian process model (GP) with five nearest neighbours, given <inline-formula id="pone.0318549.e073"><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0318549.e073g" position="anchor" orientation="portrait" xlink:href="pone.0318549.e073.jpg"/><mml:math id="m73" display="inline" overflow="scroll"><mml:mstyle mathvariant="bold-italic"><mml:msub><mml:mrow><mml:mi>t</mml:mi></mml:mrow><mml:mrow><mml:mi>m</mml:mi><mml:mi>a</mml:mi><mml:mi>x</mml:mi></mml:mrow></mml:msub></mml:mstyle></mml:math></alternatives></inline-formula>, <inline-formula id="pone.0318549.e074"><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0318549.e074g" position="anchor" orientation="portrait" xlink:href="pone.0318549.e074.jpg"/><mml:math id="m74" display="inline" overflow="scroll"><mml:msub><mml:mrow><mml:mi>t</mml:mi></mml:mrow><mml:mrow><mml:mi>m</mml:mi><mml:mi>a</mml:mi><mml:mi>x</mml:mi></mml:mrow></mml:msub><mml:mo stretchy="false">&#8712;</mml:mo><mml:mo stretchy="false">{</mml:mo><mml:mn>1</mml:mn><mml:mo stretchy="false">,</mml:mo><mml:mi>&#8230;</mml:mi><mml:mo stretchy="false">,</mml:mo><mml:mn>5</mml:mn><mml:mo stretchy="false">}</mml:mo></mml:math></alternatives></inline-formula>, days of measurements.</title><p>In black: true curve of medication effect. The dots represent the observed values.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="pone.0318549.g007.jpg"/></fig><p>Generalising this to the full cohort with <italic toggle="yes">N</italic>&#160;=&#160;200 patients, we will further focus on the comparing the predicted blood pressure values to the observed (noisy) values since in a real-world data setting, the true underlying values without any noise are not accessible. To ensure robustness, 50 datasets are simulated and the performance is compared. First, the bias and rmse results are evaluated on a daily basis as illustrated in <xref rid="pone.0318549.g008" ref-type="fig">Fig 8</xref>. With a maximum absolute bias of approximately 1 mmHg all models are almost unbiased. While for the nlme model, we observe that adding in more information, i.e., increasing the number of available days with measurement, improves the performance by lowering the RMSE, the same is not true for the GP models: there, the RMSE is not reduced if more data is added. Looking at the RMSE and bias based on the noise-free values (see Appendix, <xref rid="pcbi.0318549.s007" ref-type="supplementary-material">S2 Fig</xref>), similar observations can be made.</p><fig position="float" id="pone.0318549.g008" orientation="portrait"><object-id pub-id-type="doi">10.1371/journal.pone.0318549.g008</object-id><label>Fig 8</label><caption><title>Root mean squared error (RMSE) and bias across days (<italic toggle="yes">t</italic>&#160;=&#160;0<italic toggle="yes">&#8230;</italic>&#160;,&#160;10&#160;)&#160; compared to actually observed values, models (non-linear mixed-effects model (nlme) in blue, Gaussian process (GP) with five resp. ten nearest neighbours in yellow resp. red) (<inline-formula id="pone.0318549.e078"><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0318549.e078g" position="anchor" orientation="portrait" xlink:href="pone.0318549.e078.jpg"/><mml:math id="m78" display="inline" overflow="scroll"><mml:msub><mml:mrow><mml:mi>t</mml:mi></mml:mrow><mml:mrow><mml:mi>m</mml:mi><mml:mi>a</mml:mi><mml:mi>x</mml:mi></mml:mrow></mml:msub><mml:mo stretchy="false">=</mml:mo><mml:mn>1</mml:mn><mml:mo stretchy="false">,</mml:mo><mml:mi>&#8230;</mml:mi><mml:mo stretchy="false">,</mml:mo><mml:mn>5</mml:mn></mml:math></alternatives></inline-formula>, vertical line).</title></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="pone.0318549.g008.jpg"/></fig><p>One possible reason for this could be that the non-linear mixed-effects model implicitly has access to all training data during fitting. When NLME models are fitted to the data, they integrate information from both the fixed and random effects. The random effects are capturing the variation between different entities or subjects in the data set. In the GP models, only the population mean of these data points influences the model, while the individual fits of the residuals have access to only a fraction of the training data. Therefore, the NLME model may have the capability to fit the data more accurately, leading to a lower RMSE. This could be especially true when the data contain a significant amount of noise or individual variability. Looking at the performance of both models, the advanced GP performs slightly better for a single day in terms of RMSE, while the nlme approach demonstrates improved performance over time based on the bias as well as the RMSE. Therefore, the GP is the preferred method only if very limited data is available.</p><p>These findings appear also independent across a wide range of realistic sample sizes (<italic toggle="yes">N</italic>&#160;=&#160;60 to <italic toggle="yes">N</italic>&#160;=&#160;200). We also note that there is no major gain in performance if more subjects are added (see Appendix, <xref rid="pcbi.0318549.s008" ref-type="supplementary-material">S3 Fig</xref>) indicating that the saturation level in terms of performance is reached early.</p></sec><sec id="sec014"><title>Conclusion and outlook</title><p>This paper presents a novel simulation framework for generating blood pressure profiles, which integrates Pharmacokinetic-Pharmacodynamic modeling with individual daily rhythms, patient characteristics, and medication effects. This model is very transparent and highly flexible and therefore can be adjusted to different medication classes. Also, the underlying patient characteristics are taken into account&#8212;allowing for tailoring to a target patient population, for example if inclusion/exclusion criteria for a clinical trial are already known.</p><p>Additionally, two models for predicting steady-state responses under anti-hypertensive therapy are developed and applied, namely an advanced Gaussian process and a non-linear mixed effect model. In scenarios where only one day of measurements is available, the Gaussian process is the preferred choice. However, in the real-world setting including more data is preferred. When multiple days of data are available, the nlme model becomes the preferred choice. It significantly reduces the RMSE as well as the bias for data with noise compared to the Gaussian process and demonstrates superior performance independent of the given sample size.</p><p>The algorithm&#8217;s potential integration into wearable devices offers a innovative solution for monitoring medication adherence in hypertensive patients. The algorithm has the capability to provide a current probability or forecast of whether the patient will achieve the desired blood pressure reduction goal within the next day. This information can be used to make early adjustments to the dosage and medication if needed. A growing interest has emerged in forecasting the individual effects of anti-hypertensive medications. This trend is supported by recent studies, including [<xref rid="pone.0318549.ref036" ref-type="bibr">36</xref>], which explored the use of machine learning algorithms to predict responses to antihypertensive therapy. This innovative approach, leveraging real-time assessments through wearable technology, streamlines monitoring, enhances treatment effectiveness, and contributes to better blood pressure control. This integration signifies a promising step towards personalized healthcare for hypertension management. In further steps, the different algorithms have to be tested on real-world data to re-evaluate its performance and robustness given real-world data.</p></sec><sec id="sec015"><title>Appendix</title></sec><sec sec-type="supplementary-material" id="sec016"><title>Supporting information</title><sec id="sec017"><title>Simulation</title><supplementary-material id="pcbi.0318549.s001" position="float" content-type="local-data" orientation="portrait"><label>S1 Table</label><caption><title>Overview of systolic and diastolic blood pressure (SBP and DBP) ranges for different hypertension stages [<xref rid="pone.0318549.ref037" ref-type="bibr">37</xref>].</title></caption><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="pcbi.0318549.s001.jpg" position="float" orientation="portrait"/></supplementary-material><supplementary-material id="pcbi.0318549.s002" position="float" content-type="local-data" orientation="portrait"><label>S1 Fig</label><caption><title>Pharmacokinetic-Pharmacodynamic scheme.</title><p>top left: Relationship between time and plasma concentration given a single dose, top right: Relationship between plasma concentration and effect given a single dose, bottom: Relationship between time and effect given a single dose (based on [<xref rid="pone.0318549.ref038" ref-type="bibr">38</xref>]).</p></caption><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="pcbi.0318549.s002.tif" position="float" orientation="portrait"/></supplementary-material><supplementary-material id="pcbi.0318549.s003" position="float" content-type="local-data" orientation="portrait"><label>S2 Table</label><caption><title>Literature sources for the influence of covariates.</title><p>Based on <xref rid="pone.0318549.g005" ref-type="fig">Fig 5</xref>.</p></caption><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="pcbi.0318549.s003.jpg" position="float" orientation="portrait"/></supplementary-material><supplementary-material id="pcbi.0318549.s004" position="float" content-type="local-data" orientation="portrait"><label>S3 Table</label><caption><title>Parameter choices for simulating the circadian rhythm, based on internal study c.f. [<xref rid="pone.0318549.ref039" ref-type="bibr">39</xref>].</title><p>The parameters for the average circadian rhythm are determined based on the parameter estimators provided by [<xref rid="pone.0318549.ref039" ref-type="bibr">39</xref>] and are further modified by the parameters derived from the average circadian rhythm observed in the internal study (see <xref rid="pone.0318549.g004" ref-type="fig">Fig 4</xref>).</p></caption><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="pcbi.0318549.s004.jpg" position="float" orientation="portrait"/></supplementary-material><supplementary-material id="pcbi.0318549.s005" position="float" content-type="local-data" orientation="portrait"><label>S4 Table</label><caption><title>Parameter choices for simulating the medication effect using Pharmacokinetic-Pharmacodynamic (PKPD) modeling assuming normal distribution; For <inline-formula id="pone.0318549.e081"><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0318549.e081g" position="anchor" orientation="portrait" xlink:href="pone.0318549.e081.jpg"/><mml:math id="m81" display="inline" overflow="scroll"><mml:mstyle mathvariant="bold-italic"><mml:msub><mml:mrow><mml:mi>E</mml:mi></mml:mrow><mml:mrow><mml:mi>m</mml:mi><mml:mi>a</mml:mi><mml:mi>x</mml:mi></mml:mrow></mml:msub></mml:mstyle></mml:math></alternatives></inline-formula> covariate effects need to be added (see <xref rid="pcbi.0318549.s006" ref-type="supplementary-material">S5 tab</xref>).</title></caption><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="pcbi.0318549.s005.jpg" position="float" orientation="portrait"/></supplementary-material><supplementary-material id="pcbi.0318549.s006" position="float" content-type="local-data" orientation="portrait"><label>S5 Table</label><caption><title>Parameter choices for simulating the influence of the covariates Age, Weight, Ethnicity, and Sex, on baseline blood pressure &#160;(&#160;<italic toggle="yes">BSL</italic>&#160;)&#160;, maximum effect (<inline-formula id="pone.0318549.e083"><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0318549.e083g" position="anchor" orientation="portrait" xlink:href="pone.0318549.e083.jpg"/><mml:math id="m83" display="inline" overflow="scroll"><mml:mstyle mathvariant="bold-italic"><mml:msub><mml:mrow><mml:mi>E</mml:mi></mml:mrow><mml:mrow><mml:mi>m</mml:mi><mml:mi>a</mml:mi><mml:mi>x</mml:mi></mml:mrow></mml:msub></mml:mstyle></mml:math></alternatives></inline-formula>), and volume capacity (<italic toggle="yes">VC</italic>).</title></caption><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="pcbi.0318549.s006.jpg" position="float" orientation="portrait"/></supplementary-material></sec><sec id="sec018"><title>Modeling approaches</title><sec id="sec019"><title>Derivation of model formula for non-linear mixed effects model.</title><p>The equation can be motivated by the cumulative distribution function of the exponential distribution<disp-formula id="pone.0318549.e111"><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0318549.e111g" position="anchor" orientation="portrait" xlink:href="pone.0318549.e111.jpg"/><mml:math id="m022" display="block" overflow="scroll"><mml:mtable><mml:mtr><mml:mtd><mml:mi>f</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:mi>x</mml:mi><mml:mo stretchy="false">)</mml:mo><mml:mo stretchy="false">=</mml:mo><mml:mn>1</mml:mn><mml:mo stretchy="false">&#8722;</mml:mo><mml:msup><mml:mrow><mml:mi>e</mml:mi></mml:mrow><mml:mrow><mml:mo stretchy="false">&#8722;</mml:mo><mml:mi>&#955;</mml:mi><mml:mi>x</mml:mi></mml:mrow></mml:msup><mml:mo stretchy="false">,</mml:mo><mml:mspace width="34.5021pt"/><mml:mi>&#955;</mml:mi><mml:mo stretchy="false">&#8712;</mml:mo><mml:mi>&#8477;</mml:mi></mml:mtd><mml:mtd/><mml:mtd/></mml:mtr></mml:mtable></mml:math></alternatives><label>(20)</label></disp-formula></p><p>which is generalized by<disp-formula id="pone.0318549.e112"><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0318549.e112g" position="anchor" orientation="portrait" xlink:href="pone.0318549.e112.jpg"/><mml:math id="m023" display="block" overflow="scroll"><mml:mtable><mml:mtr><mml:mtd><mml:mi>f</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:mi>x</mml:mi><mml:mo stretchy="false">)</mml:mo><mml:mo stretchy="false">=</mml:mo><mml:mi>a</mml:mi><mml:mo stretchy="false">&#8722;</mml:mo><mml:msup><mml:mrow><mml:mi>e</mml:mi></mml:mrow><mml:mrow><mml:mo stretchy="false">&#8722;</mml:mo><mml:mi>b</mml:mi><mml:mo stretchy="false">&#8901;</mml:mo><mml:mi>x</mml:mi><mml:mo stretchy="false">+</mml:mo><mml:mi>c</mml:mi></mml:mrow></mml:msup><mml:mo stretchy="false">,</mml:mo><mml:mspace width="34.5021pt"/><mml:mi>&#955;</mml:mi><mml:mo stretchy="false">,</mml:mo><mml:mi>a</mml:mi><mml:mo stretchy="false">,</mml:mo><mml:mi>b</mml:mi><mml:mo stretchy="false">,</mml:mo><mml:mi>c</mml:mi><mml:mo stretchy="false">&#8712;</mml:mo><mml:mi>&#8477;</mml:mi></mml:mtd><mml:mtd/><mml:mtd/></mml:mtr></mml:mtable></mml:math></alternatives><label>(21)</label></disp-formula></p><p>so that the plateau value denoted by <italic toggle="yes">a</italic> and the factor <italic toggle="yes">b</italic> determining the time to reach the plateau can vary. Additionally, in our application zero must be mapped to zero since there is no medication effect prior to the first dose, which leads to<disp-formula id="pone.0318549.e113"><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0318549.e113g" position="anchor" orientation="portrait" xlink:href="pone.0318549.e113.jpg"/><mml:math id="m024" display="block" overflow="scroll"><mml:mtable><mml:mtr><mml:mtd><mml:mi>f</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:mi>x</mml:mi><mml:mo stretchy="false">)</mml:mo><mml:mo stretchy="false">=</mml:mo><mml:mi>a</mml:mi><mml:mo stretchy="false">&#8722;</mml:mo><mml:msup><mml:mrow><mml:mi>e</mml:mi></mml:mrow><mml:mrow><mml:mo stretchy="false">&#8722;</mml:mo><mml:mi>b</mml:mi><mml:mi>x</mml:mi><mml:mo stretchy="false">+</mml:mo><mml:mi>l</mml:mi><mml:mi>n</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:mi>a</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:msup><mml:mspace class="nbsp" width="0.33em"/><mml:mspace class="nbsp" width="0.33em"/><mml:mo stretchy="false">,</mml:mo></mml:mtd><mml:mtd/><mml:mtd/></mml:mtr></mml:mtable></mml:math></alternatives><label>(22)</label></disp-formula></p><p>which finally leads to formula (<xref rid="pone.0318549.e100" ref-type="disp-formula">9</xref>).</p></sec></sec><sec sec-type="results" id="sec020"><title>Results</title><supplementary-material id="pcbi.0318549.s007" position="float" content-type="local-data" orientation="portrait"><label>S2 Fig</label><caption><title>Comparing predictive accuracy based on noise-free values.</title><p>Root mean squared error (RMSE) and bias across days (<italic toggle="yes">t</italic>&#160;=&#160;0<italic toggle="yes">&#8230;</italic>&#160;,&#160;10&#160;)&#160; based on values without noise, models (non-linear mixed-effects model (nlme) in blue, advanced Gaussian process (GP) with five resp. ten nearest neighbours in yellow resp. red), and known measurements (<inline-formula id="pone.0318549.e086"><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0318549.e086g" position="anchor" orientation="portrait" xlink:href="pone.0318549.e086.jpg"/><mml:math id="m86" display="inline" overflow="scroll"><mml:msub><mml:mrow><mml:mi>t</mml:mi></mml:mrow><mml:mrow><mml:mi>m</mml:mi><mml:mi>a</mml:mi><mml:mi>x</mml:mi></mml:mrow></mml:msub><mml:mo stretchy="false">=</mml:mo><mml:mn>1</mml:mn><mml:mo stretchy="false">,</mml:mo><mml:mi>&#8230;</mml:mi><mml:mo stretchy="false">,</mml:mo><mml:mn>5</mml:mn></mml:math></alternatives></inline-formula>).</p></caption><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="pcbi.0318549.s007.tif" position="float" orientation="portrait"/></supplementary-material><supplementary-material id="pcbi.0318549.s008" position="float" content-type="local-data" orientation="portrait"><label>S3 Fig</label><caption><title>Comparison of sample size effect on root mean squared error (RMSE) and bias for observed values and noise-free values.</title><p>Given five days of measurements: (Non-linear in yellow) mixed-effects model (nlme) in blue, advanced Gaussian process (GP) with five nearest neighbours. We assess the impact of different sample sizes on the model performance using the five nearest neighbours for the GP model. Three different scenarios are analysed, given by sample sizes of <italic toggle="yes">N</italic>&#160;=&#160;60, <italic toggle="yes">N</italic>&#160;=&#160;120, and <italic toggle="yes">N</italic>&#160;=&#160;200. Again, for robustness 50 datasets are simulated and assessed for each case.</p><p>The RMSE as well as the bias are evaluated for noise-free and noisy values given 5 days of measurements. It can be seen that increasing the sample size will not change the models performance in terms of the RMSE, neither looking at the noisy nor the noise-free values. Looking at the bias, a higher sample size does not change the bias of the nlme model. Using the GP model, a higher sample size can reduce the bias.</p><p>This suggests that, given the data assumptions (such as noise, rhythm, effect size, etc.), a sample size of approximately 120 patients would be sufficient to make an adequate prediction based on 5 days of provided measurements.</p></caption><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="pcbi.0318549.s008.tif" position="float" orientation="portrait"/></supplementary-material></sec></sec></body><back><ack id="ak001"><p>Katja Ickstadt acknowledges the support of BMBF and MKW.NRW within the Lamarr-Institute for Machine Learning and Artificial Intelligence. This research has been conducted using the UK Biobank Resource (Application 28807).</p></ack><ref-list><title>References</title><ref id="pone.0318549.ref001"><label>1</label><mixed-citation publication-type="book"><collab>WHO</collab>. <article-title>Hypertension</article-title>; <year>2021</year>. Available from: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.who.int/news-room/fact-sheets/detail/hypertension" ext-link-type="uri">https://www.who.int/news-room/fact-sheets/detail/hypertension</ext-link></mixed-citation></ref><ref id="pone.0318549.ref002"><label>2</label><mixed-citation publication-type="journal"><collab>WHO</collab>. <article-title>Global report on hypertension: the race against a silent killer</article-title>. <year>2023</year>.</mixed-citation></ref><ref id="pone.0318549.ref003"><label>3</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Gaziano</surname><given-names>TA</given-names></name>, <name name-style="western"><surname>Bitton</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Anand</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Weinstein</surname><given-names>MC</given-names></name>. <article-title>The global cost of nonoptimal blood pressure</article-title>. <source>J Hypertens</source><year>2009</year>;<volume>27</volume>(<issue>7</issue>):<fpage>1472</fpage>&#8211;<lpage>7</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1097/hjh.0b013e32832a9ba3</pub-id><pub-id pub-id-type="pmid">19474763</pub-id></mixed-citation></ref><ref id="pone.0318549.ref004"><label>4</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Williams</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Mancia</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Spiering</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Agabiti Rosei</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Azizi</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Burnier</surname><given-names>M</given-names></name>, <etal>et al</etal>. <article-title>2018 ESC/ESH Guidelines for the management of arterial hypertension</article-title>. <source>Eur Heart J</source><year>2018</year>;<volume>39</volume>(<issue>33</issue>):<fpage>3021</fpage>&#8211;<lpage>104</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1093/eurheartj/ehy339</pub-id><pub-id pub-id-type="pmid">30165516</pub-id></mixed-citation></ref><ref id="pone.0318549.ref005"><label>5</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Eisenkraft</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Goldstein</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Merin</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Fons</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Ishay</surname><given-names>AB</given-names></name>, <name name-style="western"><surname>Nachman</surname><given-names>D</given-names></name>, <etal>et al</etal>. <article-title>Developing a real-time detection tool and an early warning score using a continuous wearable multi-parameter monitor</article-title>. <source>Front Physiol</source>. <year>2023</year>;<volume>14</volume>:<fpage>1138647</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.3389/fphys.2023.1138647</pub-id><pub-id pub-id-type="pmid">37064911</pub-id><pub-id pub-id-type="pmcid">PMC10090377</pub-id></mixed-citation></ref><ref id="pone.0318549.ref006"><label>6</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Sola</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Vybornova</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Fallet</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Polychronopoulou</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Wurzner-Ghajarzadeh</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Wuerzner</surname><given-names>G</given-names></name>. <article-title>Validation of the optical Aktiia bracelet in different body positions for the persistent monitoring of blood pressure</article-title>. <source>Sci Rep</source><year>2021</year>;<volume>11</volume>(<issue>1</issue>):<fpage>20644</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1038/s41598-021-99294-w</pub-id><pub-id pub-id-type="pmid">34667230</pub-id><pub-id pub-id-type="pmcid">PMC8526831</pub-id></mixed-citation></ref><ref id="pone.0318549.ref007"><label>7</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Kim</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Chang</surname><given-names>S-A</given-names></name>, <name name-style="western"><surname>Park</surname><given-names>SW</given-names></name>. <article-title>First-in-human study for evaluating the accuracy of smart ring based cu&#64260;ess blood pressure measurement</article-title>. <source>J Korean Med Sci</source><year>2024</year>;<volume>39</volume>(<issue>2</issue>):<fpage>e18</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.3346/jkms.2024.39.e18</pub-id><pub-id pub-id-type="pmid">38225785</pub-id><pub-id pub-id-type="pmcid">PMC10789523</pub-id></mixed-citation></ref><ref id="pone.0318549.ref008"><label>8</label><mixed-citation publication-type="journal">Schutte AE. Wearable cu&#64260;ess blood pressure tracking: when will they be good enough? J Hum Hypertens. 2024;38(9):669&#8211;72. <comment>doi: </comment><pub-id pub-id-type="doi">10.1038/s41371-024-00932-3</pub-id><pub-id pub-id-type="pmid">38997475</pub-id><pub-id pub-id-type="pmcid">PMC11387187</pub-id></mixed-citation></ref><ref id="pone.0318549.ref009"><label>9</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Sudlow</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Gallacher</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Allen</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Beral</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Burton</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Danesh</surname><given-names>J</given-names></name>, <etal>et al</etal>. <article-title>UK biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age</article-title>. <source>PLoS Med</source><year>2015</year>;<volume>12</volume>(<issue>3</issue>):<fpage>e1001779</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1371/journal.pmed.1001779</pub-id><pub-id pub-id-type="pmid">25826379</pub-id><pub-id pub-id-type="pmcid">PMC4380465</pub-id></mixed-citation></ref><ref id="pone.0318549.ref010"><label>10</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Lasserson</surname><given-names>DS</given-names></name>, <name name-style="western"><surname>Buclin</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Glasziou</surname><given-names>P</given-names></name>. <article-title>How quickly should we titrate antihypertensive medication? Systematic review modelling blood pressure response from trial data</article-title>. <source>Heart</source><year>2011</year>;<volume>97</volume>(<issue>21</issue>):<fpage>1771</fpage>&#8211;<lpage>5</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1136/hrt.2010.221473</pub-id><pub-id pub-id-type="pmid">21586424</pub-id></mixed-citation></ref><ref id="pone.0318549.ref011"><label>11</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Baek</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Yun</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Yun</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Kwon</surname><given-names>K</given-names></name>. <article-title>Pharmacokinetic/pharmacodynamic modeling of the cardiovascular effects of beta blockers in humans</article-title>. <source>Arch Pharm Res</source><year>2008</year>;<volume>31</volume>(<issue>6</issue>):<fpage>814</fpage>&#8211;<lpage>21</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1007/s12272-001-1231-4</pub-id><pub-id pub-id-type="pmid">18563366</pub-id></mixed-citation></ref><ref id="pone.0318549.ref012"><label>12</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Heo</surname><given-names>YA</given-names></name>, <name name-style="western"><surname>Holford</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Son</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Park</surname><given-names>K</given-names></name>. <article-title>Quantitative model for the blood pressure-lowering interaction of valsartan and amlodipine</article-title>. <source>Br. J. Clin. Pharmacol</source><year>2016</year>;<volume>82</volume>(<issue>6</issue>):<fpage>1557</fpage>&#8211;<lpage>1567</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1111/bcp.13082</pub-id><pub-id pub-id-type="pmid">27504853</pub-id><pub-id pub-id-type="pmcid">PMC5099563</pub-id></mixed-citation></ref><ref id="pone.0318549.ref013"><label>13</label><mixed-citation publication-type="journal"><name name-style="western"><surname>van Rijn-Bikker</surname><given-names>PC</given-names></name>, <name name-style="western"><surname>Ackaert</surname><given-names>O</given-names></name>, <name name-style="western"><surname>Snelder</surname><given-names>N</given-names></name>, <name name-style="western"><surname>van Hest</surname><given-names>RM</given-names></name>, <name name-style="western"><surname>Ploeger</surname><given-names>BA</given-names></name>, <name name-style="western"><surname>Koopmans</surname><given-names>RP</given-names></name>, <etal>et al</etal>. <article-title>Pharmacokinetic-pharmacodynamic modeling of the antihypertensive effect of eprosartan in Black and White hypertensive patients</article-title>. <source>Clin Pharmacokinet</source><year>2013</year>;<volume>52</volume>(<issue>9</issue>):<fpage>793</fpage>&#8211;<lpage>803</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1007/s40262-013-0073-6</pub-id><pub-id pub-id-type="pmid">23696281</pub-id></mixed-citation></ref><ref id="pone.0318549.ref014"><label>14</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Rowland</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Tozer</surname><given-names>T</given-names></name>. <article-title>Clinical pharmacokinetics and pharmacodynamics</article-title>. <year>2019</year>.</mixed-citation></ref><ref id="pone.0318549.ref015"><label>15</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Upton</surname><given-names>RN</given-names></name>. <article-title>The two-compartment recirculatory pharmacokinetic model&#8211;an introduction to recirculatory pharmacokinetic concepts</article-title>. <source>Br J Anaesth</source><year>2004</year>;<volume>92</volume>(<issue>4</issue>):<fpage>475</fpage>&#8211;<lpage>84</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1093/bja/aeh089</pub-id><pub-id pub-id-type="pmid">14766714</pub-id></mixed-citation></ref><ref id="pone.0318549.ref016"><label>16</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Baek</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Yun</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Yun</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Kwon</surname><given-names>K</given-names></name>. <article-title>Pharmacokinetic/pharmacodynamic modeling of the cardiovascular effects of beta blockers in humans</article-title>. <source>Arch Pharm Res</source><year>2008</year>;<volume>31</volume>(<issue>6</issue>):<fpage>814</fpage>&#8211;<lpage>21</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1007/s12272-001-1231-4</pub-id><pub-id pub-id-type="pmid">18563366</pub-id></mixed-citation></ref><ref id="pone.0318549.ref017"><label>17</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Oie</surname><given-names>S</given-names></name>. <article-title>Drug distribution and binding</article-title>. <source>J Clin Pharmacol</source><year>1986</year>;<volume>26</volume>(<issue>8</issue>):<fpage>583</fpage>&#8211;<lpage>6</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1002/j.1552-4604.1986.tb02953.x</pub-id><pub-id pub-id-type="pmid">3793947</pub-id></mixed-citation></ref><ref id="pone.0318549.ref018"><label>18</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Weber</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Birnb&#168;ock</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Leube</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Kobrin</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Kleinbloesem</surname><given-names>CH</given-names></name>, <name name-style="western"><surname>Brummelen</surname><given-names>P</given-names></name>. <article-title>Multiple dose pharmacokinetics and concentration effect relationship of the orally active renin inhibitor remikiren (RO 42-5892) in hypertensive patients</article-title>. <source>Br J Clin Pharmacol</source><year>1993</year>;<volume>36</volume>(<issue>6</issue>):<fpage>547</fpage>&#8211;<lpage>554</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1111/j.1365-2125.1993.tb00413.x</pub-id><pub-id pub-id-type="pmid">12959271</pub-id><pub-id pub-id-type="pmcid">PMC1364659</pub-id></mixed-citation></ref><ref id="pone.0318549.ref019"><label>19</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Tsai</surname><given-names>MC</given-names></name>, <name name-style="western"><surname>Wu</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Kupfer</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Vakilynejad</surname><given-names>M</given-names></name>. <article-title>Population pharmacokinetics and exposure-response of a fixed-dose combination of azilsartan medoxomil and chlorthalidone in patients with stage 2 hypertension</article-title>. <source>J Clin Pharmacol</source><year>2016</year>;<volume>56</volume>(<issue>8</issue>):<fpage>988</fpage>&#8211;<lpage>98</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1002/jcph.684</pub-id><pub-id pub-id-type="pmid">26632101</pub-id></mixed-citation></ref><ref id="pone.0318549.ref020"><label>20</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Lee</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Jang</surname><given-names>I-J</given-names></name>, <name name-style="western"><surname>Yu</surname><given-names>K-S</given-names></name>, <name name-style="western"><surname>Choi</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Oh</surname><given-names>B-H</given-names></name>. <article-title>A population pharmacokinetic analysis of fimasartan, a selective angiotensin II receptor antagonist, in healthy caucasian subjects and korean patients with hypertension</article-title>. <source>Clin Pharmacol Drug Dev</source><year>2013</year>;<volume>2</volume>(<issue>2</issue>):<fpage>162</fpage>&#8211;<lpage>72</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1002/cpdd.10</pub-id><pub-id pub-id-type="pmid">27121670</pub-id></mixed-citation></ref><ref id="pone.0318549.ref021"><label>21</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Otani</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Kasai</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Tanigawara</surname><given-names>Y</given-names></name>. <article-title>Pharmacodynamic analysis of hypertension caused by lenvatinib using real-world postmarketing surveillance data</article-title>. <source>CPT Pharmacomet Syst Pharmacol</source><year>2021</year>;<volume>10</volume>(<issue>3</issue>):<fpage>188</fpage>&#8211;<lpage>98</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1002/psp4.12587</pub-id><pub-id pub-id-type="pmid">33471960</pub-id><pub-id pub-id-type="pmcid">PMC7965839</pub-id></mixed-citation></ref><ref id="pone.0318549.ref022"><label>22</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Larsson</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Karlberg</surname><given-names>BE</given-names></name>, <name name-style="western"><surname>Gelin</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Aberg</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Reg&#229;rdh</surname><given-names>CG</given-names></name>. <article-title>Acute and steady-state pharmacokinetics and antihypertensive effects of felodipine in patients with normal and impaired renal function</article-title>. <source>J Clin Pharmacol</source><year>1990</year>;<volume>30</volume>(<issue>11</issue>):<fpage>1020</fpage>&#8211;<lpage>30</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1002/j.1552-4604.1990.tb03589.x</pub-id><pub-id pub-id-type="pmid">2243149</pub-id></mixed-citation></ref><ref id="pone.0318549.ref023"><label>23</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Terakawa</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Tokuma</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Kuwahara</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Shishido</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Noguchi</surname><given-names>H</given-names></name>. <article-title>Multiple-dose pharmacokinetics of nilvadipine in healthy volunteers</article-title>. <source>J Clin Pharmacol</source><year>1988</year>;<volume>28</volume>(<issue>4</issue>):<fpage>350</fpage>&#8211;<lpage>5</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1002/j.1552-4604.1988.tb03157.x</pub-id><pub-id pub-id-type="pmid">3392233</pub-id></mixed-citation></ref><ref id="pone.0318549.ref024"><label>24</label><mixed-citation publication-type="journal">Jackson R, Bellamy M. Antihypertensive drugs. BJA Education. 2015;15(6):280&#8211;5. <comment>doi: </comment><pub-id pub-id-type="doi">10.1093/bjaceaccp/mku061</pub-id></mixed-citation></ref><ref id="pone.0318549.ref025"><label>25</label><mixed-citation publication-type="journal"><name name-style="western"><surname>van Rijn-Bikker</surname><given-names>PC</given-names></name>, <name name-style="western"><surname>Ackaert</surname><given-names>O</given-names></name>, <name name-style="western"><surname>Snelder</surname><given-names>N</given-names></name>, <name name-style="western"><surname>van Hest</surname><given-names>RM</given-names></name>, <name name-style="western"><surname>Ploeger</surname><given-names>BA</given-names></name>, <name name-style="western"><surname>Koopmans</surname><given-names>RP</given-names></name>, <etal>et al</etal>. <article-title>Pharmacokinetic-pharmacodynamic modeling of the antihypertensive effect of eprosartan in Black and White hypertensive patients</article-title>. <source>Clin Pharmacokinet</source><year>2013</year>;<volume>52</volume>(<issue>9</issue>):<fpage>793</fpage>&#8211;<lpage>803</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1007/s40262-013-0073-6</pub-id><pub-id pub-id-type="pmid">23696281</pub-id></mixed-citation></ref><ref id="pone.0318549.ref026"><label>26</label><mixed-citation publication-type="journal">Costello HM, Gumz ML. Circadian rhythm, clock genes, and hypertension: recent advances in hypertension. Hypertension. 2021;78(5):1185&#8211;96. <comment>doi: </comment><pub-id pub-id-type="doi">10.1161/HYPERTENSIONAHA.121.14519</pub-id><pub-id pub-id-type="pmid">34601963</pub-id><pub-id pub-id-type="pmcid">PMC8596297</pub-id></mixed-citation></ref><ref id="pone.0318549.ref027"><label>27</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Douma</surname><given-names>LG</given-names></name>, <name name-style="western"><surname>Gumz</surname><given-names>ML</given-names></name>. <article-title>Circadian clock-mediated regulation of blood pressure</article-title>. <source>Free Radic Biol Med</source>. <year>2018</year>;<volume>119</volume>:<fpage>108</fpage>&#8211;<lpage>14</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2017.11.024</pub-id><pub-id pub-id-type="pmid">29198725</pub-id><pub-id pub-id-type="pmcid">PMC5910276</pub-id></mixed-citation></ref><ref id="pone.0318549.ref028"><label>28</label><mixed-citation publication-type="journal"><name name-style="western"><surname>van Rijn-Bikker</surname><given-names>PC</given-names></name>, <name name-style="western"><surname>Snelder</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Ackaert</surname><given-names>O</given-names></name>, <name name-style="western"><surname>van Hest</surname><given-names>RM</given-names></name>, <name name-style="western"><surname>Ploeger</surname><given-names>BA</given-names></name>, <name name-style="western"><surname>van Montfrans</surname><given-names>GA</given-names></name>, <etal>et al</etal>. <article-title>Nonlinear mixed effects modeling of the diurnal blood pressure profile in a multiracial population</article-title>. <source>Am J Hypertens</source><year>2013</year>;<volume>26</volume>(<issue>9</issue>):<fpage>1103</fpage>&#8211;<lpage>13</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1093/ajh/hpt088</pub-id><pub-id pub-id-type="pmid">23939415</pub-id></mixed-citation></ref><ref id="pone.0318549.ref029"><label>29</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Chia</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Kario</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Tomitani</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Park</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Shin</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Turana</surname><given-names>Y</given-names></name>, <etal>et al</etal>. <article-title>Comparison of day-to-day blood pressure variability in hypertensive patients with type 2 diabetes mellitus to those without diabetes: Asia BP@Home study</article-title>. <source>J Clin Hypertens</source><year>2019</year>;<volume>22</volume>(<issue>3</issue>):<fpage>407</fpage>&#8211;<lpage>414</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1111/jch.13731</pub-id><pub-id pub-id-type="pmcid">PMC8030068</pub-id><pub-id pub-id-type="pmid">31891447</pub-id></mixed-citation></ref><ref id="pone.0318549.ref030"><label>30</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Troc&#243;niz</surname><given-names>IF</given-names></name>, <name name-style="western"><surname>de Alwis</surname><given-names>DP</given-names></name>, <name name-style="western"><surname>Tillmann</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Callies</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Mitchell</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Schaefer</surname><given-names>HG</given-names></name>. <article-title>Comparison of manual versus ambulatory blood pressure measurements with pharmacokinetic-pharmacodynamic modeling of antihypertensive compounds: application to moxonidine</article-title>. <source>Clin Pharmacol Ther</source><year>2000</year>;<volume>68</volume>(<issue>1</issue>):<fpage>18</fpage>&#8211;<lpage>27</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1067/mcp.2000.106907</pub-id><pub-id pub-id-type="pmid">10945312</pub-id></mixed-citation></ref><ref id="pone.0318549.ref031"><label>31</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Heo</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Holford</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Son</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Park</surname><given-names>K</given-names></name>. <article-title>Quantitative model for the blood pressure&#8208;lowering interaction of valsartan and amlodipine</article-title>. <source>Brit J Clinical Pharma</source><year>2016</year>;<volume>82</volume>(<issue>6</issue>):<fpage>1557</fpage>&#8211;<lpage>67</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1111/bcp.13082</pub-id><pub-id pub-id-type="pmcid">PMC5099563</pub-id><pub-id pub-id-type="pmid">27504853</pub-id></mixed-citation></ref><ref id="pone.0318549.ref032"><label>32</label><mixed-citation publication-type="journal"><name name-style="western"><surname>B&#252;rkner</surname><given-names>P-C</given-names></name>. <article-title>brms: An R package for Bayesian multilevel models using stan</article-title>. <source>J Stat Soft</source>. <year>2017</year>;<volume>80</volume>(<issue>1</issue>). <comment>doi: </comment><pub-id pub-id-type="doi">10.18637/jss.v080.i01</pub-id></mixed-citation></ref><ref id="pone.0318549.ref033"><label>33</label><mixed-citation publication-type="journal">Quadrianto N, Kersting K, Xu Z. In: Sammut C, Webb GI, editors. Gaussian process. Boston, MA: Springer; 2010. p. 428&#8211;439. <comment>doi: </comment><pub-id pub-id-type="doi">10.1007/978-0-387-30164-8_324</pub-id></mixed-citation></ref><ref id="pone.0318549.ref034"><label>34</label><mixed-citation publication-type="journal">Rasmussen C, Williams C. Gaussian processes for machine learning. MIT Press; 2008.</mixed-citation></ref><ref id="pone.0318549.ref035"><label>35</label><mixed-citation publication-type="journal"><collab>GPy</collab>. <article-title>GPy: A Gaussian process framework in python</article-title>. <year>2012</year>.</mixed-citation></ref><ref id="pone.0318549.ref036"><label>36</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Mroz</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Griffin</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Cartabuke</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Laffin</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Russo-Alvarez</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Thomas</surname><given-names>G</given-names></name>, <etal>et al</etal>. <article-title>Predicting hypertension control using machine learning</article-title>. <source>PLoS One</source><year>2024</year>;<volume>19</volume>(<issue>3</issue>):<fpage>e0299932</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1371/journal.pone.0299932</pub-id><pub-id pub-id-type="pmid">38507433</pub-id><pub-id pub-id-type="pmcid">PMC10954144</pub-id></mixed-citation></ref><ref id="pone.0318549.ref037"><label>37</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Whelton</surname><given-names>PK</given-names></name>, <name name-style="western"><surname>Carey</surname><given-names>RM</given-names></name>, <name name-style="western"><surname>Aronow</surname><given-names>WS</given-names></name>, <name name-style="western"><surname>Casey DE</surname><given-names>Jr</given-names></name>, <name name-style="western"><surname>Collins</surname><given-names>KJ</given-names></name>, <name name-style="western"><surname>Dennison Himmelfarb</surname><given-names>C</given-names></name>, <etal>et al</etal>. <article-title>2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American college of cardiology/American heart association task force on clinical practice guidelines</article-title>. <source>Hypertension</source><year>2018</year>;<volume>71</volume>(<issue>6</issue>):<fpage>e13</fpage>&#8211;<lpage>115</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1161/HYP.0000000000000065</pub-id><pub-id pub-id-type="pmid">29133356</pub-id></mixed-citation></ref><ref id="pone.0318549.ref038"><label>38</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Derendorf</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Meibohm</surname><given-names>B</given-names></name>. <article-title>Modeling of pharmacokinetic/pharmacodynamic (PK/PD) relationships: concepts and perspectives</article-title>. <source>Pharmaceutical research</source>. <year>1999</year>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1023/a:1011907920641</pub-id><pub-id pub-id-type="pmid">10100300</pub-id></mixed-citation></ref><ref id="pone.0318549.ref039"><label>39</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Hempel</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Karlsson</surname><given-names>MO</given-names></name>, <name name-style="western"><surname>de Alwis</surname><given-names>DP</given-names></name>, <name name-style="western"><surname>Toublanc</surname><given-names>N</given-names></name>, <name name-style="western"><surname>McNay</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Schaefer</surname><given-names>HG</given-names></name>. <article-title>Population pharmacokinetic-pharmacodynamic modeling of moxonidine using 24-hour ambulatory blood pressure measurements</article-title>. <source>Clin Pharmacol Ther</source><year>1998</year>;<volume>64</volume>(<issue>6</issue>):<fpage>622</fpage>&#8211;<lpage>35</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/s0009-9236(98)90053-4</pub-id><pub-id pub-id-type="pmid">9871427</pub-id></mixed-citation></ref></ref-list></back><sub-article article-type="author-comment" id="pone.0318549.r001" specific-use="rebutted-decision-letter-unavailable"><front-stub><article-id pub-id-type="doi">10.1371/journal.pone.0318549.r001</article-id><title-group><article-title>Author response to Decision Letter 0</article-title></title-group><custom-meta-group><custom-meta><meta-name>Submission Version</meta-name><meta-value>0</meta-value></custom-meta></custom-meta-group></front-stub><body><p>
<named-content content-type="author-response-date">7 Oct 2024</named-content>
</p></body></sub-article><sub-article article-type="aggregated-review-documents" id="pone.0318549.r002" specific-use="decision-letter"><front-stub><article-id pub-id-type="doi">10.1371/journal.pone.0318549.r002</article-id><title-group><article-title>Decision Letter 0</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Vashistha</surname><given-names initials="V">Vinod</given-names></name><role>Academic Editor</role></contrib></contrib-group><permissions><copyright-statement>&#169; 2025 Vinod Vashistha</copyright-statement><copyright-year>2025</copyright-year><copyright-holder>Vinod Vashistha</copyright-holder><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open access article distributed under the terms of the <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p></license></permissions><related-article xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="doi" xlink:href="10.1371/journal.pone.0318549" id="rel-obj002" related-article-type="reviewed-article"/><custom-meta-group><custom-meta><meta-name>Submission Version</meta-name><meta-value>0</meta-value></custom-meta></custom-meta-group></front-stub><body><p>
<named-content content-type="letter-date">8 Nov 2024</named-content>
</p><p>PONE-D-24-44640A Simulation-Based Framework for Modeling and Prediction of Personalized Blood Pressure Trajectories in Hypertensive Patients after Antihypertensive TreatmentPLOS ONE</p><p>Dear Dr. Hunsdieck,</p><p>Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE&#8217;s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.</p><p>Please submit your revised manuscript by Dec 23 2024 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at&#160;<email>plosone@plos.org</email>. When you're ready to submit your revision, log on to <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.editorialmanager.com/pone/" ext-link-type="uri">https://www.editorialmanager.com/pone/</ext-link> and select the 'Submissions Needing Revision' folder to locate your manuscript file.</p><p>Please include the following items when submitting your revised manuscript:</p><p><list list-type="bullet"><list-item><p>A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.</p></list-item><list-item><p>A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.</p></list-item><list-item><p>An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.</p></list-item></list>
</p><p>If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.</p><p>If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols" ext-link-type="uri">https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols</ext-link>. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://plos.org/protocols?utm_medium=editorial-email&amp;utm_source=authorletters&amp;utm_campaign=protocols" ext-link-type="uri">https://plos.org/protocols?utm_medium=editorial-email&amp;utm_source=authorletters&amp;utm_campaign=protocols</ext-link>.</p><p>We look forward to receiving your revised manuscript.</p><p>Kind regards,</p><p>Dr. Vinod</p><p>Academic Editor</p><p>PLOS ONE</p><p>Journal Requirements:</p><p>When submitting your revision, we need you to address these additional requirements.</p><p>1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at&#160;</p><p><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf" ext-link-type="uri">https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf</ext-link> and&#160;</p><p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf" ext-link-type="uri">https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf</ext-link>
</p><p>2. Please note that PLOS ONE has specific guidelines on code sharing for submissions in which author-generated code underpins the findings in the manuscript. In these cases, all author-generated code must be made available without restrictions upon publication of the work.&#160;</p><p>Please review our guidelines at <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://journals.plos.org/plosone/s/materials-and-software-sharing#loc-sharing-code" ext-link-type="uri">https://journals.plos.org/plosone/s/materials-and-software-sharing#loc-sharing-code</ext-link> and ensure that your code is shared in a way that follows best practice and facilitates reproducibility and reuse.</p><p>3. Please update your submission to use the PLOS LaTeX template. The template and more information on our requirements for LaTeX submissions can be found at <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://journals.plos.org/plosone/s/latex." ext-link-type="uri">http://journals.plos.org/plosone/s/latex</ext-link>.</p><p>4. Please note that your Data Availability Statement is currently missing the DOI/accession number of each dataset or a direct link to access each database. If your manuscript is accepted for publication, you will be asked to provide these details on a very short timeline. We therefore suggest that you provide this information now, though we will not hold up the peer review process if you are unable.</p><p>5. For studies involving third-party data, we encourage authors to share any data specific to their analyses that they can legally distribute. PLOS recognizes, however, that authors may be using third-party data they do not have the rights to share. When third-party data cannot be publicly shared, authors must provide all information necessary for interested researchers to apply to gain access to the data. (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://journals.plos.org/plosone/s/data-availability#loc-acceptable-data-access-restrictions)&#xA0;" ext-link-type="uri">https://journals.plos.org/plosone/s/data-availability#loc-acceptable-data-access-restrictions)&#160;</ext-link></p><p>For any third-party data that the authors cannot legally distribute, they should include the following information in their Data Availability Statement upon submission:</p><p>1) A description of the data set and the third-party source</p><p>2) If applicable, verification of permission to use the data set</p><p>3) Confirmation of whether the authors received any special privileges in accessing the data that other researchers would not have</p><p>4) All necessary contact information others would need to apply to gain access to the data</p><p>6. Please ensure that you refer to Figure 2 in your text as, if accepted, production will need this reference to link the reader to the figure.</p><p>7. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article&#8217;s retracted status in the References list and also include a citation and full reference for the retraction notice.</p><p>[Note: HTML markup is below. Please do not edit.]</p><p>Reviewers' comments:</p><p>Reviewer's Responses to Questions</p><p>

<bold>Comments to the Author</bold>
</p><p>1. Is the manuscript technically sound, and do the data support the conclusions?</p><p>The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. </p><p>Reviewer #1:&#160;Yes</p><p>Reviewer #2:&#160;Yes</p><p>**********</p><p>2. Has the statistical analysis been performed appropriately and rigorously? </p><p>Reviewer #1:&#160;Yes</p><p>Reviewer #2:&#160;Yes</p><p>**********</p><p>3. Have the authors made all data underlying the findings in their manuscript fully available?</p><p>The <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://www.plosone.org/static/policies.action#sharing" ext-link-type="uri">PLOS Data policy</ext-link> requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data&#8212;e.g. participant privacy or use of data from a third party&#8212;those must be specified.</p><p>Reviewer #1:&#160;Yes</p><p>Reviewer #2:&#160;Yes</p><p>**********</p><p>4. Is the manuscript presented in an intelligible fashion and written in standard English?</p><p>PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.</p><p>Reviewer #1:&#160;Yes</p><p>Reviewer #2:&#160;No</p><p>**********</p><p>5. Review Comments to the Author</p><p>Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)</p><p>Reviewer #1:&#160;The manusript is written well including correct mathematical expressions. However, i have a few suggestions to make:</p><p>1. Abstract: first few sentences of abstract contain useless information which can be shifted to introduction. The abstract must revise the abstract completely by highlighting the significance of this work carried and some of key results obtained from this study.</p><p>2. Data in first 3 sentences of the introduction needs correction of data as per recent literature.</p><p>3. In the introduction, mention which blood pressure monitoring devices have been developed in the recent past and author must discuss the key developments in a paragraph by proper citing the literature.</p><p>4. Mention the accuracies of wrist based blood pressure monitoring devices.</p><p>5. Last paragraph of the introdcution is seems to be copied from a thesis or book. revise the introduction carefully by incorporating compititive studies.</p><p>6. Figure numbers are not in order. Check the citations of Fig. 2.</p><p>7. Figure 3 is not found in the manusript.</p><p>8. Literature described or followed are old and outdated e.g. two compartment model outlined in literature of 2004 and 2008. The simulations are fast updating everyday. Thus authors could have folllowed recent model.</p><p>Reviewer #2:&#160;The manuscript has some merits in terms of theoretical content whereas it seems to be poorly written in terms of language, which I feel must be addressed carefully by proofreading.</p><p>1. Abstract to be revised thoroughly for better clarity. Some key results of simulation study have to be presented here.</p><p>2. Keywords are not appropriate.</p><p>3. Introduction needs drastic revisions by incorporating discussion of key literature and models presented.</p><p>4. Also add a small paragraph on the key highlight of the work and novelty of the work.</p><p>5. Correct the citation of Figure 2 in the text.</p><p>6. Fig. 3 is missing.</p><p>**********</p><p>6. PLOS authors have the option to publish the peer review history of their article (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://journals.plos.org/plosone/s/editorial-and-peer-review-process#loc-peer-review-history" ext-link-type="uri">what does this mean?</ext-link>). If published, this will include your full peer review and any attached files.</p><p>If you choose &#8220;no&#8221;, your identity will remain anonymous but your review may still be made public.</p><p><bold>Do you want your identity to be public for this peer review?</bold> For information about this choice, including consent withdrawal, please see our <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.plos.org/privacy-policy" ext-link-type="uri">Privacy Policy</ext-link>.</p><p>Reviewer #1:&#160;No</p><p>Reviewer #2:&#160;No</p><p>**********</p><p>[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]</p><p>While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool,&#160;<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pacev2.apexcovantage.com/" ext-link-type="uri">https://pacev2.apexcovantage.com/</ext-link>. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at&#160;<email>figures@plos.org</email>. Please note that Supporting Information files do not need this step.</p></body></sub-article><sub-article article-type="author-comment" id="pone.0318549.r003"><front-stub><article-id pub-id-type="doi">10.1371/journal.pone.0318549.r003</article-id><title-group><article-title>Author response to Decision Letter 1</article-title></title-group><related-article xmlns:xlink="http://www.w3.org/1999/xlink" related-article-type="editor-report" id="rel-obj003" xml:lang="en" ext-link-type="doi" xlink:href="10.1371/journal.pone.0318549"/><custom-meta-group><custom-meta><meta-name>Submission Version</meta-name><meta-value>1</meta-value></custom-meta></custom-meta-group></front-stub><body><p>
<named-content content-type="author-response-date">16 Jan 2025</named-content>
</p><p>Dear reviewers,</p><p>Thank you for your helpful comments. We apologize for the errors in the manuscript. In response to your suggestions, we have revised the mentioned parts in the updated manuscript. We carefully considered the comments and tried our best to address every one of them. We hope that these changes and the enhanced text will meet your expectations. Attached ("Response to Reviewers.pdf"), you can find the detailed response to all comments. The changes have been highlighted in green (added) and yellow (changed).</p><supplementary-material id="pone.0318549.s002" position="float" content-type="local-data" orientation="portrait"><label>Attachment</label><caption><p>Submitted filename: <named-content content-type="submitted-filename">Response to Reviewers.pdf</named-content></p></caption><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="pone.0318549.s002.pdf" position="float" orientation="portrait"/></supplementary-material></body></sub-article><sub-article article-type="editor-report" id="pone.0318549.r004" specific-use="decision-letter"><front-stub><article-id pub-id-type="doi">10.1371/journal.pone.0318549.r004</article-id><title-group><article-title>Decision Letter 1</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Vashistha</surname><given-names initials="V">Vinod</given-names></name><role>Academic Editor</role></contrib></contrib-group><permissions><copyright-statement>&#169; 2025 Vinod Vashistha</copyright-statement><copyright-year>2025</copyright-year><copyright-holder>Vinod Vashistha</copyright-holder><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open access article distributed under the terms of the <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p></license></permissions><related-article xmlns:xlink="http://www.w3.org/1999/xlink" related-article-type="reviewed-article" id="rel-obj004" xml:lang="en" ext-link-type="doi" xlink:href="10.1371/journal.pone.0318549"/><custom-meta-group><custom-meta><meta-name>Submission Version</meta-name><meta-value>1</meta-value></custom-meta></custom-meta-group></front-stub><body><p>
<named-content content-type="letter-date">19 Jan 2025</named-content>
</p><p>A Simulation-Based Framework for Modeling and Prediction of Personalized Blood Pressure Trajectories in Hypertensive Patients after Antihypertensive Treatment</p><p>PONE-D-24-44640R1</p><p>Dear Dr. Hunsdieck,</p><p>We&#8217;re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.</p><p>Within one week, you&#8217;ll receive an e-mail detailing the required amendments. When these have been addressed, you&#8217;ll receive a formal acceptance letter and your manuscript will be scheduled for publication.</p><p>An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.editorialmanager.com/pone/" ext-link-type="uri">Editorial Manager&#174;</ext-link>&#160;and clicking the &#8216;Update My Information' link at the top of the page. If you have any questions relating to publication charges, please contact our Author Billing department directly at authorbilling@plos.org.</p><p>If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they&#8217;ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.</p><p>Kind regards,</p><p>Vinod Kumar Vashistha</p><p>Academic Editor</p><p>PLOS ONE</p><p>Additional Editor Comments (optional):</p><p>Reviewers' comments:</p></body></sub-article><sub-article article-type="editor-report" id="pone.0318549.r005" specific-use="acceptance-letter"><front-stub><article-id pub-id-type="doi">10.1371/journal.pone.0318549.r005</article-id><title-group><article-title>Acceptance letter</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Vashistha</surname><given-names initials="V">Vinod</given-names></name><role>Academic Editor</role></contrib></contrib-group><permissions><copyright-statement>&#169; 2025 Vinod Vashistha</copyright-statement><copyright-year>2025</copyright-year><copyright-holder>Vinod Vashistha</copyright-holder><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open access article distributed under the terms of the <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p></license></permissions><related-article xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="doi" xlink:href="10.1371/journal.pone.0318549" id="rel-obj005" related-article-type="reviewed-article"/></front-stub><body><p>PONE-D-24-44640R1</p><p>PLOS ONE</p><p>Dear Dr. Hunsdieck,</p><p>I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team.</p><p>At this stage, our production department will prepare your paper for publication. This includes ensuring the following:</p><p>* All references, tables, and figures are properly cited</p><p>* All relevant supporting information is included in the manuscript submission,</p><p>* There are no issues that prevent the paper from being properly typeset</p><p>If revisions are needed, the production department will contact you directly to resolve them. If no revisions are needed, you will receive an email when the publication date has been set. At this time, we do not offer pre-publication proofs to authors during production of the accepted work. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few weeks to review your paper and let you know the next and final steps.</p><p>Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.</p><p>If we can help with anything else, please email us at customercare@plos.org.</p><p>Thank you for submitting your work to PLOS ONE and supporting open access.</p><p>Kind regards,</p><p>PLOS ONE Editorial Office Staff</p><p>on behalf of</p><p>Dr. Vinod Kumar Vashistha</p><p>Academic Editor</p><p>PLOS ONE</p></body></sub-article></article></pmc-articleset>